Processing 00000000.tx.1: Distinct Binding Sites in the Structure of 2-Macroglobulin Mediate the Interaction with -Amyloid Peptide and Growth Factors* Joseph M. 

Phrase: "Distinct Binding Sites in the Structure of 2-Macroglobulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   764   C0005456:Binding Sites [Receptor]
   745   C2945843:Site of [Qualitative Concept]
   742   C0205145:Sites [Spatial Concept]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   731 E C0682969:Binding Site [Amino Acid Sequence]
   708 E C1515974:Site [Body Location or Region]
   708 E C2825164:Site [Spatial Concept]

Phrase: "Mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the Interaction with -Amyloid Peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "Growth Factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "* Joseph M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Mettenburg, Donna J. 

Phrase: "Mettenburg,"

Phrase: "Donna J."
Processing 00000000.tx.3: Webb, and Steven L. 

Phrase: "Webb,"

Phrase: "and"

Phrase: "Steven L."
Processing 00000000.tx.4: Gonias From the Departments of Biochemistry and Molecular Genetics, Cell Biology, and Pathology, University of Virginia School of Medicine, Charlottesville, Virginia 22908 Received for publication, July 18,2001, and in revised form, December 21,2001  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES 2-Macroglobulin (2M) and its receptor, low density lipoprotein receptor-related protein (LRP), function together to facilitate the cellular uptake and degradation of -amyloid peptide (A). 

Phrase: "Gonias From the Departments of Biochemistry"

Phrase: "and"

Phrase: "Molecular Genetics,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "Cell Biology,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "Pathology,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "University of Virginia School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "Charlottesville,"

Phrase: "Virginia 22908"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042753:Virginia [Geographic Area]
   861   C1256310:Virginia [Reptile]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "July 18,"

Phrase: "2001,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "December 21,"

Phrase: "2001  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "2-Macroglobulin (2M)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "its receptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "low density lipoprotein receptor-related protein (LRP),"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   901   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   901   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   895   C0242972:low protein [Therapeutic or Preventive Procedure]
   895   C0748025:low protein [Finding]
   861   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   827   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0178587:density [Quantitative Concept]
   799   C0205251:low [Qualitative Concept]
   799   C0439849:Related [Qualitative Concept]
   799   C0445223:Related [Finding]
   799   C1299352:Low [Qualitative Concept]
   799   C1550472:low [Idea or Concept]
   766 E C0163712:Relate [Organic Chemical]
   727 E C0080103:Relation [Family Group]
   727 E C0439794:Dense [Qualitative Concept]
   727 E C0869014:Relations [Social Behavior]

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "together to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883357:Together [Qualitative Concept]

Phrase: "facilitate"

Phrase: "the cellular uptake"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0007634:Cellular [Cell]
   861   C0178539:Cellular [Functional Concept]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]
   789 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "degradation of -amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.5: In this study, we demonstrate that A binds selectively to 2M that has been induced to undergo conformational change by reaction with methylamine. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that"

Phrase: "A"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "selectively to 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "undergo"

Phrase: "conformational change by reaction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0301641:Conformational change [Molecular Function]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "with methylamine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0066318:methylamine [Organic Chemical]
Processing 00000000.tx.6: Denatured 2M subunits, which were immobilized on polyvinylidene difluoride membranes, bound A, suggesting that 2M tertiary and quaternary structure are not necessary. 

Phrase: "Denatured"

Phrase: "2M subunits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1711351:Subunit [Quantitative Concept]

Phrase: "which"

Phrase: "were"

Phrase: "immobilized on polyvinylidene difluoride membranes,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0071710:polyvinylidene difluoride [Organic Chemical]
   760   C0025255:Membranes [Tissue]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "A,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "tertiary"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205372:Tertiary [Quantitative Concept]

Phrase: "and"

Phrase: "quaternary structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "are"

Phrase: "not necessary."
Processing 00000000.tx.7: To determine whether a specific sequence in 2M is responsible for A binding, we prepared and analyzed defined 2M fragments and glutathione S-transferase-2M peptide fusion proteins. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "a specific sequence in 2M"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]

Phrase: "is"

Phrase: "responsible for A binding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "we"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "2M fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "glutathione S-transferase-2M peptide fusion proteins."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0332466:Fusion [Functional Concept]
   793   C1293131:Fusion [Therapeutic or Preventive Procedure]
   779   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.8: A single sequence, centered at amino acids (aa) 1314-1365, was identified as the only major A-binding site. 

Phrase: "A single sequence,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "centered at amino acids (aa) 1314-1365,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   753   C0205099:centered [Spatial Concept]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "was"

Phrase: "identified as the only major A-binding site."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0005456:Binding Site [Receptor]
   770   C0682969:Binding Site [Amino Acid Sequence]
   744   C0205145:Site [Spatial Concept]
   744   C0205164:Major [Qualitative Concept]
   744   C0205171:Only [Quantitative Concept]
   744   C0205396:Identified [Qualitative Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1515974:Site [Body Location or Region]
   744   C1550043:Identified [Finding]
   744   C1551388:Identified [Functional Concept]
   744   C1720467:Only [Intellectual Product]
   744   C2825164:Site [Spatial Concept]
Processing 00000000.tx.9: Importantly, A did not bind to the previously characterized growth factor-binding site (aa 718-734). 

Phrase: "Importantly,"

Phrase: "A"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind to the previously characterized growth factor-binding site"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   790   C1149299:Growth Factor Binding [Molecular Function]
   764   C0005456:Binding Site [Receptor]
   764   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0682969:Binding Site [Amino Acid Sequence]
   742   C0018270:'growth' NOS [Organism Function]
   742   C0205145:Site [Spatial Concept]
   742   C0220844:growth [Physiologic Function]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Bind [Activity]
           Binding
   742   C1167622:Binding [Molecular Function]
           bind
   742   C1515974:Site [Body Location or Region]
   742   C1521761:Factor [Functional Concept]
   742   C1621966:Growth [Organ or Tissue Function]
   742   C1880022:Characterized [Activity]
   742   C2825164:Site [Spatial Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C2911660:Growth [Activity]

Phrase: "(aa 718-734"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.10: Although the A binding sequence is adjacent to the binding site for LRP, the results of experiments with mutated fusion proteins indicate that the two sites are distinct. 

Phrase: "Although"

Phrase: "the A binding sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "adjacent to the binding site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0205117:Adjacent to [Spatial Concept]
           Adjacent

Phrase: "for LRP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the results of experiments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   761   C2825142:Experimental Result [Finding]
           Result
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]

Phrase: "with mutated fusion proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   896   C0298973:mutated protein [Amino Acid, Peptide, or Protein,Enzyme]
   867   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332466:Fusion [Functional Concept]
   827   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "indicate"

Phrase: "that"

Phrase: "the two sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "distinct."
Processing 00000000.tx.11: Furthermore, a saturating concentration of A did not inhibit LRP-mediated clearance of 2M-MA in mice. 

Phrase: "Furthermore,"

Phrase: "a saturating concentration of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "LRP-mediated clearance of 2M-MA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0449297:Clearance [Qualitative Concept]
   739   C1382187:Clearance [Clinical Attribute]
   739   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.12: Using various methods, we determined that the KD for the interaction of A with its binding site in the individual 2M subunit is 0.7-2.4 M. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "various methods,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "we"

Phrase: "determined"

Phrase: "that"

Phrase: "the KD for the interaction of A with its binding site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0026691:KD [Disease or Syndrome]
   738   C1705240:KD [Gene or Genome]
   738   C1839259:KD [Disease or Syndrome]

Phrase: "in the individual 2M subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1711351:Subunit [Quantitative Concept]

Phrase: "is"

Phrase: "0.7-2.4 M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.13: The capacity of 2M to bind A and deliver it to LRP may be greater than that predicted by the KD, because each 2M subunit may bind A and the bound A may multimerize. 

Phrase: "The capacity of 2M to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1516240:Capacity [Quantitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "A"

Phrase: "and"

Phrase: "deliver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
  1000   C1705822:Deliver [Activity]
  1000   C1874964:DELIVER [Pharmacologic Substance]

Phrase: "it to LRP"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   790   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   783   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   753   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]

Phrase: "may"

Phrase: "be"

Phrase: "greater than that"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]

Phrase: "predicted by the KD,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0026691:KD [Disease or Syndrome]
   770   C0681842:Predicted [Idea or Concept]
   770   C1705240:KD [Gene or Genome]
   770   C1839259:KD [Disease or Syndrome]
   770   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "because"

Phrase: "each 2M subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "may"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "A"

Phrase: "and"

Phrase: "the bound A"

Phrase: "may"

Phrase: "multimerize."
Processing 00000000.tx.14: These studies suggest a model in which 2M has three protein interaction sites with distinct specificities, mediating the interaction with A, growth factors, and LRP.  

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a model in which 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3161035:Model [Intellectual Product]

Phrase: "has"

Phrase: "three protein interaction sites with distinct specificities,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0205145:Sites [Spatial Concept]
   716   C0449604:Specific site [Spatial Concept]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "the interaction with A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "growth factors,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "LRP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.15: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Accumulation of -amyloid peptide (A(1-40) and A(1-42))1 in the brain plays a central role in the development and progression of Alzheimer's disease (AD) (1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Accumulation of -amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A(1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "A(1-42"

Phrase: ")"

Phrase: ")"

Phrase: "1 in the brain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006104:Brain [Body Part, Organ, or Organ Component]
   770   C1269537:Brain [Body Part, Organ, or Organ Component]
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a central role in the development"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "progression of Alzheimer's disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0242656:Disease Progression [Pathologic Function]
           progression
   819   C1947900:Disease progression NOS [Finding]
   770   C0449258:Progression [Functional Concept]

Phrase: "(AD) (1"

Phrase: ")."
Processing 00000000.tx.16: Mutations in -amyloid precursor protein (APP), which result in increased production of A, are associated with autosomal dominant forms of familial AD in humans (2-4). 

Phrase: "Mutations in -amyloid precursor protein (APP),"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "which"

Phrase: "result in increased production of A,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0033268:production [Occupational Activity]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "are"

Phrase: "associated with autosomal dominant forms of familial AD"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   793   C0265385:AD - Autosomal dominant [Disease or Syndrome]
   793   C0443147:AD - Autosomal dominant [Intellectual Product]
           Autosomal dominant
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   750   C1832428:Familial form [Finding]
   744   C0015576:familial [Family Group]
   744   C0241888:Familial [Functional Concept]
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   744   C0596142:autosomal [Cell Component]
   744   C1527180:Dominant [Functional Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1522492:Form [Functional Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in humans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Humans [Human]

Phrase: "(2-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.17: Mutated forms of human APP may also induce changes consistent with AD when expressed as transgenes in mice (5-8). 

Phrase: "Mutated forms of human APP"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "may"

Phrase: "also"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "consistent with AD"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "when"

Phrase: "expressed as transgenes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0282641:Transgenes [Gene or Genome]

Phrase: "in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "(5-8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.18: Furthermore, immunization with A(1-42) prevents progression of AD in animal model systems and may reverse symptoms by promoting resorption of A-containing plaques (9, 10). 

Phrase: "Furthermore,"

Phrase: "immunization with A(1-42"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   760   C0042196:immunisation [Therapeutic or Preventive Procedure]
   760   C3244291:immunization [Functional Concept]

Phrase: ")"

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "progression of AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0242656:progression [Pathologic Function]
   790   C0449258:Progression [Functional Concept]

Phrase: "in animal model systems"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   884   C0026339:Model System [Intellectual Product,Research Device]
   884   C3161035:Model System [Intellectual Product]
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]
   734   C0599779:Animal Model [Animal]

Phrase: "and"

Phrase: "may"

Phrase: "reverse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "symptoms by promoting resorption of A-containing plaques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0683368:symptoms [Functional Concept]
   744   C1457887:Symptoms [Sign or Symptom]

Phrase: "(9,"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.19: These results suggest that A accumulation in the brain is a dynamic and reversible process. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "A accumulation in the brain"

Phrase: "is"

Phrase: "a dynamic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0729333:Dynamic [Functional Concept]

Phrase: "and"

Phrase: "reversible process."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.20: Proteins other than antibodies with the capacity to bind A and promote its catabolism may influence disease progression. 

Phrase: "Proteins other than antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   786   C1445860:Protein antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with the capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "A"

Phrase: "and"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "its catabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0543484:catabolism [Functional Concept]
  1000   C0699900:Catabolism [Organism Function]
  1000   C1516314:Catabolism [Physiologic Function]

Phrase: "may"

Phrase: "influence"

Phrase: "disease progression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0242656:Disease Progression [Pathologic Function]
           progression
  1000   C1947900:Disease progression NOS [Finding]
   861   C0449258:Progression [Functional Concept]
Processing 00000000.tx.21: 2-Macroglobulin (2M) is a 718-kDa homotetrameric glycoprotein, which is well characterized as an extracellular proteinase inhibitor (11) and as a carrier of specific growth factors, including transforming growth factor- (TGF-) and nerve growth factor- (NGF-) (12, 13). 

Phrase: "2-Macroglobulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "is"

Phrase: "a 718-kDa homotetrameric glycoprotein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]

Phrase: "which"

Phrase: "is"

Phrase: "well characterized as an extracellular proteinase inhibitor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205170:Well [Qualitative Concept]
   748   C1880022:Characterized [Activity]
   748   C3146287:Well [Manufactured Object]

Phrase: "(11"

Phrase: ")"

Phrase: "and as a carrier of specific growth factors,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   770   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750   C0960756:factor A [Organic Chemical]
   744   C0007294:Carrier [Finding]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0205369:Specific [Qualitative Concept]
   744   C0220844:growth [Physiologic Function]
   744   C0560175:Carrier [Finding]
   744   C1515981:And [Idea or Concept]
   744   C1552740:specific [Intellectual Product]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1706209:Carrier [Medical Device]
   744   C2911660:Growth [Activity]
   744   C3273162:Carrier [Intellectual Product]
   711   C1521761:Factor [Functional Concept]
   711   C2827422:Factor [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "transforming growth factor-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "nerve growth factor-"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   873   C0814002:Neural Growth [Cell Function,Organism Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C0220844:growth [Physiologic Function]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]

Phrase: "(12,"

Phrase: "13"

Phrase: ")."
Processing 00000000.tx.22: At least two separate polymorphisms in the A2M gene may be associated with increased risk of late-onset AD. 

Phrase: "At least two separate polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0032529:polymorphisms [Genetic Function]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in the A2M gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412046:A2M gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "may"

Phrase: "be"

Phrase: "associated with increased risk of late-onset AD."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0035647:Risk [Qualitative Concept]
   744   C0205087:Late [Temporal Concept]
   744   C0205217:Increased [Quantitative Concept]
   744   C0332162:Onset [Qualitative Concept]
   744   C0442805:Increased [Functional Concept]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.23: The first involves a region within intron 17,at the 5' splice acceptor site for exon 18(14). 

Phrase: "The first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "involves"

Phrase: "a region within intron 17,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]

Phrase: "at the 5' splice acceptor site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0887917:5' Splice Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   923   C0887918:Splice Acceptor Site [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0000901:acceptor [Population Group]
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "for exon 18"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.24: This exon is important because it encodes part of the bait region, where proteinases initiate reaction with 2M by cleaving susceptible peptide bonds (15, 16), and a segment of the growth factor binding sequence (17-19). 

Phrase: "This exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "is"

Phrase: "important"

Phrase: "because"

Phrase: "it"

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "part of the bait region,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1292711:Part of [Spatial Concept]
   760   C0449719:Part [Spatial Concept]
   760   C1709471:Part [Quantitative Concept]

Phrase: "where proteinases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827 E C1622131:proteinase [Molecular Function]
   827 E C1947941:Proteinase [Enzyme]

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "reaction with 2M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0443286:Reaction [Functional Concept]
   770   C1114821:Reaction [Clinical Attribute]

Phrase: "by cleaving susceptible peptide bonds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0678595:peptide bond [Natural Phenomenon or Process]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(15,"

Phrase: "16"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a segment of the growth factor binding sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0441635:Segment [Spatial Concept]

Phrase: "(17-19"

Phrase: ")."
Processing 00000000.tx.25: In the second A2M gene polymorphism, Val-1000 is replaced by Ile (20). 

Phrase: "In the second A2M gene polymorphism,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678951:gene polymorphism [Genetic Function]
   812   C0032529:Polymorphism [Genetic Function]
   812   C1882417:Polymorphism [Qualitative Concept]

Phrase: "Val-1000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042285:Val [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "replaced by Ile (20"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1299987:Replaced by [Functional Concept]
           replaced
   770   C0022192:Ile [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0523728:ILE [Laboratory Procedure]
   770   C0559956:Replaced [Functional Concept]
   737 E C1554078:Replace [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.26: The linkage of A2M gene polymorphisms to late-onset AD remains incompletely understood, because the original observations have been confirmed in only a limited number of populations (21-25) and because there is no molecular explanation regarding how A2M gene mutations may affect 2M structure, function, and expression. 

Phrase: "The linkage of A2M gene polymorphisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0023745:linkage [Molecular Function]

Phrase: "to late-onset AD"

Phrase: "remains"

Phrase: "incompletely"

Phrase: "understood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]

Phrase: ","

Phrase: "because"

Phrase: "the original observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "have"

Phrase: "been"

Phrase: "confirmed in only"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0205171:Only [Quantitative Concept]
   790   C0521093:confirmed [Qualitative Concept]
   790   C0750484:Confirmed [Idea or Concept]
   790   C1720467:Only [Intellectual Product]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "a limited number of populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "(21-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450347:21/25 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "because"

Phrase: "there"

Phrase: "is"

Phrase: "no molecular explanation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681841:Explanation [Intellectual Product]

Phrase: "regarding"

Phrase: "how A2M gene mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0596611:gene mutations [Genetic Function]
   861   C1412046:A2M gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "2M structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:Structure [Spatial Concept]

Phrase: "function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.27: 2M is expressed by microglia, which accumulate near amyloid plaques (26). 

Phrase: "2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "expressed by microglia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0206116:Microglia [Cell]
   718 E C0521398:Microglial [Body Location or Region]

Phrase: "which"

Phrase: "accumulate"

Phrase: "near amyloid plaques"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0333463:amyloid plaques [Acquired Abnormality]
           plaques
   901   C2936349:Plaques, Amyloid [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]

Phrase: "(26"

Phrase: ")."
Processing 00000000.tx.28: Thus, locally synthesized 2M may affect AD progression by regulating the activity of various proteinases or by binding important growth factors. 

Phrase: "Thus,"

Phrase: "locally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517927:Locally [Spatial Concept]

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "may"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "AD progression by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0242656:progression [Pathologic Function]
   790   C0449258:Progression [Functional Concept]

Phrase: "regulating"

Phrase: "the activity of various proteinases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   781   C1150095:proteinase activity [Molecular Function]
   781   C1622131:proteinase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "or by binding important growth factors."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   804   C1149299:Growth Factor Binding [Molecular Function]
   790   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0220844:growth [Physiologic Function]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2911660:Growth [Activity]
   719   C1521761:Factor [Functional Concept]
   719   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.29: The previously demonstrated ability of 2M to bind and neutralize the activity of TGF- (12, 13, 27-29) may be detrimental in AD, because TGF- stimulates A clearance by microglial cells and reduces A accumulation in the brain parenchyma of mice that overexpress human APP (30). 

Phrase: "The previously demonstrated ability of 2M to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0085732:Ability [Organism Attribute]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "neutralize"

Phrase: "the activity of TGF-"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   833   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   820   C1149472:growth factor activity [Molecular Function]
   790   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0018270:'growth' NOS [Organism Function]
   753   C0205177:Activity [Functional Concept]
   753   C0220844:growth [Physiologic Function]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1510411:Transforming [Pathologic Function]
   753   C1521761:Factor [Functional Concept]
   753   C1561536:*Activity [Idea or Concept]
   753   C1621966:Growth [Organ or Tissue Function]
   753   C2827422:Factor [Conceptual Entity]
   753   C2911660:Growth [Activity]

Phrase: "(12,"

Phrase: "13,"

Phrase: "27-29"

Phrase: ")"

Phrase: "may"

Phrase: "be"

Phrase: "detrimental in AD,"

Phrase: "because"

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "stimulates"

Phrase: "A clearance by microglial cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "reduces"

Phrase: "A accumulation in the brain parenchyma of mice"

Phrase: "that"

Phrase: "overexpress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:overexpress [Genetic Function]

Phrase: "human APP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   902   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.30: Furthermore, TGF- has been reported to antagonize the cytotoxic activity of A (29, 31, 32). 

Phrase: "Furthermore,"

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "antagonize"

Phrase: "the cytotoxic activity of A (29,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   753   C1511636:cytotoxic [Functional Concept]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "32"

Phrase: ")."
Processing 00000000.tx.31: Another mechanism whereby 2M may regulate AD progression involves its ability to bind A, forming a complex that is internalized by the 2M receptor, low density lipoprotein receptor-related protein (LRP) and then degraded (33-35). 

Phrase: "Another mechanism whereby 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "may"

Phrase: "regulate"

Phrase: "AD progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0242656:progression [Pathologic Function]
   861   C0449258:Progression [Functional Concept]

Phrase: "involves"

Phrase: "its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "A,"

Phrase: "forming"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205431:Forming [Functional Concept]
  1000   C1522492:Forming [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]

Phrase: "a complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "is"

Phrase: "internalized by the 2M receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "low density lipoprotein receptor-related protein"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   901   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   901   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   895   C0242972:low protein [Therapeutic or Preventive Procedure]
   895   C0748025:low protein [Finding]
   861   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   827   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0178587:density [Quantitative Concept]
   799   C0205251:low [Qualitative Concept]
   799   C0439849:Related [Qualitative Concept]
   799   C0445223:Related [Finding]
   799   C1299352:Low [Qualitative Concept]
   799   C1550472:low [Idea or Concept]
   766 E C0163712:Relate [Organic Chemical]
   727 E C0080103:Relation [Family Group]
   727 E C0439794:Dense [Qualitative Concept]
   727 E C0869014:Relations [Social Behavior]

Phrase: "(LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(33-35"

Phrase: ")."
Processing 00000000.tx.32: Du et al. 

Phrase: "Du et al."
Processing 00000000.tx.33: (36) originally reported that A(1-40) and A(1-42) bind to native 2M and to 2M that has been transformed into the LRP-recognized or "activated" conformation by reaction with methylamine (2M-MA). 

Phrase: "(36"

Phrase: ")"

Phrase: "originally"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that A(1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "A(1-42"

Phrase: ")"

Phrase: "bind to native 2M"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0302891:Native [Functional Concept]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]

Phrase: "and to 2M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1515981:And [Idea or Concept]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "transformed into the LRP-recognized or """
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   818   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   764   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   762   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   742   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C1510411:Transformed [Pathologic Function]

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: """ conformation by reaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0026377:Conformation [Spatial Concept]

Phrase: "with methylamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0066318:methylamine [Organic Chemical]

Phrase: "(2M-MA"

Phrase: ")."
Processing 00000000.tx.34: Narita et al. 

Phrase: "Narita et al."
Processing 00000000.tx.35: (33) subsequently reported selective binding of A(1-40) and A(1-42) to the activated conformation of 2M. 

Phrase: "(33"

Phrase: ")"

Phrase: "subsequently"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "selective binding of A(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: ")"

Phrase: "and"

Phrase: "A(1-42"

Phrase: ")"

Phrase: "to the activated conformation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026377:Conformation [Spatial Concept]

Phrase: "of 2M."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.36: 2M-MA apparently binds A(1-40) and A(1-42) with equivalent affinity (33). 

Phrase: "2M-MA apparently"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "A(1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "A(1-42"

Phrase: ")"

Phrase: "with equivalent affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.37: Hughes et al. 

Phrase: "Hughes et al."
Processing 00000000.tx.38: (37) executed a yeast two-hybrid screen using A(1-42) as bait and identified a 250-amino acid peptide from the C terminus of 2M as a strong and specific interactor. 

Phrase: "(37"

Phrase: ")"

Phrase: "executed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705848:Executed [Activity]
   966 E C3245498:execute [Functional Concept]

Phrase: "a yeast two-hybrid screen"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0599647:Two Hybrid [Molecular Biology Research Technique]
   812   C0020205:Hybrid [Organism]
   812   C0036025:yeast [Fungus]
   812   C0043392:Yeast [Food]
   812   C0043393:Yeast [Fungus]
   812   C0205448:Two [Quantitative Concept]
   812   C0220908:screen [Health Care Activity]
   812   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   812   C1305399:screen [Functional Concept]
   812   C1705053:Screen [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "A(1-42"

Phrase: ")"

Phrase: "as"

Phrase: "bait"

Phrase: "and"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a 250-amino acid peptide from the C terminus of 2M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   751   C0071642:peptide C [Amino Acid, Peptide, or Protein]
   736   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "as a strong"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0442821:Strong [Qualitative Concept]
   928 E C0237897:Strength [Quantitative Concept]
   928 E C0808080:Strength [Idea or Concept]
   928 E C1705922:Strength [Qualitative Concept]

Phrase: "and"

Phrase: "specific interactor."
Processing 00000000.tx.39: The same group also reported experiments confirming the interaction of A with intact 2M; 

Phrase: "The same group also reported experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0681814:Experiments [Research Activity]
   771 E C1706386:Experiment [Conceptual Entity]
   721 E C1517586:Experimental [Qualitative Concept]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the interaction of A with intact 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1704675:Interaction [Functional Concept]

Phrase: ";"
Processing 00000000.tx.40: however, they did not demonstrate that the sequence identified by yeast-two hybrid screen is responsible for the binding of A to intact 2M. 

Phrase: "however,"

Phrase: "they"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "identified by yeast-two hybrid screen"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0599647:Two Hybrid [Molecular Biology Research Technique]
   783   C2598686:Yeast identified [Laboratory or Test Result]
   753   C0020205:Hybrid [Organism]
   753   C0036025:yeast [Fungus]
   753   C0043392:Yeast [Food]
   753   C0043393:Yeast [Fungus]
   753   C0205396:Identified [Qualitative Concept]
   753   C0205448:Two [Quantitative Concept]
   753   C0220908:screen [Health Care Activity]
   753   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   753   C1305399:screen [Functional Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1705053:Screen [Medical Device]

Phrase: "is"

Phrase: "responsible for the binding of A to intact 2M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1273518:Responsible to [Finding]
           Responsible
Processing 00000000.tx.41: The growth factor binding site in 2M is contained within a 16-amino acid peptide located ~500 amino acids N-terminal to the A-binding site identified by yeast-two hybrid screen (19). 

Phrase: "The growth factor binding site in 2M"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   800   C1149299:Growth Factor Binding [Molecular Function]
   770   C0005456:Binding Site [Receptor]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0682969:Binding Site [Amino Acid Sequence]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0205145:Site [Spatial Concept]
   744   C0220844:growth [Physiologic Function]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1515974:Site [Body Location or Region]
   744   C1521761:Factor [Functional Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2825164:Site [Spatial Concept]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]

Phrase: "is"

Phrase: "contained within a 16-amino acid peptide"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C2917660:Amino Acid [Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0332256:contained [Functional Concept]
   748   C2700400:Contained [Activity]

Phrase: "located"

Phrase: "~500 amino acids N-terminal to the A-binding site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   781   C1706793:N-Terminal Amino Acid [Amino Acid Sequence]
   777   C1323338:N-terminal binding [Molecular Function]
   775   C3154958:amino-terminal binding [Molecular Function]
   739   C0205088:Terminal [Temporal Concept]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]

Phrase: "identified by yeast-two hybrid screen"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0599647:Two Hybrid [Molecular Biology Research Technique]
   783   C2598686:Yeast identified [Laboratory or Test Result]
   753   C0020205:Hybrid [Organism]
   753   C0036025:yeast [Fungus]
   753   C0043392:Yeast [Food]
   753   C0043393:Yeast [Fungus]
   753   C0205396:Identified [Qualitative Concept]
   753   C0205448:Two [Quantitative Concept]
   753   C0220908:screen [Health Care Activity]
   753   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   753   C1305399:screen [Functional Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1705053:Screen [Medical Device]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.42: The growth factor binding sequence is composed mainly of hydrophobic amino acids with two potentially important acidic residues. 

Phrase: "The growth factor binding sequence"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C1519249:Sequence [Functional Concept]
   756   C1149299:Growth Factor Binding [Molecular Function]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "composed"

Phrase: "mainly of hydrophobic amino acids"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   773 E C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acids [Chemical]
   760   C0598629:Hydrophobic [Qualitative Concept]
   726 E C0202406:Acid [Laboratory Procedure]

Phrase: "with two potentially important acidic residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   771   C1709915:Residue [Conceptual Entity]
   771   C1882936:RESIDUE [Phenomenon or Process]
   721 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.43: TGF-, platelet-derived growth factor-BB (PDGF-BB), and NGF- all interact with the growth factor-binding site in 2M (18, 19), despite the fact that these proteins demonstrate limited sequence identity. 

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: ","

Phrase: "platelet-derived growth factor-BB (PDGF-BB),"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
  1000   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   937   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0004739:BB [Geographic Area]
   804   C0005821:Platelet [Cell]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0332297:BB [Spatial Concept]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   804   C3245521:derived [Idea or Concept]
   721 E C1963076:Platelets [Finding]

Phrase: "and"

Phrase: "NGF-"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   873   C0814002:Neural Growth [Cell Function,Organism Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C0220844:growth [Physiologic Function]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]

Phrase: "all"

Phrase: "interact with the growth factor-binding site"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   814   C1149299:Growth Factor Binding [Molecular Function]
   778   C0005456:Binding Site [Receptor]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0682969:Binding Site [Amino Acid Sequence]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0205145:Site [Spatial Concept]
   748   C0220844:growth [Physiologic Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1515974:Site [Body Location or Region]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2825164:Site [Spatial Concept]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "in 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(18,"

Phrase: "19"

Phrase: ")"

Phrase: ","

Phrase: "despite the fact"

Phrase: "that"

Phrase: "these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "demonstrate"

Phrase: "limited sequence identity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0424215:Identity [Mental Process]
   827   C2003939:Identity [Finding]
Processing 00000000.tx.44: Based on this promiscuous behavior, we hypothesized that the growth factor-binding site in 2M may also function as an A-binding site. 

Phrase: "Based on this promiscuous behavior,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0562558:Promiscuous behavior [Social Behavior]
   760   C0004927:Behavior [Individual Behavior]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   760   C2707008:Behavior [Clinical Attribute]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "the growth factor-binding site in 2M"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   800   C1149299:Growth Factor Binding [Molecular Function]
   770   C0005456:Binding Site [Receptor]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0682969:Binding Site [Amino Acid Sequence]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0205145:Site [Spatial Concept]
   744   C0220844:growth [Physiologic Function]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1515974:Site [Body Location or Region]
   744   C1521761:Factor [Functional Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2825164:Site [Spatial Concept]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]

Phrase: "may"

Phrase: "also"

Phrase: "function as an A-binding site."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0005456:Binding Site [Receptor]
   790   C0682969:Binding Site [Amino Acid Sequence]
   753   C0031843:function [Physiologic Function]
   753   C0205145:Site [Spatial Concept]
   753   C0243122:binding [Functional Concept]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1515974:Site [Body Location or Region]
   753   C1705273:Function [Intellectual Product]
   753   C2825164:Site [Spatial Concept]
Processing 00000000.tx.45: To test our hypothesis, we undertook a comprehensive molecular analysis to identify sequences in 2M with A binding activity. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "our hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "we"

Phrase: "undertook"

Phrase: "a comprehensive molecular analysis to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1513380:Molecular Analysis [Molecular Biology Research Technique]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "identify"

Phrase: "sequences in 2M"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0162326:Sequences [Nucleotide Sequence]
   737 E C0004793:Sequence [Nucleotide Sequence]
   737 E C0162327:Sequence [Nucleotide Sequence]
   737 E C1519249:Sequence [Functional Concept]

Phrase: "with A binding activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2266866:Binding Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.46: Our results demonstrate that a single sequence, located near the C terminus of the 2M subunit, constitutes the only significant A-binding site. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "a single sequence,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "located near the C terminus of the 2M subunit,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C1711351:Subunit [Quantitative Concept]

Phrase: "constitutes"

Phrase: "the only significant A-binding site."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0005456:Binding Site [Receptor]
   840   C0682969:Binding Site [Amino Acid Sequence]
   804   C0205145:Site [Spatial Concept]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1515974:Site [Body Location or Region]
   804   C2825164:Site [Spatial Concept]
Processing 00000000.tx.47: Importantly, this sequence is entirely distinct from the growth factor-binding site. 

Phrase: "Importantly,"

Phrase: "this sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "entirely distinct from the growth factor-binding site."
Processing 00000000.tx.48: The LRP recognition sequence is also located near the C terminus of the 2M subunit (38-42); 

Phrase: "The LRP recognition sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   839   C0002518:Protein Sequence [Amino Acid Sequence]
   799   C0004793:Sequence [Nucleotide Sequence]
   799   C0162326:Sequence [Nucleotide Sequence]
   799   C0162327:Sequence [Nucleotide Sequence]
   799   C1519249:Sequence [Functional Concept]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   727 E C1548958:Sequential [Idea or Concept]
   727 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "also"

Phrase: "located near the C terminus of the 2M subunit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C1711351:Subunit [Quantitative Concept]

Phrase: "(38-42"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.49: however, our evidence indicates that the LRP recognition site and the A binding sequence are distinct. 

Phrase: "however,"

Phrase: "our evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "indicates"

Phrase: "that"

Phrase: "the LRP recognition site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   876   C0005456:Receptor site, NOS [Receptor]
   799   C0205145:Site [Spatial Concept]
   799   C0524637:Recognition [Mental Process]
   799   C1515974:Site [Body Location or Region]
   799   C2825164:Site [Spatial Concept]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "and"

Phrase: "the A binding sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "distinct."
Processing 00000000.tx.50: Thus, in addition to the bait region, the 2M subunit has at least three distinct "protein interaction sites" with distinct binding specificities. 

Phrase: "Thus,"

Phrase: "in addition to the bait region,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "the 2M subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "has at least three distinct ""protein interaction sites"""
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0872079:protein interaction [Molecular Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205145:Sites [Spatial Concept]
   744   C0205449:Three [Quantitative Concept]
   744   C1704675:Interaction [Functional Concept]
   744   C3539897:Has [Qualitative Concept]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "with distinct binding specificities."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   793   C0037791:Specificity [Quantitative Concept]
   793   C1511884:Specificity [Quantitative Concept]
   743 E C0205369:Specific [Qualitative Concept]
   743 E C1552740:specific [Intellectual Product]
Processing 00000000.tx.51: These sites mediate interactions with growth factors, A and LRP.  

Phrase: "These sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205145:Sites [Spatial Concept]
   966 E C1515974:Site [Body Location or Region]
   966 E C2825164:Site [Spatial Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "interactions with growth factors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1704675:Interaction [Functional Concept]

Phrase: "A"

Phrase: "and"

Phrase: "LRP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.52: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Proteins and Reagents-- 2M was purified from human plasma by the method of Imber and Pizzo (43). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "--"

Phrase: "2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "purified from human plasma"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0544357:Human plasma [Pharmacologic Substance]
   770   C0032105:Plasma [Body Substance]
   770   C0086418:Human [Human]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   770   C1998793:Purified [Functional Concept]

Phrase: "by the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "of Imber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3393516:Imber [Eukaryote]

Phrase: "and"

Phrase: "Pizzo"

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.53: 2M-MA was prepared by dialyzing 2M against 200mM methylamine-HCl in 50mM Tris-HCl, pH 8.2,for 12h at 22C and then exhaustively against 20mM sodium phosphate, 150mM NaCl, pH 7.4.

Phrase: "2M-MA"

Phrase: "was"

Phrase: "prepared by dialyzing 2M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   726   C1521827:Prepare [Functional Concept]

Phrase: "against 200mM methylamine-HCl"

Phrase: "in 50mM Tris-HCl,"

Phrase: "pH 8.2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "for 12h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0456695:/12h [Temporal Concept]

Phrase: "at 22C"

Phrase: "and"

Phrase: "then exhaustively against 20mM sodium phosphate,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   753   C1883708:Then [Temporal Concept]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "pH 7.4."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
Processing 00000000.tx.54: Modification of 2M by methylamine was confirmed by demonstrating the characteristic increase in 2M electrophoretic mobility by non-denaturing PAGE (15). 

Phrase: "Modification of 2M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392747:Modification [Functional Concept]
   770   C1554963:modification [Qualitative Concept]

Phrase: "by methylamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0066318:methylamine [Organic Chemical]

Phrase: "was"

Phrase: "confirmed by"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   833   C0750484:Confirmed [Idea or Concept]
   799 E C1456348:Confirm [Qualitative Concept]

Phrase: "demonstrating"

Phrase: "the characteristic increase in 2M electrophoretic mobility"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "by non-denaturing PAGE (15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C3494467:Non-Denaturing PAGE [Laboratory Procedure]
   812   C1518422:Non [Functional Concept]
   812   C1704732:Page [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.55: 2M-MA was radioiodinated using IODO-BEADs (Pierce) and stored at 4C for no more than 2weeks. 

Phrase: "2M-MA"

Phrase: "was"

Phrase: "radioiodinated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "IODO-BEADs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0991566:Beads [Biomedical or Dental Material]
   827 E C2346972:Bead [Spatial Concept]

Phrase: "(Pierce"

Phrase: ")"

Phrase: "and"

Phrase: "stored at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   756   C1698986:Store [Functional Concept]

Phrase: "for no more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "than 2weeks."
Processing 00000000.tx.56: The specific activity was 0.5-1.0 Ci/g. 

Phrase: "The specific activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205177:Activity [Functional Concept]
   861   C0205369:Specific [Qualitative Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1552740:specific [Intellectual Product]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "0.5-1.0 Ci/g."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2348019:Ci/g [Quantitative Concept]
Processing 00000000.tx.57: Receptor-associated protein (RAP), which blocks binding of 2M-MA to LRP (65), was expressed as a glutathione S-transferase (GST) fusion protein in bacteria and purified by chromatography on glutathione-Sepharose. 

Phrase: "Receptor-associated protein (RAP),"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   913   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]

Phrase: "which"

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "binding of 2M-MA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "expressed as a glutathione S-transferase (GST) fusion protein"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   800   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   770   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   767   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1418948:PROTEIN S [Gene or Genome]
   744   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0332466:Fusion [Functional Concept]
   744   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "in bacteria"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0004611:Bacteria [Bacterium]
  1000   C1510439:bacteria [Functional Concept]
  1000   C2347473:% Bacteria [Quantitative Concept]
   928 E C0521009:Bacterial [Qualitative Concept]

Phrase: "and"

Phrase: "purified by chromatography"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0008550:Chromatography [Laboratory Procedure]
   790   C1998793:Purified [Functional Concept]

Phrase: "on glutathione-Sepharose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036681:Sepharose [Carbohydrate]
Processing 00000000.tx.58: A(1-40) was purchased from Bachem and radioiodinated using 125I-labeled Bolton-Hunter reagent (di-iodinated, PerkinElmer Life Sciences). 

Phrase: "A(1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "was"

Phrase: "purchased from Bachem"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0869011:purchased [Activity]

Phrase: "and"

Phrase: "radioiodinated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "125I-labeled Bolton-Hunter reagent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0890573:Bolton-Hunter reagent, 125I-labeled [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   884   C0053915:Bolton-Hunter reagent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   804   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   804   C0239971:HUNTER [Professional or Occupational Group]

Phrase: "(di-iodinated, PerkinElmer Life Sciences"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0005526:Life Sciences [Occupation or Discipline]
   804   C0036397:Sciences [Occupation or Discipline]
   804   C0376558:Life [Idea or Concept]
   721 E C0595998:lives [Finding]

Phrase: ")."
Processing 00000000.tx.59: Biotinylated A(1-40) was prepared by reacting A(1-40) with 4M sulfo-N-hydroxysuccinimide biotin (Pierce) for 2h at 4C in siliconized tubes. 

Phrase: "Biotinylated"

Phrase: "A(1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "was"

Phrase: "prepared by reacting A(1-40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439509:/40 [Temporal Concept]
   719   C1521827:Prepare [Functional Concept]

Phrase: ")"

Phrase: "with 4M sulfo-N-hydroxysuccinimide biotin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   937   C0084682:sulfo-N-hydroxysuccinimide-biotin [Organic Chemical]
   804   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   804   C2700256:Biotin [Laboratory Procedure]

Phrase: "(Pierce"

Phrase: ")"

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "in siliconized tubes."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0175730:tubes [Medical Device]
   861   C1547937:Tubes [Intellectual Product]
   861   C1704474:Tubes [Quantitative Concept]
   827 E C1561954:tube [Conceptual Entity]
   827 E C1704730:TUBE [Medical Device]
Processing 00000000.tx.60: The reaction mixture was dialyzed extensively against water. 

Phrase: "The reaction mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "dialyzed"

Phrase: "extensively against water."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   790   C0599638:WATER [Substance]
   790   C1550678:Water [Inorganic Chemical]
   718 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.61: Biotinylated A was stored for up to 1month at 4C or frozen at 80C and thawed once without affecting its ability to bind to 2M. 

Phrase: "Biotinylated"

Phrase: "A"

Phrase: "was"

Phrase: "stored for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1698986:Store [Functional Concept]

Phrase: "up to 1month"

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "or"

Phrase: "frozen at 80C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0016701:Frozen [Natural Phenomenon or Process]
   790   C0677542:Frozen [Functional Concept]

Phrase: "and"

Phrase: "thawed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710378:Thaw [Laboratory Procedure]

Phrase: "once without affecting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0392760:Affecting [Functional Concept]
   790   C1314939:Affecting [Functional Concept]
   790   C1720092:Once [Intellectual Product]
   790   C1948045:Once [Temporal Concept]
   756 E C0001721:Affect [Mental Process]

Phrase: "its ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "bind to 2M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
Processing 00000000.tx.62: GST-specific IgG, bovine serum albumin (BSA, greater than 99% pure), dithiothreitol (DTT), and iodoacetamide were from Sigma Chemical Co. 

Phrase: "GST-specific IgG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "(BSA,"

Phrase: "greater than 99% pure"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0439093:Greater Than [Quantitative Concept]
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "dithiothreitol (DTT),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "iodoacetamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021973:Iodoacetamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "were from Sigma Chemical Co."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220806:Chemical [Chemical]
   760   C1719918:Sigma [Intellectual Product]
   760   C3272558:Chemical [Intellectual Product]
Processing 00000000.tx.63: Bis(sulfosuccinimidyl) suberate (BS3) and horseradish peroxidase-conjugated avidin were from Pierce. 

Phrase: "Bis("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0556985:BIS [Temporal Concept]
  1000   C2247301:BIS [Molecular Function]
  1000   C3540495:BIS [Intellectual Product]

Phrase: "sulfosuccinimidyl"

Phrase: ")"

Phrase: "suberate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0947344:Suberate [Organic Chemical]

Phrase: "(BS3"

Phrase: ")"

Phrase: "and"

Phrase: "horseradish peroxidase-conjugated avidin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0004434:Avidin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were from Pierce."
Processing 00000000.tx.64: Polyclonal A-specific rabbit antibody was from Zymed Laboratories Inc. 

Phrase: "Polyclonal A-specific rabbit antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   897   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   853   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was from Zymed Laboratories Inc."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1421478:WAS [Gene or Genome]
   760   C1619828:Laboratories [Intellectual Product]
   726 E C3244292:laboratory [Functional Concept]
Processing 00000000.tx.65: Methods for Defined Fragmentation of 2M-- When 2M is treated with papain under mildly acidic conditions, an 18-kDa fragment is released from the C terminus of each 2M subunit (aa 1314-1451) (38). 

Phrase: "Methods for Defined Fragmentation of 2M"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   789   C0449354:Method of fragmentation [Intellectual Product]
   748   C0025663:Methods [Intellectual Product]
   748   C0025664:methods [Intellectual Product]
   748   C0449851:Methods [Functional Concept]
   714 E C0871511:METHOD [Intellectual Product]

Phrase: "-"

Phrase: "-"

Phrase: "When"

Phrase: "2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "treated with papain"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0030346:Papain [Enzyme,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "under mildly acidic conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "an 18-kDa fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "released from the C terminus of each 2M subunit"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   739   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0391871:Released [Functional Concept]
   739   C1283071:Released [Functional Concept]
   739   C1711351:Subunit [Quantitative Concept]
   706 E C0030685:Release [Health Care Activity]
   706 E C0439180:% release [Quantitative Concept]
   706 E C0680255:release [Health Care Activity]
   706 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(aa 1314-1451"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.66: The 18-kDa fragment includes the intact receptor-binding site and is thus referred to as the receptor binding fragment (RBF). 

Phrase: "The 18-kDa fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the intact receptor-binding site"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   875   C0005456:Receptor site, NOS [Receptor]
           Binding Site
   861   C0597358:Receptor Binding [Molecular Function]
   861   C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "is"

Phrase: "thus"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "the receptor binding fragment (RBF)."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0597358:Receptor Binding [Molecular Function]
   827   C0243122:binding [Functional Concept]
   827   C0332255:fragment [Functional Concept]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.67: The residual 600-kDa 2M remnant retains the major structural features of the parent molecule (45). 

Phrase: "The residual 600-kDa 2M remnant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C3272697:Remnant [Embryonic Structure]

Phrase: "retains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "the major structural features of the parent molecule"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   711   C1521970:Feature [Qualitative Concept]
   711   C1706388:Feature [Conceptual Entity]
   711   C2346469:Feature [Qualitative Concept]
   711   C2348519:Feature [Qualitative Concept]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.68: To obtain the 18-and 600-kDa 2M fragments, 4.0M 2M-MA was treated with 2.4M papain in 50mM sodium acetate, 1mM cysteine, pH 5.0,for 20h at 22C. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the 18-"

Phrase: "and"

Phrase: "600-kDa 2M fragments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0332255:fragments [Functional Concept]
   804   C0486805:Fragments [Body Substance]
   771 E C1708096:Fragment [Qualitative Concept]

Phrase: "4.0M 2M-MA"

Phrase: "was"

Phrase: "treated with 2.4M papain"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0030346:Papain [Enzyme,Pharmacologic Substance]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "in 50mM sodium acetate,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0142785:Sodium Acetate [Organic Chemical,Pharmacologic Substance]
   827   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   827   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "1mM cysteine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "pH 5.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "for 20h"

Phrase: "at 22C."
Processing 00000000.tx.69: The pH of the reaction mixture was increased to 7.4,and the products were purified by molecular exclusion chromatography on Ultrogel AcA-22. 

Phrase: "The pH of the reaction mixture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0020283:[pH] [Quantitative Concept]
   753   C0450407:ph+ [Finding]
   753   C0450408:ph++ [Finding]
   753   C0450409:ph+++ [Finding]

Phrase: "was"

Phrase: "increased to 7.4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: "and"

Phrase: "the products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "purified by molecular exclusion chromatography"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0008559:Chromatography, Exclusion [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0680251:EXCLUSION [Functional Concept]
   760   C1521991:Molecular [Qualitative Concept]
   760   C1998793:Purified [Functional Concept]
   760   C2828389:Exclusion [Activity]

Phrase: "on Ultrogel AcA-22."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0149561:ACA [Body Part, Organ, or Organ Component]
Processing 00000000.tx.70: Each 2M subunit has a single thiol ester bond formed by the side chains of Cys-949 and Gln-952 (11, 46, 47). 

Phrase: "Each 2M subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "has"

Phrase: "a single thiol ester bond"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   902   C0759863:single bond [Organic Chemical,Pharmacologic Substance]

Phrase: "formed by the side chains of Cys-949"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205431:Formed [Functional Concept]
   744   C0337112:chains [Manufactured Object]
   744   C0441987:Side [Spatial Concept]
   744   C1524075:Chains [Idea or Concept]
   711 E C0348078:Form [Qualitative Concept]
   711 E C0376315:Form [Manufactured Object]
   711 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "Gln-952"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017797:Gln [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(11,"

Phrase: "46,"

Phrase: "47"

Phrase: ")."
Processing 00000000.tx.71: When 2M is heated in the presence of SDS, the thiol esters react internally, and, as a result, the 2M peptide backbone is cleaved (47, 48). 

Phrase: "When"

Phrase: "2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "heated in the presence of SDS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   719   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "the thiol esters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014898:Esters [Organic Chemical]
   861   C0038734:thiol [Organic Chemical]

Phrase: "react"

Phrase: "internally,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205102:Internally [Spatial Concept]

Phrase: "and"

Phrase: ","

Phrase: "as"

Phrase: "a result,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "the 2M peptide backbone"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037949:Backbone [Body Part, Organ, or Organ Component]
   812   C1267072:Backbone [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "(47,"

Phrase: "48"

Phrase: ")."
Processing 00000000.tx.72: The products include a 120-kDa N-terminal heat fragment and a 60-kDa C-terminal heat fragment. 

Phrase: "The products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "a 120-kDa N-terminal heat fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332255:fragment [Functional Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "a 60-kDa C-terminal heat fragment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332255:fragment [Functional Concept]
   799   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.73: To produce 2M heat fragments, native 2M was incubated at 100C in 2% SDS (w/v) and 14mM DTT for the indicated periods of time. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "2M heat fragments,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0332255:fragments [Functional Concept]
   812   C0486805:Fragments [Body Substance]
   779 E C1708096:Fragment [Qualitative Concept]
   708   C0093056:2-HEAT [Organic Chemical,Pharmacologic Substance]

Phrase: "native 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "incubated at 100C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "in 2% SDS (w/v"

Phrase: ")"

Phrase: "and"

Phrase: "14mM DTT for the indicated periods of time."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.74: The products were treated with iodoacetamide (70mM) and subjected to SDS-PAGE. 

Phrase: "The products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "treated with iodoacetamide"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021973:Iodoacetamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(70mM"

Phrase: ")"

Phrase: "and"

Phrase: "subjected to SDS-PAGE."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.75: 2M-peptide-GST Fusion Proteins-- Six previously described fusion proteins, which collectively encode amino acids 99-1451 of the human 2M sequence, were expressed in BL-21 cells (17, 18). 

Phrase: "2M-peptide-GST Fusion Proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0332466:Fusion [Functional Concept]
   793   C1293131:Fusion [Therapeutic or Preventive Procedure]
   779   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "--"

Phrase: "Six previously described fusion proteins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "which collectively"

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "amino acids 99-1451 of the human 2M sequence,"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   761   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   760   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   739   C0001128:Acids [Chemical]
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0086418:Human [Human]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C1519249:Sequence [Functional Concept]
   726 E C2917660:Amino Acid [Pharmacologic Substance]
   706 E C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "expressed in BL-21 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0006413:BL [Neoplastic Process]
   760   C0007634:Cells [Cell]
   760   C1552663:BL [Idea or Concept]
   760   C2827109:BL [Geographic Area]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.76: These fusion proteins include: FP1 (aa 99-392), FP2 (aa 341-590), FP3 (aa 591-774), FP4 (aa 775-1059), FP5 (aa 1030-1279), and FP6 (aa 1242-1451). 

Phrase: "These fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: ":"

Phrase: "FP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0628612:FP-1 [Organic Chemical,Pharmacologic Substance]

Phrase: "(aa 99-392"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "FP2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0628615:FP-2 [Organic Chemical,Pharmacologic Substance]

Phrase: "(aa 341-590"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "FP3"

Phrase: "(aa 591-774"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "FP4"

Phrase: "(aa 775-1059"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "FP5"

Phrase: "(aa 1030-1279"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "FP6"

Phrase: "(aa 1242-1451"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.77: Constructs encoding new GST fusion proteins, including FP6a (aa 1242-1365), FP6b (aa 1242-1400), and FP6c (aa 1365-1451), were generated using PCR and the intact A2M cDNA in pBluescript as a template. 

Phrase: "Constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "new GST fusion proteins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0332466:Fusion [Functional Concept]
   799   C1293131:Fusion [Therapeutic or Preventive Procedure]
   793   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "FP6a"

Phrase: "(aa 1242-1365"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "FP6b"

Phrase: "(aa 1242-1400"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "FP6c"

Phrase: "(aa 1365-1451"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "and"

Phrase: "the intact A2M cDNA in pBluescript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as a template."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0728990:TEMPLATE [Medical Device]
  1000   C1514575:Template [Conceptual Entity]
  1000   C1705542:Template [Idea or Concept]
Processing 00000000.tx.78: The oligonucleotides included recognition sequences for BamHI and EcoRI, to allow direct cloning into the vector, pGEX-2T. 

Phrase: "The oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0524637:Recognition [Mental Process]

Phrase: "sequences for BamHI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004793:Sequence [Nucleotide Sequence]
   790   C0162326:Sequence [Nucleotide Sequence]
   790   C0162327:Sequence [Nucleotide Sequence]
   790   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "EcoRI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011516:Eco-RI [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "direct cloning into the vector,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0086022:Cloning Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0009015:Cloning [Research Activity]

Phrase: "pGEX-2T."
Processing 00000000.tx.79: Final constructs were subjected to sequence analysis to verify proper orientation and reading frame. 

Phrase: "Final constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "subjected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "to sequence analysis to"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   861   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C0936012:Analysis [Research Activity]
   812   C1519249:Sequence [Functional Concept]
   812   C1524024:analysis [Functional Concept]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]

Phrase: "verify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711411:Verify [Functional Concept]

Phrase: "proper orientation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0029266:Orientation [Mental Process]
   861   C1704322:orientation [Spatial Concept]
   861   C1704972:Orientation [Spatial Concept]
   861   C3539923:Orientation [Intellectual Product]

Phrase: "and"

Phrase: "reading frame."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0080089:Reading Frame [Nucleotide Sequence]
           Frame
   861   C0034754:Reading [Daily or Recreational Activity]
   861   C0180979:Frame [Medical Device]
   861   C1705179:Reading [Finding]
   861   C1705858:Frame [Manufactured Object]
Processing 00000000.tx.80: Two constructs, labeled FP6d, correspond in sequence exactly to the 18-kDa RBF (aa 1314-1451). 

Phrase: "Two constructs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "labeled FP6d,"

Phrase: "correspond in sequence exactly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]

Phrase: "to the 18-kDa RBF"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0597358:Receptor Binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C0332255:fragment [Functional Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "(aa 1314-1451"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.81: In FP6d-AA, Lys residues at aa 1370and 1374,which are critical for LRP binding (39, 40), were mutated to Ala, using the QuikChange system (Stratagene). 

Phrase: "In FP6d-AA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "Lys residues at aa 1370and 1374,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1709915:Residue [Conceptual Entity]
   714   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "which"

Phrase: "are"

Phrase: "critical for LRP binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511545:Critical [Qualitative Concept]

Phrase: "(39,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "mutated to Ala,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1705285:Mutated [Cell or Molecular Dysfunction]
   756 E C1513776:Mutate [Genetic Function]
   718   C0702172:Alar [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the QuikChange system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "(Stratagene"

Phrase: ")."
Processing 00000000.tx.82: In FP6d-AR, Lys-1370 was mutated to Ala, and Lys-1374 was mutated to Arg. 

Phrase: "In FP6d-AR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986463:AR+ [Finding]

Phrase: "Lys-1370"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024337:Lys [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "mutated to Ala,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1705285:Mutated [Cell or Molecular Dysfunction]
   756 E C1513776:Mutate [Genetic Function]
   718   C0702172:Alar [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "and"

Phrase: "Lys-1374"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024337:Lys [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "mutated to Arg."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1705285:Mutated [Cell or Molecular Dysfunction]
   756 E C1513776:Mutate [Genetic Function]
Processing 00000000.tx.83: All of the fusion proteins were partially purified from induced bacterial suspensions by selective detergent extraction, as previously described (17). 

Phrase: "All of the fusion proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   773   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332466:Fusion [Functional Concept]
   760   C0444868:All [Quantitative Concept]
   760   C1293131:Fusion [Therapeutic or Preventive Procedure]
   760   C3539085:All [Idea or Concept]

Phrase: "were"

Phrase: "partially"

Phrase: "purified from induced bacterial suspensions"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0038960:Suspensions [Biomedical or Dental Material]
   760   C0205263:Induced [Functional Concept]
   760   C0521009:Bacterial [Qualitative Concept]
   760   C1998793:Purified [Functional Concept]
   726 E C1382107:Suspension [Substance]
   726 E C1705537:Suspension [Functional Concept]

Phrase: "by selective detergent extraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185115:Extraction [Therapeutic or Preventive Procedure]
   827   C0684295:extraction [Laboratory Procedure]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.84: The resulting preparations yielded clearly defined bands, with the correct molecular masses when assessed by Coomassie Blue staining of SDS gels or immunoblot analysis with GST-specific antibody. 

Phrase: "The resulting preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "yielded"

Phrase: "clearly defined bands,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0175723:Bands [Medical Device]
   793 E C0439645:Band [Spatial Concept]
   793 E C1521913:band [Cell Component]

Phrase: "with the correct molecular masses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   793   C0577559:Mass [Finding]
   793   C1306372:*Mass [Quantitative Concept]

Phrase: "when"

Phrase: "assessed by Coomassie Blue staining of SDS gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   744   C0017243:Gels [Biomedical or Dental Material]
   744   C0487602:Staining [Laboratory Procedure]
   744   C1260957:Blue [Qualitative Concept]
   744   C1516048:Assessed [Activity]
   744   C1704680:Staining [Finding]
   711 E C1382104:Gel [Substance]

Phrase: "or"

Phrase: "immunoblot analysis with GST-specific antibody."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
Processing 00000000.tx.85: FP3, FP6, and FP6d-AA were purified to homogeneity by chromatography on glutathione-Sepharose. 

Phrase: "FP3,"

Phrase: "FP6,"

Phrase: "and"

Phrase: "FP6d-AA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "were"

Phrase: "purified to homogeneity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1881065:Homogeneity [Qualitative Concept]
   790   C1998793:Purified [Functional Concept]

Phrase: "by chromatography"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008550:Chromatography [Laboratory Procedure]
   900 E C0302647:chromatograph [Medical Device]

Phrase: "on glutathione-Sepharose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036681:Sepharose [Carbohydrate]
Processing 00000000.tx.86: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.87: 1 shows the sequences of the GST fusion proteins used in this investigation. 

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the sequences of the GST fusion proteins"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   745   C0002518:protein sequences [Amino Acid Sequence]
   742   C0162326:Sequences [Nucleotide Sequence]
   708 E C0004793:Sequence [Nucleotide Sequence]
   708 E C0162327:Sequence [Nucleotide Sequence]
   708 E C1519249:Sequence [Functional Concept]

Phrase: "used in this investigation."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C1261322:Investigation [Health Care Activity]
   770   C1273517:used [Finding]
   770   C1552578:investigation [Idea or Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.88: View larger version (20K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.89: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.90: Sequences of GST-2M peptide fusion proteins. 

Phrase: "Sequences of GST-2M peptide fusion proteins."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   741   C0002518:protein sequences [Amino Acid Sequence]
   741   C0920679:peptide sequence [Amino Acid Sequence]
   739   C0162326:Sequences [Nucleotide Sequence]
   706 E C0004793:Sequence [Nucleotide Sequence]
   706 E C0162327:Sequence [Nucleotide Sequence]
   706 E C1519249:Sequence [Functional Concept]
Processing 00000000.tx.91: The 18-kDa RBF was purified after proteolytic dissociation from intact 2M-MA. 

Phrase: "The 18-kDa RBF"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0597358:Receptor Binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C0332255:fragment [Functional Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "was"

Phrase: "purified after proteolytic dissociation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   770   C0597304:Proteolytic [Molecular Function]
   770   C1947941:proteolytic [Enzyme]
   770   C1998793:Purified [Functional Concept]

Phrase: "from intact 2M-MA."
Processing 00000000.tx.92: All of the other GST fusion proteins were expressed in bacteria. 

Phrase: "All of the"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444868:All [Quantitative Concept]
   790   C3539085:All [Idea or Concept]

Phrase: "other GST fusion proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   804   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0332466:Fusion [Functional Concept]
   804   C1293131:Fusion [Therapeutic or Preventive Procedure]
   717   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "expressed in bacteria."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0004611:Bacteria [Bacterium]
   790   C1510439:bacteria [Functional Concept]
   790   C2347473:% Bacteria [Quantitative Concept]
   718 E C0521009:Bacterial [Qualitative Concept]
Processing 00000000.tx.93: The mutations in FP6d are in amino acids 1370and 1374.

Phrase: "The mutations in FP6d"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are in amino acids 1370and 1374."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   753   C1551058:Are [Quantitative Concept]
   719 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.94: The vertical lines show the relationship between the sequences of the fusion proteins and the amino acids that constitute the helix, which is the center of the LRP recognition sequence in 2M. 

Phrase: "The vertical lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the relationship between the sequences of the fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0439849:Relationship [Qualitative Concept]
   742   C1705630:Relationship [Idea or Concept]
   742   C1706279:Relationship [Idea or Concept]
   742   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "the amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "that"

Phrase: "constitute"

Phrase: "the helix,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018882:Helix [Eukaryote]
  1000   C0229304:Helix [Body Part, Organ, or Organ Component]
  1000   C1704821:Helix [Spatial Concept]
  1000   C1705682:Helix [Anatomical Structure]

Phrase: "which"

Phrase: "is"

Phrase: "the center of the LRP recognition sequence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205099:Center [Spatial Concept]

Phrase: "in 2M."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.95: Non-denaturing PAGE Analysis of A Binding to 2M-- 125I-A (2.5nM) was incubated with native 2M, 2M-MA, or the purified 600-kDa fragment (0.3-1.0 M) in 20mM sodium phosphate, 150mM NaCl, pH 7.4,for 2h at 37C. 

Phrase: "Non-denaturing PAGE Analysis of A Binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "to 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "--"

Phrase: "125I-A (2.5nM"

Phrase: ")"

Phrase: "was"

Phrase: "incubated with native 2M,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0302891:Native [Functional Concept]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "2M-MA,"

Phrase: "or"

Phrase: "the purified 600-kDa fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "(0.3-1.0"

Phrase: "M) in 20mM sodium phosphate,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.96: In some experiments, increasing concentrations of the 18-kDa RBF (0.2-2.8 M) were co-incubated with 125I-A and 2M-MA. 

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "concentrations of the 18-kDa RBF"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0086045:Concentrations [Mental Process]
   711 E C1446561:Concentration [Quantitative Concept]

Phrase: "(0.2-2.8"

Phrase: "M)"

Phrase: "were"

Phrase: "co-incubated with 125I-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "A"

Phrase: "and"

Phrase: "2M-MA."
Processing 00000000.tx.97: Reaction mixtures were subjected to non-denaturing PAGE, using the buffer system described by Van Leuven et al. 

Phrase: "Reaction mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "were"

Phrase: "subjected to non-denaturing PAGE,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C3494467:Non-Denaturing PAGE [Laboratory Procedure]
   760   C1518422:Non [Functional Concept]
   760   C1704732:Page [Intellectual Product]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the buffer system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "described by Van Leuven et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557775:Van [Manufactured Object]
   753   C1552738:described [Idea or Concept]
Processing 00000000.tx.98: (49). 

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.99: 125I-A binding to 2M was detected as radioactivity co-migrating with the 2M band. 

Phrase: "125I-"

Phrase: "A binding to 2M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "detected as radioactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0034553:Radioactivity [Natural Phenomenon or Process]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "co-migrating with the 2M band."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0175723:Band [Medical Device]
   748   C0232902:migrating [Functional Concept]
   748   C0439645:Band [Spatial Concept]
   748   C1521913:band [Cell Component]
Processing 00000000.tx.100: In control experiments, free 125I-A did not migrate near 2M. 

Phrase: "In control experiments,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009932:control experiments [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0681814:Experiments [Research Activity]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "free 125I-"

Phrase: "A"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "migrate near 2M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0232902:migrate [Functional Concept]
Processing 00000000.tx.101: To quantitate 125I-A binding to 2M, gels were subjected to PhosphorImager analysis using ImageQuant software. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "quantitate"

Phrase: "125I-"

Phrase: "A binding to 2M,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "subjected to PhosphorImager analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ImageQuant software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.102: Non-denaturing PAGE preserves non-covalent interactions; 

Phrase: "Non-denaturing PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3494467:Non-Denaturing PAGE [Laboratory Procedure]
   827   C1704732:Page [Intellectual Product]

Phrase: "preserves"

Phrase: "non-covalent interactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1511539:Covalent Interaction [Molecular Function]
   793   C1704675:Interaction [Functional Concept]

Phrase: ";"
Processing 00000000.tx.103: however, the amount of binding detected may be influenced by dissociation of protein complexes during electrophoresis (13). 

Phrase: "however,"

Phrase: "the amount of binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "be"

Phrase: "influenced by dissociation of protein complexes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   767   C1180347:complex protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756 E C1523872:protein complex [Cell Component]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   753   C1704241:Complexes [Chemical Viewed Structurally]
   719 E C0439855:Complex [Qualitative Concept]

Phrase: "during electrophoresis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.104: Determination of Apparent Equilibrium Dissociation Constants-- Because A binding to 2M is reversible and probably subject to rapid dissociation when methods such as non-denaturing PAGE or chromatography are used, we utilized the BS3 rapid cross-linking method to determine the apparent KD for the binding of A to 2M-MA. 

Phrase: "Determination of Apparent Equilibrium Dissociation Constants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1148554:determination [Laboratory Procedure]

Phrase: "-"

Phrase: "-"

Phrase: "Because"

Phrase: "A binding to 2M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "reversible"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205343:Reversible [Functional Concept]
   928 E C0449261:Reversibility [Temporal Concept]

Phrase: "and"

Phrase: "probably subject to rapid dissociation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   760   C0439831:Rapid [Qualitative Concept]
   760   C0681850:Subject [Group]
   760   C0750492:Probably [Idea or Concept]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]

Phrase: "when"

Phrase: "methods such as non-denaturing PAGE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0025663:Methods [Intellectual Product]
   753   C0025664:methods [Intellectual Product]
   753   C0449851:Methods [Functional Concept]
   719 E C0871511:METHOD [Intellectual Product]

Phrase: "or"

Phrase: "chromatography"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008550:Chromatography [Laboratory Procedure]
   900 E C0302647:chromatograph [Medical Device]

Phrase: "are"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "we"

Phrase: "utilized"

Phrase: "the BS3"

Phrase: "rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "method to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "determine"

Phrase: "the apparent KD for the binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0026691:KD [Disease or Syndrome]
   753   C1705240:KD [Gene or Genome]
   753   C1839259:KD [Disease or Syndrome]

Phrase: "of A to 2M-MA."
Processing 00000000.tx.105: This method has been used previously to determine KD values for the interaction of 2M with multiple growth factors and cytokines (12, 13, 50). 

Phrase: "This method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "previously to"

Phrase: "determine"

Phrase: "KD values for the interaction of 2M"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0026691:KD [Disease or Syndrome]
   744   C0042295:Values [Qualitative Concept]
   744   C1705240:KD [Gene or Genome]
   744   C1839259:KD [Disease or Syndrome]
   711 E C1522609:Value [Quantitative Concept]

Phrase: "with multiple growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(12,"

Phrase: "13,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.106: Increasing concentrations of 2M-MA were incubated with 25nM 125I-A for 2h at 37C. 

Phrase: "Increasing concentrations of 2M-MA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "were"

Phrase: "incubated with 25nM 125I-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "A for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292425:2H [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.107: Freshly dissolved BS3 (5mM) or vehicle (H2O) was then added for 5min. 

Phrase: "Freshly dissolved BS3"

Phrase: "(5mM"

Phrase: ")"

Phrase: "or"

Phrase: "vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0042444:Vehicle [Biomedical or Dental Material]
  1000   C0348005:Vehicle [Manufactured Object]
   928 E C0445373:Vehicular [Functional Concept]

Phrase: "(H2O"

Phrase: ")"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added for 5min."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]
Processing 00000000.tx.108: Cross-linking reactions were quickly terminated by rapid acidification, followed by transfer to buffered SDS. 

Phrase: "Cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "quickly"

Phrase: "terminated by rapid acidification,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0439831:Rapid [Qualitative Concept]
   770   C1522821:acidification [Cell Function]
   770   C1553404:terminated [Idea or Concept]
   770   C2348570:Terminated [Functional Concept]
   770   C2987513:Acidification [Phenomenon or Process]

Phrase: "followed by transfer"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0040671:Transfer [Mental Process]
   790   C1705822:Transfer [Activity]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "to buffered SDS."
Processing 00000000.tx.109: Under pseudo-first order conditions, a constant fraction of the non-covalent 125I-A2M-MA complex is covalently stabilized by the BS3 (13). 

Phrase: "Under pseudo-first order conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]

Phrase: "a constant fraction of the non-covalent 125I-A2M-MA complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1264633:Fraction of [Quantitative Concept]
           Fraction
   738   C1554103:Fraction [Idea or Concept]

Phrase: "is"

Phrase: "covalently"

Phrase: "stabilized by the BS3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0184512:Stabilized [Qualitative Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.110: To quantitate the amount of covalently stabilized complex, BS3-treated and vehicle-treated samples were subjected to SDS-PAGE. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "quantitate"

Phrase: "the amount of covalently stabilized complex,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "BS3-treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332293:treated [Therapeutic or Preventive Procedure]
   861   C1522326:Treated [Functional Concept]
   827 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "vehicle-treated samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "subjected to SDS-PAGE."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.111: 125I-A that was covalently cross-linked to 2M-MA (bound) and free 125I-A (free), which includes free A and A that was bound to 2M-MA but not cross-linked, were quantitated by PhosphorImager analysis. 

Phrase: "125I-"

Phrase: "A that"

Phrase: "was"

Phrase: "covalently"

Phrase: "cross-linked to 2M-MA ("
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0178576:Cross Linked [Natural Phenomenon or Process]
   790   C0332220:cross linked [Functional Concept]
   783   C0612672:MA-2 [Organic Chemical]
   753   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C2828360:Cross [Conceptual Entity]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "free 125I-A (free"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "free A"

Phrase: "and"

Phrase: "A that"

Phrase: "was"

Phrase: "bound to 2M-MA"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0612672:MA-2 [Organic Chemical]
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: ","

Phrase: "were"

Phrase: "quantitated by PhosphorImager analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.112: Results were analyzed according to the following equation (12), (Eq.1) The cross-linking efficiency, z, is a constant, derived from the y intercept, for each set of proteins and conditions (12). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "analyzed according to the following equation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0552449:Equation [Conceptual Entity]
   753   C0680240:according [Social Behavior]
   753   C0936012:Analyzed [Research Activity]
   719   C0332283:follow [Temporal Concept]
   719   C1719822:Follow [Intellectual Product]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "(Eq.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205163:EQ [Qualitative Concept]
   861   C0439185:Eq [Quantitative Concept]

Phrase: ")"

Phrase: "The"

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "efficiency,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013682:Efficiency [Quantitative Concept]
   928 E C0442799:Efficient [Qualitative Concept]

Phrase: "z,"

Phrase: "is"

Phrase: "a constant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547014:*Constant [Quantitative Concept]
  1000   C1948059:Constant [Qualitative Concept]

Phrase: "derived from the y"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "intercept"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0598981:Intercept [Organic Chemical,Pharmacologic Substance]
  1000   C3146232:Intercept [Quantitative Concept]

Phrase: ","

Phrase: "for each"

Phrase: "set of proteins"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   841   C1137947:Protein SET [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]

Phrase: "and"

Phrase: "conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.113: z is referred to as the BS3-cross-linking efficiency but may also be affected if a fraction of the radioiodinated protein is incapable of binding to the 2M. 

Phrase: "z"

Phrase: "is"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "the BS3-"

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "efficiency"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0013682:Efficiency [Quantitative Concept]
   928 E C0442799:Efficient [Qualitative Concept]

Phrase: "but"

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "if"

Phrase: "a fraction of the radioiodinated protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1264633:Fraction of [Quantitative Concept]
           Fraction
   753   C1554103:Fraction [Idea or Concept]

Phrase: "is"

Phrase: "incapable of binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1550518:incapable [Idea or Concept]

Phrase: "to the 2M."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.114: The apparent KD was determined from the slope when free/bound was plotted against 1/[2M-MA]. 

Phrase: "The apparent KD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: "was"

Phrase: "determined from the slope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0807955:Slope [Quantitative Concept]

Phrase: "when"

Phrase: "free/bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0332297:bound [Spatial Concept]
   861   C1145667:Bound [Activity]
   861   C1167622:Bound [Molecular Function]
   861   C1689898:% bound [Quantitative Concept]
   861   C2349209:Bound [Conceptual Entity]

Phrase: "was"

Phrase: "plotted against 1/"

Phrase: "[2M-MA"

Phrase: "]."
Processing 00000000.tx.115: This value is based on the assumption that there is a single binding site for A in 2M. 

Phrase: "This value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "is"

Phrase: "based on the assumption"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that there"

Phrase: "is"

Phrase: "a single binding site for A in 2M."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0005456:Binding Site [Receptor]
   764   C0682969:Binding Site [Amino Acid Sequence]
   742   C0205145:Site [Spatial Concept]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]
Processing 00000000.tx.116: Assuming one A-binding site/2M subunit, as suggested by our data, then the KD must be corrected by multiplying the apparent KD by a factor of four. 

Phrase: "Assuming one A-binding site/2M subunit,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1711351:Subunit [Quantitative Concept]

Phrase: "as"

Phrase: "suggested by our data,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]
   737   C1705535:Suggest [Idea or Concept]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the KD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026691:KD [Disease or Syndrome]
  1000   C1705240:KD [Gene or Genome]
  1000   C1839259:KD [Disease or Syndrome]

Phrase: "must"

Phrase: "be"

Phrase: "corrected by multiplying"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205202:Corrected [Qualitative Concept]
   756   C1719797:Multiply [Functional Concept]
   756 E C2349182:Correct [Qualitative Concept]
   756   C2911648:Multiply [Quantitative Concept]

Phrase: "the apparent KD by a factor of four."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0026691:KD [Disease or Syndrome]
   744   C1705240:KD [Gene or Genome]
   744   C1839259:KD [Disease or Syndrome]
Processing 00000000.tx.117: Ligand Blotting-- This method has been previously used to demonstrate specific and saturable binding of growth factors to denatured 2M subunits, 2M fragments, and GST-2M-peptide fusion proteins (17-19). 

Phrase: "Ligand Blotting"

Phrase: "-"

Phrase: "-"

Phrase: "This method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "saturable binding of growth factors"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1149299:Growth Factor Binding [Molecular Function]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to denatured 2M subunits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1711351:Subunit [Quantitative Concept]

Phrase: "2M fragments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "GST-2M-peptide fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0332466:Fusion [Functional Concept]
   793   C1293131:Fusion [Therapeutic or Preventive Procedure]
   779   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "(17-19"

Phrase: ")."
Processing 00000000.tx.118: Protein preparations were denatured in 2% SDS or treated with 1mM DTT in 2% SDS and then with 5mM iodoacetamide for 2h, as previously described (17). 

Phrase: "Protein preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0455052:Preparation [Health Care Activity]
   827   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "denatured in 2% SDS"

Phrase: "or"

Phrase: "treated with 1mM DTT"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "in 2% SDS"

Phrase: "and"

Phrase: "then with 5mM iodoacetamide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021973:Iodoacetamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C1883708:Then [Temporal Concept]

Phrase: "for 2h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.119: Samples were then subjected to SDS-PAGE and electrotransferred to polyvinylidene fluoride (PVDF) membranes. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "electrotransferred to polyvinylidene fluoride (PVDF) membranes."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0071710:polyvinylidene fluoride [Organic Chemical]
   760   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   760   C0025255:Membranes [Tissue]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.120: The membranes were blocked with 5% milk in 20mM sodium phosphate, 150mM NaCl, 0.1% Tween 20,pH 7.4,and probed for 2h with 125I-A or biotinylated-A. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "blocked with 5% milk"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   770   C0026131:Milk [Body Substance]
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C0349374:Milk [Food]
   770   C0444318:Milk [Substance]
   770   C2825079:Milk [Food]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]
   715 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   715 E C1281353:Lacteal [Body Part, Organ, or Organ Component]

Phrase: "in 20mM sodium phosphate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "150mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "0.1% Tween 20,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "probed for 2h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1292425:2H [Temporal Concept]
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "with 125I-"

Phrase: "A"

Phrase: "or"

Phrase: "biotinylated"

Phrase: "-"

Phrase: "A."
Processing 00000000.tx.121: 125I-A ligand blots were washed and subjected to PhosphorImager analysis. 

Phrase: "125I-"

Phrase: "A ligand blots"

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "subjected to PhosphorImager analysis."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.122: Biotinylated A ligand blots were probed with horseradish peroxidase-conjugated avidin (1:5000 dilution). 

Phrase: "Biotinylated"

Phrase: "A ligand blots"

Phrase: "were"

Phrase: "probed with horseradish peroxidase-conjugated avidin"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   753   C0004434:Avidin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0330510:Horseradish [Food]
   753   C0522529:Conjugated [Spatial Concept]
   753   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   753   C1110641:Horseradish [Plant]
   753   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   719   C0182400:Probe [Medical Device]
   719   C1704681:Probe [Gene or Genome]
   719   C2347609:Probe [Chemical Viewed Functionally]
   719   C3536729:Probe [Manufactured Object]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "5000 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: ")."
Processing 00000000.tx.123: The membranes were then subjected to enhanced chemiluminescence (ECL) and densitometry. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to enhanced chemiluminescence (ECL)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C2349975:Enhanced [Activity]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "densitometry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011321:Densitometry [Laboratory Procedure]
Processing 00000000.tx.124: Equivalent loading and transfer of proteins were demonstrated by Coomassie Blue staining or, when applicable, by immunoblot analysis with GST-specific antibody (17). 

Phrase: "Equivalent loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]

Phrase: "and"

Phrase: "transfer of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0040671:Transfer [Mental Process]
   790   C1705822:Transfer [Activity]

Phrase: "were"

Phrase: "demonstrated by Coomassie Blue staining"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1260957:Blue [Qualitative Concept]
   760   C1704680:Staining [Finding]

Phrase: "or"

Phrase: ","

Phrase: "when"

Phrase: "applicable,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1272460:applicable [Qualitative Concept]
  1000   C1706839:Applicable [Qualitative Concept]

Phrase: "by immunoblot analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "with GST-specific antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.125: A-peptide Immunoblotting-- Denatured 2M subunits and BSA were treated with 1mM DTT and then with 5mM iodoacetamide to block free sulfhydryl groups, subjected to SDS-PAGE, and electrotransferred to PVDF. 

Phrase: "A-peptide Immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "-"

Phrase: "-"

Phrase: "Denatured"

Phrase: "2M subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "BSA"

Phrase: "were"

Phrase: "treated with 1mM DTT"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "then with 5mM iodoacetamide to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021973:Iodoacetamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1883708:Then [Temporal Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "free sulfhydryl groups,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0038734:sulfhydryl group [Organic Chemical]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "subjected to SDS-PAGE,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "electrotransferred to PVDF."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0071710:polyvinylidene fluoride [Organic Chemical]
   770   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.126: The membranes were blocked with 5% milk. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "blocked with 5% milk."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   770   C0026131:Milk [Body Substance]
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C0349374:Milk [Food]
   770   C0444318:Milk [Substance]
   770   C2825079:Milk [Food]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]
   715 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   715 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
Processing 00000000.tx.127: Unlabeled A(1-40) was incubated with the immobilized 2M and BSA in PBS-T at 37C for 2h. 

Phrase: "Unlabeled A(1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "was"

Phrase: "incubated with the immobilized 2M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "BSA in PBS-T"

Phrase: "at 37C"

Phrase: "for 2h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]
Processing 00000000.tx.128: The membranes were then washed extensively and probed with rabbit A-specific IgG (1:4000) in PBS-T and 0.1% milk (v/v), followed by anti-rabbit IgG-horseradish peroxidase conjugate (1:10,000). 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "extensively"

Phrase: "and"

Phrase: "probed with rabbit A-specific IgG (1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0034493:Rabbit [Mammal]
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]
   714   C0182400:Probe [Medical Device]
   714   C1704681:Probe [Gene or Genome]
   714   C2347609:Probe [Chemical Viewed Functionally]
   714   C3536729:Probe [Manufactured Object]

Phrase: ":"

Phrase: "4000"

Phrase: ")"

Phrase: "in PBS-T"

Phrase: "and"

Phrase: "0.1% milk"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0026131:Milk [Body Substance]
   827   C0349374:Milk [Food]
   827   C0444318:Milk [Substance]
   827   C2825079:Milk [Food]
   771 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   771 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   755 E C0443260:Milky [Finding]

Phrase: "(v/v),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0560268:%V/V [Quantitative Concept]
  1000   C2349105:V(V) [Element, Ion, or Isotope]

Phrase: "followed by anti-rabbit IgG-horseradish peroxidase conjugate"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   800   C0063351:IGG-horseradish peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0332283:Followed by [Temporal Concept]
           followed
   767   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0034493:Rabbit [Mammal]
   744   C0301869:Conjugate [Immunologic Factor]
   744   C0330510:Horseradish [Food]
   744   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   744   C1110641:Horseradish [Plant]
   744   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   711 E C1719822:Follow [Intellectual Product]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10,000"

Phrase: ")."
Processing 00000000.tx.129: Membranes were analyzed by ECL and densitometry. 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "analyzed by ECL"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   770   C0936012:Analyzed [Research Activity]
   770   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   770   C2349975:Enhanced [Activity]

Phrase: "and"

Phrase: "densitometry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011321:Densitometry [Laboratory Procedure]
Processing 00000000.tx.130: Plasma Clearance Experiments in Mice-- 125I-2M-MA (20nM) was incubated with 20M A or with vehicle for 2h at 37C. 

Phrase: "Plasma Clearance Experiments in Mice"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "--"

Phrase: "125I-2M-MA (20nM"

Phrase: ")"

Phrase: "was"

Phrase: "incubated with 20M A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "or with vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0042444:Vehicle [Biomedical or Dental Material]
   790   C0348005:Vehicle [Manufactured Object]
   718 E C0445373:Vehicular [Functional Concept]

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.131: The 125I-2M-MA (0.3Ci) was then injected, in the presence and absence of GST-RAP (40or 80g), into the lateral tail veins of CD-1 female mice (30g). 

Phrase: "The 125I-2M-MA (0.3Ci"

Phrase: ")"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: ","

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "absence of GST-RAP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332197:absence [Quantitative Concept]
   744   C1689985:Absence [Anatomical Abnormality]

Phrase: "(40or 80g"

Phrase: ")"

Phrase: ","

Phrase: "into the lateral tail veins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C2985205:Tail Vein [Body Part, Organ, or Organ Component]
   827   C0042449:Veins [Body Part, Organ, or Organ Component]
   793 E C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "of CD-1 female mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(30g"

Phrase: ")."
Processing 00000000.tx.132: Blood samples (40l) were withdrawn from the retro-orbital venous plexus, using heparinized capillary tubes, at the designated times (0.5-30 min). 

Phrase: "Blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "(40l"

Phrase: ")"

Phrase: "were"

Phrase: "withdrawn from the retro-orbital venous plexus,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0226503:Venous plexus [Body System]
   748   C0042449:Venous [Body Part, Organ, or Organ Component]
   748   C0205095:Retro- [Spatial Concept]
   748   C0348013:Venous [Spatial Concept]
   748   C0424092:Withdrawn [Finding]
   748   C0521438:RETRO [Spatial Concept]
   748   C0699036:Orbital [Spatial Concept]
   748   C1184808:Plexus [Body Part, Organ, or Organ Component]
   748   C2349954:Withdrawn [Activity]
   748   C2825032:Withdrawn [Mental or Behavioral Dysfunction]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "heparinized capillary tubes,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0184108:capillary tubes [Medical Device]
   827   C0175730:tubes [Medical Device]
   827   C1547937:Tubes [Intellectual Product]
   827   C1704474:Tubes [Quantitative Concept]
   793 E C1561954:tube [Conceptual Entity]
   793 E C1704730:TUBE [Medical Device]

Phrase: "at the designated times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "(0.5-30 min)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0456693:/30 min [Temporal Concept]
   861   C1442458:30 min [Temporal Concept]
   812   C0702093:/min [Temporal Concept]
Processing 00000000.tx.133: The radioactivity in each sample was determined using a gamma counter and expressed as a fraction of that present in the 0.5-min time point.  

Phrase: "The radioactivity in each sample"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a gamma counter"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0677601:Counter [Manufactured Object]
   861   C1705206:Counter [Medical Device]

Phrase: "and"

Phrase: "expressed as a fraction of that present"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C1264633:Fraction of [Quantitative Concept]
           Fraction
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]
   748   C1554103:Fraction [Idea or Concept]

Phrase: "in the 0.5-min time point."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   840   C2348792:Time Point [Temporal Concept]
   804   C0040223:Time [Temporal Concept]
   804   C1552961:Point [Quantitative Concept]
   804   C2347617:point [Quantitative Concept]
   804   C3541383:Time [Temporal Concept]
   748 E C0442043:Temporal [Spatial Concept]
   748 E C2362314:Temporal [Temporal Concept]
   721 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.134: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES A Binding to 2M Is 2M Conformation-dependent-- A(1-40) and A(1-42) function differently in the initiation and progression of AD; 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "A Binding to 2M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "Is"

Phrase: "2M Conformation-dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0851827:Dependent [Qualitative Concept]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]

Phrase: "--"

Phrase: "A(1-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "A(1-42"

Phrase: ")"

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "differently in the initiation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0589507:Initiation [Mental Process]
   770   C1158830:Initiation [Genetic Function]
   770   C1704686:Initiation [Functional Concept]

Phrase: "and"

Phrase: "progression of AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0242656:progression [Pathologic Function]
   790   C0449258:Progression [Functional Concept]

Phrase: ";"
Processing 00000000.tx.135: however, both forms of A bind to 2M equivalently (33). 

Phrase: "however,"

Phrase: "both"

Phrase: "forms of A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1522492:Form [Functional Concept]

Phrase: "bind to 2M equivalently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.136: Thus, we conducted our analysis of A binding to 2M and its derivatives using one form of A (A(1-40)). 

Phrase: "Thus,"

Phrase: "we"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "our analysis of A binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "to 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "its derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243072:derivatives [Chemical Viewed Structurally]
   966 E C1527240:Derivative [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "one form of A (A(1-40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: ")"

Phrase: ")."
Processing 00000000.tx.137: To determine whether A binding to 2M is 2M conformation-specific, as has been demonstrated with growth factors (12, 13), 125I-A (2.5nM) was incubated with native 2M or 2M-MA (each at 0.3M) in solution. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "A binding to 2M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "2M conformation-specific,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205369:Specific [Qualitative Concept]
   812   C1552740:specific [Intellectual Product]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated with growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "(12,"

Phrase: "13"

Phrase: ")"

Phrase: ","

Phrase: "125I-A (2.5nM"

Phrase: ")"

Phrase: "was"

Phrase: "incubated with native 2M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0302891:Native [Functional Concept]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "2M-MA ("

Phrase: "each at 0.3M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332060:3M [Health Care Related Organization]
   770   C1457900:Each [Quantitative Concept]

Phrase: ")"

Phrase: "in solution."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037633:Solution [Substance]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.138: The products were analyzed by non-denaturing PAGE, which preserves non-covalent interactions. 

Phrase: "The products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "analyzed by non-denaturing PAGE,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C3494467:Non-Denaturing PAGE [Laboratory Procedure]
   760   C0936012:Analyzed [Research Activity]
   760   C1518422:Non [Functional Concept]
   760   C1704732:Page [Intellectual Product]

Phrase: "which"

Phrase: "preserves"

Phrase: "non-covalent interactions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1511539:Covalent Interaction [Molecular Function]
   793   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.139: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.140: 2A, 125I-A bound to 2M-MA, whereas binding was not detected with native 2M. 

Phrase: "2A,"

Phrase: "125I-"

Phrase: "A"

Phrase: "bound to 2M-MA,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0612672:MA-2 [Organic Chemical]
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "whereas"

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected with native 2M."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0302891:Native [Functional Concept]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.141: Free 125I-A migrated near the dye front. 

Phrase: "Free 125I-"

Phrase: "A"

Phrase: "migrated near the dye front."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   760   C0205094:front [Spatial Concept]
   760   C0232902:Migrated [Functional Concept]
Processing 00000000.tx.142: These results suggest that A binds selectively to 2M that has undergone conformational change. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "A"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "selectively to 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "that"

Phrase: "has"

Phrase: "undergone conformational change."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0301641:Conformational change [Molecular Function]
   827   C0392747:Change [Functional Concept]
   827   C0443172:change [Quantitative Concept]
   827   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.143: View larger version (31K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.144: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.145: 2M conformation dependence of A binding. 

Phrase: "2M conformation dependence of A binding."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0011546:Dependence [Mental Process]
   748   C0439857:Dependence [Mental or Behavioral Dysfunction]
   748   C2698668:DEPENDENCE [Regulation or Law]
Processing 00000000.tx.146: A, 125I-A was incubated in buffer alone, with native 2M, or with 2M-MA (0.3M) for 2h at 37C and then subjected to non-denaturing PAGE. 

Phrase: "A,"

Phrase: "125I-"

Phrase: "A"

Phrase: "was"

Phrase: "incubated in buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "with native 2M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or with 2M-MA (0.3M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0612672:MA-2 [Organic Chemical]
   748   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0332060:3M [Health Care Related Organization]

Phrase: ")"

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at 37C"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to non-denaturing PAGE."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C3494467:Non-Denaturing PAGE [Laboratory Procedure]
   760   C1518422:Non [Functional Concept]
   760   C1704732:Page [Intellectual Product]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.147: The gel was dried and stained. 

Phrase: "The gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "was"

Phrase: "dried"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1512080:Dried [Qualitative Concept]
  1000   C2827485:Dried [Body Substance]
   966 E C0011682:Dry [Natural Phenomenon or Process]
   966 E C0205222:Dry [Qualitative Concept]

Phrase: "and"

Phrase: "stained."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.148: 2M-associated 125I-A was detected by PhosphorImager analysis. 

Phrase: "2M-associated 125I-"

Phrase: "A"

Phrase: "was"

Phrase: "detected by PhosphorImager analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C0936012:Analysis [Research Activity]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.149: Free 125I-A migrated near the dye front (not shown). 

Phrase: "Free 125I-"

Phrase: "A"

Phrase: "migrated near the dye front"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   760   C0205094:front [Spatial Concept]
   760   C0232902:Migrated [Functional Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.150: B, increasing concentrations of 2M-MA were incubated with 25nM 125I-A for 2h at 37C. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "concentrations of 2M-MA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "were"

Phrase: "incubated with 25nM 125I-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "A for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1292425:2H [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.151: Samples were treated with BS3 and subjected to SDS-PAGE. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "treated with BS3"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "subjected to SDS-PAGE."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.152: BS3-stabilized 125I-A2M-MA complex (bound) and 125I-A that was not cross-linked to 2M-MA (free) were determined and plotted against the reciprocal of the 2M-MA concentration. 

Phrase: "BS3-stabilized 125I-A2M-MA complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0439855:Complex [Qualitative Concept]
   799   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "125I-"

Phrase: "A that"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cross-linked to 2M-MA ("
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0178576:Cross Linked [Natural Phenomenon or Process]
   790   C0332220:cross linked [Functional Concept]
   783   C0612672:MA-2 [Organic Chemical]
   753   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C2828360:Cross [Conceptual Entity]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "free"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332296:free [Functional Concept]
  1000   C1880497:Free [Qualitative Concept]
  1000   C1996904:Free [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "determined"

Phrase: "and"

Phrase: "plotted against the reciprocal of the 2M-MA concentration."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0612672:MA-2 [Organic Chemical]
   739   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0086045:Concentration [Mental Process]
   739   C1446561:Concentration [Quantitative Concept]
   739   C1882911:Reciprocal [Qualitative Concept]
Processing 00000000.tx.153: To estimate the KD for A binding to 2M-MA, we used the BS3-rapid cross-linking method, which has been used extensively to determine binding affinities for 2M and growth factors (12, 13, 50). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "estimate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: "the KD for A binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0026691:KD [Disease or Syndrome]
   760   C1705240:KD [Gene or Genome]
   760   C1839259:KD [Disease or Syndrome]

Phrase: "to 2M-MA,"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the BS3-rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439831:Rapid [Qualitative Concept]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "method,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "extensively to"

Phrase: "determine"

Phrase: "binding affinities for 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(12,"

Phrase: "13,"

Phrase: "50"

Phrase: ")."
Processing 00000000.tx.154: A major advantage of this method is that it is not necessary to resolve free and bound A, which typically involves the use of steps, such as chromatography or PAGE, that promote dissociation of non-covalent protein complexes. 

Phrase: "A major advantage of this method"

Phrase: "is"

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "not necessary to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1518422:Not [Functional Concept]

Phrase: "resolve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699488:Resolve [Conceptual Entity]

Phrase: "free"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332296:free [Functional Concept]
  1000   C1880497:Free [Qualitative Concept]
  1000   C1996904:Free [Qualitative Concept]

Phrase: "and"

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "A,"

Phrase: "which typically"

Phrase: "involves"

Phrase: "the use of steps,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "such as chromatography"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0008550:Chromatography [Laboratory Procedure]
   900 E C0302647:chromatograph [Medical Device]

Phrase: "or"

Phrase: "PAGE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "that"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "dissociation of non-covalent protein complexes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0086168:Dissociation [Mental or Behavioral Dysfunction]
Processing 00000000.tx.155: A representative study in which 125I-A was incubated with increasing concentrations of 2M-MA is shown in Fig. 

Phrase: "A representative study in which 125I-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "A"

Phrase: "was"

Phrase: "incubated with increasing concentrations of 2M-MA"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   767   C0612672:MA-2 [Organic Chemical]
   744   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0086045:Concentrations [Mental Process]
   744   C0442808:Increasing [Functional Concept]
   744   C1439852:Incubated [Laboratory Procedure]
   711 E C1446561:Concentration [Quantitative Concept]

Phrase: "is"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.156: 2B. 

Phrase: "2B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450354:2b [Intellectual Product]
  1000   C1706096:2B [Research Activity]
Processing 00000000.tx.157: The exact fraction of the non-covalent 2MA complex, which was cross-linked by BS3 (z), was determined from the y intercept, as previously described (12). 

Phrase: "The exact fraction of the non-covalent 2MA complex,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1264633:Fraction of [Quantitative Concept]
           Fraction
   742   C1554103:Fraction [Idea or Concept]

Phrase: "which"

Phrase: "was"

Phrase: "cross-linked by BS3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0178576:Cross Linked [Natural Phenomenon or Process]
   833   C0332220:cross linked [Functional Concept]
   770   C2828360:Cross [Conceptual Entity]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "(z"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "determined from the y"

Phrase: "intercept"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0598981:Intercept [Organic Chemical,Pharmacologic Substance]
  1000   C3146232:Intercept [Quantitative Concept]

Phrase: ","

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.158: In three separate experiments, z=0.06-0.14, compared with z values that are typically in the range of 0.15-0.40 for the binding of growth factors to 2M (12). 

Phrase: "In three separate experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "z=0.06-0.14,"

Phrase: "compared with z values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0042295:Values [Qualitative Concept]
   770   C1707455:Compared [Activity]
   737 E C1522609:Value [Quantitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "typically in the range of 0.15-0.40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0439509:/40 [Temporal Concept]
   742   C1514721:Range [Quantitative Concept]
   742   C2348147:Range [Quantitative Concept]
   742   C3542016:Range [Intellectual Product]

Phrase: "for the binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "of growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "to 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.159: z may be decreased if a fraction of the 125I-A was incapable of binding to 2M-MA or if the A, which bound to 2M-MA, multimerized so that individual A monomers could not be cross-linked to the 2M-MA. 

Phrase: "z"

Phrase: "may"

Phrase: "be"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "if"

Phrase: "a fraction of the 125I-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1264633:Fraction of [Quantitative Concept]
           Fraction
   760   C1554103:Fraction [Idea or Concept]

Phrase: "A"

Phrase: "was"

Phrase: "incapable of binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1550518:incapable [Idea or Concept]

Phrase: "to 2M-MA"

Phrase: "or"

Phrase: "if"

Phrase: "the A,"

Phrase: "which"

Phrase: "bound to 2M-MA,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0612672:MA-2 [Organic Chemical]
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "multimerized"

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that individual"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027361:Individual [Population Group]
  1000   C0237401:Individual [Human]

Phrase: "A monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:monomers [Chemical Viewed Structurally]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "cross-linked to the 2M-MA."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0178576:Cross Linked [Natural Phenomenon or Process]
   778   C0332220:cross linked [Functional Concept]
   774   C0612672:MA-2 [Organic Chemical]
   748   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C2828360:Cross [Conceptual Entity]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]
Processing 00000000.tx.160: Neither of these effects would be expected to influence the calculated apparent KD. 

Phrase: "Neither of these effects"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1280500:effects [Qualitative Concept]
   770   C3274651:Neither [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "would"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "influence"

Phrase: "the calculated apparent KD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0026691:KD [Disease or Syndrome]
   827   C1705240:KD [Gene or Genome]
   827   C1839259:KD [Disease or Syndrome]
Processing 00000000.tx.161: The apparent KD for the binding of A to 2M-MA was 0.290.02M (n=3). 

Phrase: "The apparent KD for the binding of A to 2M-MA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0026691:KD [Disease or Syndrome]
   736   C1705240:KD [Gene or Genome]
   736   C1839259:KD [Disease or Syndrome]

Phrase: "was"

Phrase: "0.290.02M"

Phrase: "(n=3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.162: This value is based on the assumption that each molecule of 2M has one binding site for A. 

Phrase: "This value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "is"

Phrase: "based on the assumption"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "that"

Phrase: "each molecule of 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0567416:Molecule [Substance]

Phrase: "has"

Phrase: "one binding site for A."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0005456:Binding Site [Receptor]
   806   C0682969:Binding Site [Amino Acid Sequence]
   760   C0205145:Site [Spatial Concept]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
Processing 00000000.tx.163: If each 2M subunit has a distinct A-binding site, as the evidence to be presented will suggest, then the KD for the binding of A to the individual binding site is 1.2M. 

Phrase: "If"

Phrase: "each 2M subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "has"

Phrase: "a distinct A-binding site,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0005456:Binding Site [Receptor]
   861   C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "as"

Phrase: "the evidence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "be"

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "will"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: ","

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "the KD for the binding of A to the individual binding site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0026691:KD [Disease or Syndrome]
   736   C1705240:KD [Gene or Genome]
   736   C1839259:KD [Disease or Syndrome]

Phrase: "is"

Phrase: "1.2M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   734   C0580272:1/2 [Intellectual Product]
   734   C1519043:1-2 [Research Activity]
Processing 00000000.tx.164: Although this is a low affinity interaction, due to the homotetrameric structure of 2M, the plasma concentration of 2M subunits is 12-20 M (11). 

Phrase: "Although"

Phrase: "this"

Phrase: "is"

Phrase: "a low affinity interaction,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "due to the homotetrameric structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "of 2M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the plasma concentration of 2M subunits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0683150:plasma concentration [Quantitative Concept]
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "is"

Phrase: "12-20"

Phrase: "M ("

Phrase: "11"

Phrase: ")."
Processing 00000000.tx.165: Binding of 125I-A to Denatured 2M Subunits-- Native 2M was denatured in SDS and DTT and treated with iodoacetamide. 

Phrase: "Binding of 125I-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "A to Denatured 2M Subunits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1825406:A-2 [Gene or Genome]
   753   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   719   C1711351:Subunit [Quantitative Concept]

Phrase: "--"

Phrase: "Native 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "denatured in SDS"

Phrase: "and"

Phrase: "DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "treated with iodoacetamide."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021973:Iodoacetamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.166: A similar protocol was executed with 2M-MA and with BSA. 

Phrase: "A similar protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "was"

Phrase: "executed with 2M-MA"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   797   C0612672:MA-2 [Organic Chemical]
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1705848:Executed [Activity]
   726 E C3245498:execute [Functional Concept]

Phrase: "and with BSA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]
Processing 00000000.tx.167: The preparations were then subjected to SDS-PAGE. 

Phrase: "The preparations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0455052:Preparation [Health Care Activity]
   966   C1521827:Preparation [Functional Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to SDS-PAGE."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.168: Coomassie Blue staining revealed the 180-kDa 2M subunit as the major band in both the native 2M and 2M-MA preparations, as anticipated (Fig. 3). 

Phrase: "Coomassie Blue staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
   734   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the 180-kDa 2M subunit as the major band"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1711351:Subunit [Quantitative Concept]

Phrase: "in both"

Phrase: "the native 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "2M-MA preparations,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0455052:Preparation [Health Care Activity]
   779   C1521827:Preparation [Functional Concept]

Phrase: "as"

Phrase: "anticipated"

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.169: Faint bands with apparent masses of 120and 60kDa were observed in the native 2M lane. 

Phrase: "Faint bands with apparent masses of 120and 60kDa"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0175723:Bands [Medical Device]
   711 E C0439645:Band [Spatial Concept]
   711 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "observed in the native 2M lane."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0302891:Native [Functional Concept]
   748   C1441672:Observed [Functional Concept]
   748   C1708639:Lane [Spatial Concept]
Processing 00000000.tx.170: These bands correspond to the 2M heat fragmentation products that result from an internal reaction involving the thiol ester bonds at 100C, as previously described (48). 

Phrase: "These bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "correspond to the 2M heat fragmentation products"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0018837:Heat [Natural Phenomenon or Process]
   744   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0332472:Fragmentation [Anatomical Abnormality]
   744   C1514468:Products [Entity]
   744   C1881708:FRAGMENTATION [Phenomenon or Process]
   711 E C1704444:Product [Quantitative Concept]

Phrase: "that"

Phrase: "result from an internal reaction"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205102:Internal [Spatial Concept]
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C1553872:Internal [Intellectual Product]
   760   C1619620:Internal [Intellectual Product]
   760   C2825142:Result [Finding]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "the thiol ester bonds at 100C,"

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.171: 2M-MA does not undergo heat fragmentation, because the thiol esters have already undergone aminolysis (46, 47). 

Phrase: "2M-MA"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "undergo"

Phrase: "heat fragmentation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332472:Fragmentation [Anatomical Abnormality]
   861   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "because"

Phrase: "the thiol esters"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014898:Esters [Organic Chemical]
   861   C0038734:thiol [Organic Chemical]

Phrase: "have"

Phrase: "already undergone aminolysis"

Phrase: "(46,"

Phrase: "47"

Phrase: ")."
Processing 00000000.tx.172: View larger version (25K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.173: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.174: Ligand blot analysis of A binding to 2M. 

Phrase: "Ligand blot analysis of A binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "to 2M."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.175: Native 2M, 2M-MA, and BSA were denatured in the presence of reductant and treated with iodoacetamide. 

Phrase: "Native 2M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "2M-MA,"

Phrase: "and"

Phrase: "BSA"

Phrase: "were"

Phrase: "denatured in the presence of reductant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "treated with iodoacetamide."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021973:Iodoacetamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.176: The samples were then subjected to SDS-PAGE and electrotransferred to PVDF membranes. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "electrotransferred to PVDF membranes."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0071710:polyvinylidene fluoride [Organic Chemical]
   760   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   760   C0025255:Membranes [Tissue]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.177: Some membranes were stained with Coomassie Blue. 

Phrase: "Some membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "stained with Coomassie Blue."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   770   C1260957:Blue [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.178: Other membranes were blocked with 5% milk and then probed with 125I-A, unlabeled A, or biotinylated A. 

Phrase: "Other membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "blocked with 5% milk"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   770   C0026131:Milk [Body Substance]
   770   C0028778:Blocked [Pathologic Function]
   770   C0332206:Blocked [Functional Concept]
   770   C0349374:Milk [Food]
   770   C0444318:Milk [Substance]
   770   C2825079:Milk [Food]
   770   C2983591:BLOCKED [Research Activity]
   737 E C1533157:Block [Substance]
   737 E C1706084:Block [Geographic Area]
   737 E C2828370:Block [Quantitative Concept]
   715 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   715 E C1281353:Lacteal [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "probed with 125I-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "A,"

Phrase: "unlabeled"

Phrase: "A,"

Phrase: "or"

Phrase: "biotinylated"

Phrase: "A."
Processing 00000000.tx.179: 125I-A was detected by PhosphorImager analysis. 

Phrase: "125I-"

Phrase: "A"

Phrase: "was"

Phrase: "detected by PhosphorImager analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C0936012:Analysis [Research Activity]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.180: Unlabeled A was detected by immunoblot analysis. 

Phrase: "Unlabeled"

Phrase: "A"

Phrase: "was"

Phrase: "detected by immunoblot analysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C0936012:Analysis [Research Activity]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.181: Biotinylated A was detected with horseradish peroxidase-conjugated avidin and ECL. 

Phrase: "Biotinylated"

Phrase: "A"

Phrase: "was"

Phrase: "detected with horseradish peroxidase-conjugated avidin"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   753   C0004434:Avidin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0330510:Horseradish [Food]
   753   C0442726:Detected [Finding]
   753   C0522529:Conjugated [Spatial Concept]
   753   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   753   C1110641:Horseradish [Plant]
   753   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "ECL."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0162524:Chemiluminescence [Natural Phenomenon or Process]
   861   C1450278:Chemiluminescence [Natural Phenomenon or Process]
   861   C2349975:Enhanced [Activity]
   789 E C1627358:Enhancement [Therapeutic or Preventive Procedure]
Processing 00000000.tx.182: 125I-A bound to denatured 2M subunits that were electrotransferred to PVDF membranes. 

Phrase: "125I-"

Phrase: "A"

Phrase: "bound to denatured 2M subunits"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0332297:bound [Spatial Concept]
   753   C1145667:Bound [Activity]
   753   C1167622:Bound [Molecular Function]
   753   C1689898:% bound [Quantitative Concept]
   753   C2349209:Bound [Conceptual Entity]
   719   C1711351:Subunit [Quantitative Concept]

Phrase: "that"

Phrase: "were"

Phrase: "electrotransferred to PVDF membranes."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0071710:polyvinylidene fluoride [Organic Chemical]
   760   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   760   C0025255:Membranes [Tissue]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.183: No difference in 125I-A binding was observed with native 2M and 2M-MA, as was anticipated, because the difference in structure between these two forms of 2M is mainly conformational. 

Phrase: "No difference in 125I-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "A binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "observed with native 2M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0302891:Native [Functional Concept]
   760   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "2M-MA,"

Phrase: "as"

Phrase: "was"

Phrase: "anticipated"

Phrase: ","

Phrase: "because"

Phrase: "the difference in structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "between these two forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0348078:forms [Qualitative Concept]
   861   C0376315:Forms [Manufactured Object]
   827 E C1522492:Form [Functional Concept]

Phrase: "of 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "mainly conformational."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0026377:Conformation [Spatial Concept]
Processing 00000000.tx.184: 125I-A did not bind to BSA, suggesting that the interaction with 2M is specific. 

Phrase: "125I-"

Phrase: "A"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind to BSA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the interaction with 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "is"

Phrase: "specific."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]
Processing 00000000.tx.185: The interaction of 125I-A with 2M, in the ligand blotting system, suggests that the individual 2M subunit binds A and that 2M tertiary and quaternary structure are not necessary. 

Phrase: "The interaction of 125I-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "A with 2M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1825406:A-2 [Gene or Genome]
   770   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "in the ligand blotting system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the individual 2M subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1711351:Subunit [Quantitative Concept]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "A"

Phrase: "and"

Phrase: "that 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "tertiary"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205372:Tertiary [Quantitative Concept]

Phrase: "and"

Phrase: "quaternary structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "are"

Phrase: "not necessary."
Processing 00000000.tx.186: In this respect, A binding to 2M resembles the interaction observed with growth factors (17) but not with proteinases (11, 15). 

Phrase: "In this respect,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679133:respect [Social Behavior]

Phrase: "A binding to 2M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "resembles"

Phrase: "the interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "observed with growth factors"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C1441672:Observed [Functional Concept]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "(17"

Phrase: ")"

Phrase: "but"

Phrase: "not with proteinases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C1518422:Not [Functional Concept]
   756 E C1622131:proteinase [Molecular Function]
   756 E C1947941:Proteinase [Enzyme]

Phrase: "(11,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.187: To confirm that the interaction of A with 2M was not dependent on an unanticipated modification occurring during A radioiodination, we developed alternative methods for detecting A binding to PVDF-immobilized 2M subunits. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the interaction of A with 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704675:Interaction [Functional Concept]

Phrase: "was"

Phrase: "not dependent on an unanticipated modification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "occurring during A radioiodination,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1709305:Occur [Activity]
   737   C2745955:OCCUR [Temporal Concept]

Phrase: "we"

Phrase: "developed"

Phrase: "alternative methods for detecting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0449851:Methods [Functional Concept]
   737 E C0871511:METHOD [Intellectual Product]

Phrase: "A binding to PVDF-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "immobilized"

Phrase: "2M subunits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.188: In the first protocol, unlabeled A was used to probe the PVDF membranes. 

Phrase: "In the first protocol,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "unlabeled"

Phrase: "A"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "probe"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0182400:Probe [Medical Device]
  1000   C1704681:Probe [Gene or Genome]
  1000   C2347609:Probe [Chemical Viewed Functionally]
  1000   C3536729:Probe [Manufactured Object]

Phrase: "the PVDF membranes."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]
   734   C0071710:polyvinylidene fluoride [Organic Chemical]
Processing 00000000.tx.189: 2M-associated A was then detected by immunoblot analysis. 

Phrase: "2M-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "A"

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "detected by immunoblot analysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C0936012:Analysis [Research Activity]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.190: In the second protocol, biotinylated A was substituted for 125I-A. 

Phrase: "In the second protocol,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "biotinylated"

Phrase: "A"

Phrase: "was"

Phrase: "substituted for 125I-"

Phrase: "A."
Processing 00000000.tx.191: In both cases, binding of A to PVDF-immobilized native 2M and 2M-MA was detected whereas A binding to BSA was not. 

Phrase: "In both cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "binding of A to PVDF-immobilized native 2M"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0071710:polyvinylidene fluoride [Organic Chemical]
   739   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   739   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0243122:binding [Functional Concept]
   739   C0302891:Native [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "2M-MA"

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "whereas"

Phrase: "A binding to BSA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "not."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.192: A Binding to 2M Heat Fragments-- When 2M is heated in the presence of denaturant, the thiol ester bonds, which are formed from the side chains of Cys-949 and Gln-952, react internally with the 2M polypeptide backbone, causing scission of the 2M subunit at residue 952(46-48). 

Phrase: "A Binding to 2M Heat Fragments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]

Phrase: "-"

Phrase: "-"

Phrase: "When"

Phrase: "2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "heated in the presence of denaturant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   719   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "the thiol ester bonds,"

Phrase: "which"

Phrase: "are"

Phrase: "formed from the side chains of Cys-949"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0010654:Cys [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205431:Formed [Functional Concept]
   744   C0337112:chains [Manufactured Object]
   744   C0441987:Side [Spatial Concept]
   744   C1524075:Chains [Idea or Concept]
   711 E C0348078:Form [Qualitative Concept]
   711 E C0376315:Form [Manufactured Object]
   711 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "Gln-952,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017797:Gln [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "react"

Phrase: "internally with the 2M polypeptide backbone,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0037949:Backbone [Body Part, Organ, or Organ Component]
   748   C0205102:Internally [Spatial Concept]
   748   C1267072:Backbone [Body Part, Organ, or Organ Component]
   748   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "scission of the 2M subunit"

Phrase: "at residue 952"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1709915:Residue [Conceptual Entity]
   861   C1882936:RESIDUE [Phenomenon or Process]
   789 E C1609982:Residual [Qualitative Concept]

Phrase: "(46-48"

Phrase: ")."
Processing 00000000.tx.193: The N-terminal 120-kDa fragment includes the bait region and the growth factor binding sequence. 

Phrase: "The N-terminal 120-kDa fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332255:fragment [Functional Concept]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the bait region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "the growth factor binding sequence."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0004793:Sequence [Nucleotide Sequence]
   812   C0162326:Sequence [Nucleotide Sequence]
   812   C0162327:Sequence [Nucleotide Sequence]
   812   C1519249:Sequence [Functional Concept]
   756   C1149299:Growth Factor Binding [Molecular Function]
   741 E C1548958:Sequential [Idea or Concept]
   741 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.194: The C-terminal 60-kDa fragment includes the LRP recognition sequence (38-42) and the region identified by Hughes et al. 

Phrase: "The C-terminal 60-kDa fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332255:fragment [Functional Concept]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the LRP recognition sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   839   C0002518:Protein Sequence [Amino Acid Sequence]
   799   C0004793:Sequence [Nucleotide Sequence]
   799   C0162326:Sequence [Nucleotide Sequence]
   799   C0162327:Sequence [Nucleotide Sequence]
   799   C1519249:Sequence [Functional Concept]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   727 E C1548958:Sequential [Idea or Concept]
   727 E C1705294:Sequential [Qualitative Concept]

Phrase: "(38-42"

Phrase: ")"

Phrase: "and"

Phrase: "the region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "identified by Hughes et al."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1551730:Hughes [Population Group]
Processing 00000000.tx.195: (37) as a candidate A-binding site. 

Phrase: "(37"

Phrase: ")"

Phrase: "as a candidate A-binding site."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0005456:Binding Site [Receptor]
   861   C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]
Processing 00000000.tx.196: To determine whether A binding activity is localized to either or both of these denatured 2M fragments, 2M was subjected to heat fragmentation and analyzed by 125I-A-ligand blotting. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "A binding activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2266866:Binding Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "localized to either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392752:Localized [Spatial Concept]

Phrase: "or"

Phrase: "both of these denatured 2M fragments,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0238767:Both [Spatial Concept]
   748   C0332255:fragments [Functional Concept]
   748   C0486805:Fragments [Body Substance]
   748   C1706086:Both [Qualitative Concept]
   714 E C1708096:Fragment [Qualitative Concept]

Phrase: "2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "subjected to heat fragmentation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0018837:Heat [Natural Phenomenon or Process]
   770   C0332472:Fragmentation [Anatomical Abnormality]
   770   C1881708:FRAGMENTATION [Phenomenon or Process]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "analyzed by 125I-A-ligand blotting."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0023688:Ligand [Chemical]
   753   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.197: Only the 60-kDa 2M heat fragment bound 125I-A (Fig. 4). 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the 60-kDa 2M heat fragment bound 125I-A (Fig. 4"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   788   C0018837:Heat [Natural Phenomenon or Process]
   788   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   788   C0332255:fragment [Functional Concept]
   788   C0332297:bound [Spatial Concept]
   788   C0349966:Fig [Food]
   788   C1145667:Bound [Activity]
   788   C1167622:Bound [Molecular Function]
   788   C1337208:FIG [Food]
   788   C1532717:kDa [Quantitative Concept]
   788   C1689898:% bound [Quantitative Concept]
   788   C1708096:Fragment [Qualitative Concept]
   788   C2349209:Bound [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.198: The 120-kDa 2M heat fragment was without activity. 

Phrase: "The 120-kDa 2M heat fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0332255:fragment [Functional Concept]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "was without activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0205177:Activity [Functional Concept]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1421478:WAS [Gene or Genome]
   790   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.199: This result provides evidence that a specific sequence is responsible for the interaction of 2M with A. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "a specific sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "responsible for the interaction of 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "with A."
Processing 00000000.tx.200: Furthermore, this result suggests that the 2M growth factor-binding site and the A-binding site are distinct. 

Phrase: "Furthermore,"

Phrase: "this result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the 2M growth factor-binding site"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   861   C1149299:Growth Factor Binding [Molecular Function]
   827   C0005456:Binding Site [Receptor]
   827   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0682969:Binding Site [Amino Acid Sequence]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0205145:Site [Spatial Concept]
   799   C0220844:growth [Physiologic Function]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1515974:Site [Body Location or Region]
   799   C1521761:Factor [Functional Concept]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2825164:Site [Spatial Concept]
   799   C2827422:Factor [Conceptual Entity]
   799   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "the A-binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "distinct."
Processing 00000000.tx.201: View larger version (51K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(51K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.202: 4.  

Phrase: "4."
Processing 00000000.tx.203: Binding of 125I-A to 2M heat fragments. 

Phrase: "Binding of 125I-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "A to 2M heat fragments."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   783   C1825406:A-2 [Gene or Genome]
   753   C0018837:Heat [Natural Phenomenon or Process]
   753   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0332255:fragments [Functional Concept]
   753   C0486805:Fragments [Body Substance]
   719 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.204: Native 2M was heated at 100C, in the presence of SDS, for 5or 30min and subjected to ligand blot analysis with 125I-A (bottom panel). 

Phrase: "Native 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "was"

Phrase: "heated at 100C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of SDS,"

Phrase: "for 5or 30min"

Phrase: "and"

Phrase: "subjected to ligand blot analysis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0023688:Ligand [Chemical]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "with 125I-A (bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0441833:Panel [Idea or Concept]
   812   C1999270:Panel [Intellectual Product]
   812   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.205: As a control, unheated native 2M and BSA were studied simultaneously. 

Phrase: "As a control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "unheated native 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "BSA"

Phrase: "were"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "simultaneously."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]
Processing 00000000.tx.206: Equivalent PVDF membranes were stained with Coomassie Blue (top panel). 

Phrase: "Equivalent PVDF membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0025255:Membranes [Tissue]
   779 E C0596901:Membrane [Cell Component]
   779 E C1706182:Membrane [Manufactured Object]
   729 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "stained with Coomassie Blue"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   770   C1260957:Blue [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.207: The 18-kDa RBF Competes with 2M-MA for A Binding-- A second method for defined fragmentation of 2M involves papain treatment of the activated conformation under mildly acidic conditions. 

Phrase: "The 18-kDa RBF"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0597358:Receptor Binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C0332255:fragment [Functional Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "Competes with 2M-MA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0612672:MA-2 [Organic Chemical]
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "for A Binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "-"

Phrase: "-"

Phrase: "A second method for defined fragmentation of 2M"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0449354:Method of fragmentation [Intellectual Product]
   742   C0025663:Method [Intellectual Product]
   742   C0449851:Method [Functional Concept]
   742   C0871511:METHOD [Intellectual Product]

Phrase: "involves"

Phrase: "papain treatment of the activated conformation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "under mildly acidic conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.208: An 18-kDa fragment, which retains LRP binding activity, is dissociated from the C terminus of each 2M subunit (aa 1314-1451) (38-40). 

Phrase: "An 18-kDa fragment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "which"

Phrase: "retains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "LRP binding activity,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   904   C1152818:lipoprotein receptor activity [Molecular Function]
   876   C1152633:receptor activity [Molecular Function]
   839   C1537044:protein activity [Molecular Function]
   827   C2266866:Binding Activity [Molecular Function]
   799   C0205177:Activity [Functional Concept]
   799   C0439167:% activity [Quantitative Concept]
   799   C0441655:Activity [Activity]
   799   C1561536:*Activity [Idea or Concept]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   709   C1149323:lipoprotein binding [Molecular Function]

Phrase: "is"

Phrase: "dissociated from the C terminus of each 2M subunit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C1711351:Subunit [Quantitative Concept]

Phrase: "(aa 1314-1451"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "(38-40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.209: The residual 600-kDa fragment retains the major structural characteristics of 2M-MA, as determined by electron microscopy (45). 

Phrase: "The residual 600-kDa fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "retains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "the major structural characteristics of 2M-MA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1521970:Characteristics [Qualitative Concept]

Phrase: "as"

Phrase: "determined by electron microscopy"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0026019:Electron Microscopy [Laboratory Procedure]
   833   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   770   C0013852:Electron [Quantitative Concept]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C3463986:Electron [Bird]

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.210: The 18-and 600-kDa 2M fragments were purified and assessed for their ability to bind A without prior denaturation. 

Phrase: "The 18-"

Phrase: "and"

Phrase: "600-kDa 2M fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0332255:fragments [Functional Concept]
   804   C0486805:Fragments [Body Substance]
   771 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "and"

Phrase: "assessed for their ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085732:Ability [Organism Attribute]
   760   C1516048:Assessed [Activity]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "A without prior denaturation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301642:Denaturation [Molecular Function]
   770   C0332152:Prior [Temporal Concept]
   770   C2826257:PRIOR [Event]
Processing 00000000.tx.211: When 125I-A was incubated with the 600-kDa fragment, in solution, binding was not detected by non-denaturing PAGE (Fig. 5A). 

Phrase: "When"

Phrase: "125I-"

Phrase: "A"

Phrase: "was"

Phrase: "incubated with the 600-kDa fragment,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0332255:fragment [Functional Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1532717:kDa [Quantitative Concept]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "in solution,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037633:Solution [Substance]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected by non-denaturing PAGE (Fig. 5A"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C3494467:Non-Denaturing PAGE [Laboratory Procedure]
   748   C0349966:Fig [Food]
   748   C0442726:Detected [Finding]
   748   C1337208:FIG [Food]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1518422:Non [Functional Concept]
   748   C1553637:5a [Medical Device]
   748   C1704732:Page [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.212: Under equivalent conditions, binding was readily detected with intact 2M-MA. 

Phrase: "Under equivalent conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "readily"

Phrase: "detected with intact 2M-MA."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0612672:MA-2 [Organic Chemical]
   753   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0205266:Intact [Qualitative Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1554187:Intact [Idea or Concept]
Processing 00000000.tx.213: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.214: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.215: A binding to 2M fragments derived by papain treatment. 

Phrase: "A binding to 2M fragments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "derived by papain treatment."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0030346:Papain [Enzyme,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1441547:Derived [Qualitative Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3245521:derived [Idea or Concept]
   770   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.216: The 600-and 18-kDa papain fragments of 2M-MA were prepared and purified. 

Phrase: "The 600-"

Phrase: "and"

Phrase: "18-kDa papain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030346:Papain [Enzyme,Pharmacologic Substance]

Phrase: "fragments of 2M-MA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0612672:MA-2 [Organic Chemical]
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0332255:fragment [Functional Concept]
   760   C0486805:Fragments [Body Substance]
   760   C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "purified."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]
Processing 00000000.tx.217: A, 125I-A was incubated with 2M-MA or the 600-kDa fragment (1.0M), under non-denaturing conditions, for 2h at 37C. 

Phrase: "A,"

Phrase: "125I-"

Phrase: "A"

Phrase: "was"

Phrase: "incubated with 2M-MA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0612672:MA-2 [Organic Chemical]
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "or"

Phrase: "the 600-kDa fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "(1.0M"

Phrase: ")"

Phrase: ","

Phrase: "under non-denaturing conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.218: The samples were subjected to non-denaturing PAGE. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "subjected to non-denaturing PAGE."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C3494467:Non-Denaturing PAGE [Laboratory Procedure]
   760   C1518422:Non [Functional Concept]
   760   C1704732:Page [Intellectual Product]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.219: 125I-A was detected by PhosphorImager analysis. 

Phrase: "125I-"

Phrase: "A"

Phrase: "was"

Phrase: "detected by PhosphorImager analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0442726:Detected [Finding]
   770   C0936012:Analysis [Research Activity]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.220: B, 125I-A was incubated with 2M-MA (0.3M) and increasing concentrations of the 18-kDa RBF for 2h at 37C. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "125I-"

Phrase: "A"

Phrase: "was"

Phrase: "incubated with 2M-MA (0.3M"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0612672:MA-2 [Organic Chemical]
   748   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0332060:3M [Health Care Related Organization]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "increasing concentrations of the 18-kDa RBF"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0086045:Concentrations [Mental Process]
   708 E C1446561:Concentration [Quantitative Concept]

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "at 37C."
Processing 00000000.tx.221: The samples were then subjected to non-denaturing PAGE and PhosphorImager analysis. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to non-denaturing PAGE"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C3494467:Non-Denaturing PAGE [Laboratory Procedure]
   760   C1518422:Non [Functional Concept]
   760   C1704732:Page [Intellectual Product]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "PhosphorImager analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.222: The figure shows the fraction of the 125I-A that was associated with 2M-MA, compared with the amount observed in the absence of 18-kDa RBF. 

Phrase: "The figure"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the fraction of the 125I-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1264633:Fraction of [Quantitative Concept]
           Fraction
   760   C1554103:Fraction [Idea or Concept]

Phrase: "A that"

Phrase: "was"

Phrase: "associated with 2M-MA,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0612672:MA-2 [Organic Chemical]
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "compared with the amount"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1265611:Amount [Quantitative Concept]
   770   C1707455:Compared [Activity]

Phrase: "observed in the absence of 18-kDa RBF."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0597358:Receptor Binding [Molecular Function]
   739   C0243122:binding [Functional Concept]
   739   C0332197:absence [Quantitative Concept]
   739   C0332255:fragment [Functional Concept]
   739   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1441672:Observed [Functional Concept]
   739   C1532717:kDa [Quantitative Concept]
   739   C1689985:Absence [Anatomical Abnormality]
   739   C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.223: In separate experiments, 2.5nM 125I-A was incubated with 0.3M 2M-MA and increasing concentrations of purified 18-kDa RBF in solution. 

Phrase: "In separate experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "2.5nM 125I-"

Phrase: "A"

Phrase: "was"

Phrase: "incubated with 0.3M 2M-MA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0612672:MA-2 [Organic Chemical]
   748   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0332060:3M [Health Care Related Organization]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "increasing concentrations of purified 18-kDa RBF"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0086045:Concentrations [Mental Process]
   708 E C1446561:Concentration [Quantitative Concept]

Phrase: "in solution."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037633:Solution [Substance]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.224: 125I-A binding to 2M-MA was decreased in the presence of the 18-kDa RBF, and the magnitude of the effect was dependent on the RBF concentration (Fig. 5B). 

Phrase: "125I-"

Phrase: "A binding to 2M-MA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "decreased in the presence of the 18-kDa RBF,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   756   C0597358:Receptor Binding [Molecular Function]
   738   C0205216:Decreased [Quantitative Concept]
   738   C0243122:binding [Functional Concept]
   738   C0332255:fragment [Functional Concept]
   738   C0392148:Presence [Therapeutic or Preventive Procedure]
   738   C0392756:Decreased [Qualitative Concept]
   738   C0442797:decreased [Qualitative Concept]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1532717:kDa [Quantitative Concept]
   738   C1708096:Fragment [Qualitative Concept]
   704 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "the magnitude of the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449286:magnitude [Quantitative Concept]
   760   C1704240:Magnitude [Quantitative Concept]

Phrase: "was"

Phrase: "dependent on the RBF concentration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.225: The IC50 was 0.7M. 

Phrase: "The IC50"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600495:IC50 [Quantitative Concept]

Phrase: "was"

Phrase: "0.7M."
Processing 00000000.tx.226: Because of the relatively high concentration of 2M-MA, the KD for A binding to the 18-kDa RBF was ~2-fold lower (0.3-0.4 M) than the IC50. 

Phrase: "Because of the relatively high concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 2M-MA,"

Phrase: "the KD for A binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0026691:KD [Disease or Syndrome]
   760   C1705240:KD [Gene or Genome]
   760   C1839259:KD [Disease or Syndrome]

Phrase: "to the 18-kDa RBF"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0597358:Receptor Binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C0332255:fragment [Functional Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "was ~"

Phrase: "2-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "(0.3-0.4"

Phrase: "M) than the IC50."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C0600495:IC50 [Quantitative Concept]
Processing 00000000.tx.227: These results provide further evidence that an A-binding site is localized near the C terminus of the 2M subunit and that this site is distinct from the growth factor-binding sequence. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "further evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "an A-binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "localized near the C terminus of the 2M subunit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0392752:Localized [Spatial Concept]
   739   C1711351:Subunit [Quantitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "this site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "distinct from the growth factor-binding sequence."
Processing 00000000.tx.228: A Binding to GST-2M-peptide Fusion Proteins-- To comprehensively analyze the 2M sequence with regard to A binding, we utilized ligand blotting to screen a series of six previously described 2M-peptide-GST fusion proteins (FP1-FP6) (18). 

Phrase: "A Binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "to GST-2M-peptide Fusion Proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0332466:Fusion [Functional Concept]
   793   C1293131:Fusion [Therapeutic or Preventive Procedure]
   779   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "--"

Phrase: "To comprehensively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "analyze"

Phrase: "the 2M sequence with regard to A binding,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C1519249:Sequence [Functional Concept]

Phrase: "we"

Phrase: "utilized"

Phrase: "ligand blotting to"

Phrase: "screen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220908:screen [Health Care Activity]
  1000   C1305399:screen [Functional Concept]
  1000   C1705053:Screen [Medical Device]

Phrase: "a series of six previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205549:Series [Quantitative Concept]
   760   C2348044:Series [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "2M-peptide-GST fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0332466:Fusion [Functional Concept]
   793   C1293131:Fusion [Therapeutic or Preventive Procedure]
   779   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "(FP1-FP6"

Phrase: ")"

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.229: In the intact 2M subunit, the bait region and growth factor-binding site are located in FP3. 

Phrase: "In the intact 2M subunit,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1711351:Subunit [Quantitative Concept]

Phrase: "the bait region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "and"

Phrase: "growth factor-binding site"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   923   C1149299:Growth Factor Binding [Molecular Function]
   861   C0005456:Binding Site [Receptor]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0682969:Binding Site [Amino Acid Sequence]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0205145:Site [Spatial Concept]
   812   C0220844:growth [Physiologic Function]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1515974:Site [Body Location or Region]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2825164:Site [Spatial Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "are"

Phrase: "located in FP3."
Processing 00000000.tx.230: The residues that comprise the thiol ester bond are located in FP4, and the LRP recognition sequence is in FP6. 

Phrase: "The residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709915:Residue [Conceptual Entity]
   966   C1882936:RESIDUE [Phenomenon or Process]
   916 E C1609982:Residual [Qualitative Concept]

Phrase: "that"

Phrase: "comprise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "the thiol ester bond"

Phrase: "are"

Phrase: "located in FP4,"

Phrase: "and"

Phrase: "the LRP recognition sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   839   C0002518:Protein Sequence [Amino Acid Sequence]
   799   C0004793:Sequence [Nucleotide Sequence]
   799   C0162326:Sequence [Nucleotide Sequence]
   799   C0162327:Sequence [Nucleotide Sequence]
   799   C1519249:Sequence [Functional Concept]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   727 E C1548958:Sequential [Idea or Concept]
   727 E C1705294:Sequential [Qualitative Concept]

Phrase: "is in FP6."
Processing 00000000.tx.231: To assess A binding, the fusion proteins were treated with iodoacetamide, without prior reduction, and subjected to SDS-PAGE. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "A binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "the fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "treated with iodoacetamide,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021973:Iodoacetamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "without prior reduction,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "subjected to SDS-PAGE."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.232: After electrotransfer to PVDF, only FP6 bound 125I-A (Fig. 6A). 

Phrase: "After"

Phrase: "electrotransfer to PVDF,"

Phrase: "only FP6"

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "125I-A (Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.233: View larger version (47K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(47K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.234: 6.  

Phrase: "6."
Processing 00000000.tx.235: Ligand blot analysis of A binding to GST-2M fusion proteins. 

Phrase: "Ligand blot analysis of A binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "to GST-2M fusion proteins."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0332466:Fusion [Functional Concept]
   795   C1293131:Fusion [Therapeutic or Preventive Procedure]
   785   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   710   C1415329:GLUTATHIONE S-TRANSFERASE 2 [Gene or Genome]
Processing 00000000.tx.236: A, PVDF membranes with FP1-FP6, which had been denatured in the absence of reductant and treated with iodoacetamide, were probed with 125I-A. 

Phrase: "A,"

Phrase: "PVDF membranes with FP1-FP6,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C0025255:Membranes [Tissue]
   719 E C0596901:Membrane [Cell Component]
   719 E C1706182:Membrane [Manufactured Object]

Phrase: "which"

Phrase: "had"

Phrase: "been"

Phrase: "denatured in the absence of reductant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "and"

Phrase: "treated with iodoacetamide,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021973:Iodoacetamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "were"

Phrase: "probed with 125I-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   756   C0182400:Probe [Medical Device]
   756   C1704681:Probe [Gene or Genome]
   756   C2347609:Probe [Chemical Viewed Functionally]
   756   C3536729:Probe [Manufactured Object]

Phrase: "A."
Processing 00000000.tx.237: B, a representative study in which FP3 and FP6 were denatured in the presence of DTT, treated with iodoacetamide, and subjected to ligand blot analysis with 125I-A. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "a representative study in which FP3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0557651:Study [Manufactured Object]
   753   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "FP6"

Phrase: "were"

Phrase: "denatured in the presence of DTT,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "treated with iodoacetamide,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021973:Iodoacetamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "subjected to ligand blot analysis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0023688:Ligand [Chemical]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "with 125I-"

Phrase: "A."
Processing 00000000.tx.238: C, FP3, FP4, and FP6 were denatured in 2% SDS and DTT, treated with iodoacetamide, subjected to SDS-PAGE, and electrotransferred to PVDF membranes. 

Phrase: "C,"

Phrase: "FP3,"

Phrase: "FP4,"

Phrase: "and"

Phrase: "FP6"

Phrase: "were"

Phrase: "denatured in 2% SDS"

Phrase: "and"

Phrase: "DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "treated with iodoacetamide,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021973:Iodoacetamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "subjected to SDS-PAGE,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "electrotransferred to PVDF membranes."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0071710:polyvinylidene fluoride [Organic Chemical]
   760   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   760   C0025255:Membranes [Tissue]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.239: The membranes were probed with biotinylated A or subjected to immunoblot analysis with GST-specific antibody. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "probed with biotinylated A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0182400:Probe [Medical Device]
   737   C1704681:Probe [Gene or Genome]
   737   C2347609:Probe [Chemical Viewed Functionally]
   737   C3536729:Probe [Manufactured Object]

Phrase: "or"

Phrase: "subjected to immunoblot analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "with GST-specific antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.240: Because intact disulfide bonds may allow partial restoration of non-denatured structure following protein electrotransfer to PVDF membranes, ligand-blotting experiments were also performed using FP3 and FP6 that were reduced with DTT and then alkylated with iodoacetamide. 

Phrase: "Because"

Phrase: "intact disulfide bonds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   867   C1511997:Disulfide Bond [Amino Acid Sequence]
   827   C0012771:disulfide [Chemical Viewed Structurally]

Phrase: "may"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "partial restoration of non-denatured structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   820   C0678689:restoration of structure [Organism Function]
   753   C0449982:Restoration [Intellectual Product]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "protein electrotransfer to PVDF membranes,"

Phrase: "ligand-blotting experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "FP3"

Phrase: "and"

Phrase: "FP6"

Phrase: "that"

Phrase: "were"

Phrase: "reduced with DTT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "alkylated with iodoacetamide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021973:Iodoacetamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.241: In these experiments, 125I-A binding was still detected only with FP6 and not with FP3 (Fig. 6B). 

Phrase: "In these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "125I-"

Phrase: "A binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "still"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "only with FP6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205171:Only [Quantitative Concept]
   790   C1720467:Only [Intellectual Product]

Phrase: "and"

Phrase: "not with FP3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1518422:Not [Functional Concept]

Phrase: "(Fig. 6B"

Phrase: ")."
Processing 00000000.tx.242: Equivalent results were obtained when biotinylated A was substituted for 125I-A (Fig. 6C). 

Phrase: "Equivalent results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "when"

Phrase: "biotinylated"

Phrase: "A"

Phrase: "was"

Phrase: "substituted for 125I-A (Fig. 6C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0349966:Fig [Food]
   753   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.243: Based on these results, a model emerges in which the structure of 2M includes at least two distinct protein interaction sites with differing specificity. 

Phrase: "Based on these results,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737 E C1880279:Base [Biomedical or Dental Material]
   737   C2825142:Result [Finding]

Phrase: "a model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "emerges in which"

Phrase: "the structure of 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678594:Structure [Spatial Concept]

Phrase: "includes at least two distinct protein interaction sites"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   770   C0872079:protein interaction [Molecular Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205145:Sites [Spatial Concept]
   744   C0205448:Two [Quantitative Concept]
   744   C0332257:Includes [Functional Concept]
   744   C1552866:include [Idea or Concept]
   744   C1704675:Interaction [Functional Concept]
   744   C2700399:Include [Activity]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "with differing specificity."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]
Processing 00000000.tx.244: A site located near the center of the 2M subunit is responsible for the binding of growth factors whereas a separate site near the C terminus is exclusively responsible for the binding of A. 

Phrase: "A site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "located near the center of the 2M subunit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0205099:Center [Spatial Concept]
   742   C1711351:Subunit [Quantitative Concept]

Phrase: "is"

Phrase: "responsible for the binding of growth factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "whereas"

Phrase: "a separate site near the C terminus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "exclusively responsible for the binding of A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]
Processing 00000000.tx.245: Resolution of the LRP- and A-binding Sites in 2M-- In intact human 2M, aa 1370-1377 constitute an helix that is the center of the LRP recognition site (41, 42). 

Phrase: "Resolution of the LRP-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1514893:Resolution [Idea or Concept]
   748   C1706463:Resolution [Quantitative Concept]
   748   C2699488:Resolution [Conceptual Entity]

Phrase: "and"

Phrase: "A-binding Sites in 2M"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0005456:Binding Sites [Receptor]
   756 E C0682969:Binding Site [Amino Acid Sequence]
   753   C0205145:Sites [Spatial Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "-"

Phrase: "-"

Phrase: "In intact human 2M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "aa 1370-1377"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "constitute"

Phrase: "an helix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018882:Helix [Eukaryote]
  1000   C0229304:Helix [Body Part, Organ, or Organ Component]
  1000   C1704821:Helix [Spatial Concept]
  1000   C1705682:Helix [Anatomical Structure]

Phrase: "that"

Phrase: "is"

Phrase: "the center of the LRP recognition site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205099:Center [Spatial Concept]

Phrase: "(41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.246: The helix is anchored in position by a sandwich so that the side chains of two critical Lys residues (aa 1370and 1374) protrude at 45 angles and are surrounded by hydrophobic surface residues (41). 

Phrase: "The helix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018882:Helix [Eukaryote]
  1000   C0229304:Helix [Body Part, Organ, or Organ Component]
  1000   C1704821:Helix [Spatial Concept]
  1000   C1705682:Helix [Anatomical Structure]

Phrase: "is"

Phrase: "anchored in position"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0733755:Position [Spatial Concept]
   790   C1293132:anchored [Therapeutic or Preventive Procedure]
   718 E C0240795:POSITIONAL [Finding]

Phrase: "by a sandwich"

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "the side chains of two critical Lys residues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0337112:chains [Manufactured Object]
   744   C0441987:Side [Spatial Concept]
   744   C1524075:Chains [Idea or Concept]

Phrase: "(aa 1370and 1374"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "protrude at 45 angles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205143:angles [Spatial Concept]

Phrase: "and"

Phrase: "are"

Phrase: "surrounded by hydrophobic surface residues"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205148:Surface [Spatial Concept]
   760   C0598629:Hydrophobic [Qualitative Concept]
   760   C1282914:Surrounded [Spatial Concept]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.247: This complex secondary and tertiary structure may explain why the 18-kDa RBF is recognized by LRP, whereas tryptic peptides corresponding to the same region and partially denatured forms of the 18-kDa RBF are not (38, 41). 

Phrase: "This complex secondary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027627:secondary [Neoplastic Process]
   861   C0175668:Secondary [Temporal Concept]
   861   C0205436:Secondary [Quantitative Concept]

Phrase: "and"

Phrase: "tertiary structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205372:Tertiary [Quantitative Concept]
   861   C0678594:Structure [Spatial Concept]

Phrase: "may"

Phrase: "explain"

Phrase: "why"

Phrase: "the 18-kDa RBF"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0597358:Receptor Binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C0332255:fragment [Functional Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "recognized by LRP,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   790   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   783   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   753   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]

Phrase: "whereas"

Phrase: "tryptic peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "corresponding to the same region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C0445247:Same [Qualitative Concept]

Phrase: "and"

Phrase: "partially denatured forms of the 18-kDa RBF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   739   C0348078:forms [Qualitative Concept]
   739   C0376315:Forms [Manufactured Object]
   706 E C1522492:Form [Functional Concept]

Phrase: "are"

Phrase: "not (38,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.248: Because our ligand blotting results demonstrated that tertiary structure is not necessary for A binding to FP6, we generated a new set of fusion proteins to explore the relationship between the LRP- and A-binding sites in 2M. 

Phrase: "Because"

Phrase: "our ligand blotting results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "demonstrated"

Phrase: "that tertiary structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205372:Tertiary [Quantitative Concept]
   861   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "not necessary for A binding"

Phrase: "to FP6,"

Phrase: "we"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "a new set of fusion proteins to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1137947:Protein SET [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0036849:Set [Mental Process]
   748   C1442518:Set [Functional Concept]
   748   C1705195:Set [Conceptual Entity]

Phrase: "explore"

Phrase: "the relationship between the LRP-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0439849:Relationship [Qualitative Concept]
   744   C1705630:Relationship [Idea or Concept]
   744   C1706279:Relationship [Idea or Concept]
   744   C3540605:Relationship [Intellectual Product]
   731   C0680206:relatedness, relationship [Social Behavior]

Phrase: "and"

Phrase: "A-binding sites in 2M."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0005456:Binding Sites [Receptor]
   756 E C0682969:Binding Site [Amino Acid Sequence]
   753   C0205145:Sites [Spatial Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.249: FP6c included all of the amino acids that form the LRP recognition helix, five amino acids N-terminal to the helix and the entire sequence C-terminal to the helix; 

Phrase: "FP6c"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "all of the amino acids"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   773 E C2917660:Amino Acid [Pharmacologic Substance]
   760   C0001128:Acids [Chemical]
   760   C0444868:All [Quantitative Concept]
   760   C3539085:All [Idea or Concept]
   726 E C0202406:Acid [Laboratory Procedure]

Phrase: "that"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "the LRP recognition helix,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   839   C1704821:Protein Helix [Spatial Concept]
           Helix
   799   C0018882:Helix [Eukaryote]
   799   C0229304:Helix [Body Part, Organ, or Organ Component]
   799   C1705682:Helix [Anatomical Structure]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "five amino acids N-terminal to the helix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1706793:N-Terminal Amino Acid [Amino Acid Sequence]
   744   C0205088:Terminal [Temporal Concept]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "the entire sequence C-terminal to the helix"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1707271:C-Terminal [Amino Acid Sequence]
   744   C0205088:Terminal [Temporal Concept]
   744   C1705314:Terminal [Manufactured Object]
   744   C1705315:Terminal [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.250: however, FP6c did not bind A (Fig. 7). 

Phrase: "however,"

Phrase: "FP6c"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "A (Fig. 7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0163299:A 7 [Organic Chemical,Pharmacologic Substance]
   827   C0349966:Fig [Food]
   827   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.251: FP6a, which included the N-terminal segment of FP6 but terminated five amino acids before the start of the helix, bound A, albeit at lower levels than FP6. 

Phrase: "FP6a,"

Phrase: "which"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the N-terminal segment of FP6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0441635:Segment [Spatial Concept]

Phrase: "but"

Phrase: "terminated"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C1553404:terminated [Idea or Concept]
  1000   C2348570:Terminated [Functional Concept]
   928 E C0011065:Expired [Organism Function]
   928 E C0231800:Expired [Organ or Tissue Function]
   928 E C1704631:Expire [Idea or Concept]
   907 E C0184532:dying [Organism Function]
   907 E C1546956:Died [Finding]

Phrase: "five amino acids before the start of the helix,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   764   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0001128:Acids [Chemical]
   731 E C2917660:Amino Acid [Pharmacologic Substance]
   708 E C0202406:Acid [Laboratory Procedure]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "A,"

Phrase: "albeit at lower levels"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0441889:Levels [Qualitative Concept]
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "than FP6."
Processing 00000000.tx.252: These results suggest that the A-binding site is located N-terminal to the LRP binding helix. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the A-binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "is"

Phrase: "located"

Phrase: "N-terminal to the LRP binding helix."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   777   C1323338:N-terminal binding [Molecular Function]
   739   C0205088:Terminal [Temporal Concept]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.253: FP6b, which was equivalent to FP6a but extended through the helix to aa 1400,bound slightly increased levels of A, suggesting that amino acids 1365-1400 may impact positively on this interaction; 

Phrase: "FP6b,"

Phrase: "which"

Phrase: "was"

Phrase: "equivalent to FP6a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205163:Equivalent [Qualitative Concept]
   790   C0439185:equivalent [Quantitative Concept]

Phrase: "but"

Phrase: "extended through the helix"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0018882:Helix [Eukaryote]
   770   C0229304:Helix [Body Part, Organ, or Organ Component]
   770   C0231448:Extended [Functional Concept]
   770   C0231449:Extended [Spatial Concept]
   770   C0439792:extended [Spatial Concept]
   770   C1704821:Helix [Spatial Concept]
   770   C1705682:Helix [Anatomical Structure]

Phrase: "to aa 1400,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "slightly increased levels of A,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that amino acids 1365-1400"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "may"

Phrase: "impact positively on this interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1825598:IMPACT [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.254: however, ligand blotting results provide only an approximation of differences in binding affinity. 

Phrase: "however,"

Phrase: "ligand blotting results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "an approximation of differences"

Phrase: "in binding affinity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1510827:Affinity [Natural Phenomenon or Process]
Processing 00000000.tx.255: View larger version (26K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.256: 7.  

Phrase: "7."
Processing 00000000.tx.257: Resolution of the A- and LRP-binding sites in the 2M subunit. 

Phrase: "Resolution of the A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514893:Resolution [Idea or Concept]
   770   C1706463:Resolution [Quantitative Concept]
   770   C2699488:Resolution [Conceptual Entity]

Phrase: "and"

Phrase: "LRP-binding sites"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   901   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   885   C0684162:receptor binding sites [Receptor]
   876   C0005456:RECEPTOR SITES [Receptor]
           Binding Sites
   876   C1149323:lipoprotein binding [Molecular Function]
   858   C0597358:Receptor Binding [Molecular Function]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   827   C0033618:Protein Binding [Molecular Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0205145:Sites [Spatial Concept]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   793 E C0682969:Binding Site [Amino Acid Sequence]
   766 E C1515974:Site [Body Location or Region]
   766 E C2825164:Site [Spatial Concept]

Phrase: "in the 2M subunit."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.258: A, fusion proteins containing amino acids that constitute the LRP recognition site and other fusion proteins that do not were subjected to ligand blot analysis with 125I-A. 

Phrase: "A,"

Phrase: "fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "amino acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "that"

Phrase: "constitute"

Phrase: "the LRP recognition site"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   876   C0005456:Receptor site, NOS [Receptor]
   799   C0205145:Site [Spatial Concept]
   799   C0524637:Recognition [Mental Process]
   799   C1515974:Site [Body Location or Region]
   799   C2825164:Site [Spatial Concept]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "and"

Phrase: "other fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "that"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "were"

Phrase: "subjected to ligand blot analysis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0023688:Ligand [Chemical]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "with 125I-"

Phrase: "A."
Processing 00000000.tx.259: As a control for load, blots were stained with Coomassie Blue or subjected to immunoblot analysis with GST-specific antibody. 

Phrase: "As a control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "for load,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1550025:Load [Idea or Concept]
  1000   C1704782:Load [Manufactured Object]
  1000   C1708715:Load [Activity]

Phrase: "blots"

Phrase: "were"

Phrase: "stained with Coomassie Blue"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0056269:Coomassie blue [Organic Chemical,Pharmacologic Substance]
   770   C1260957:Blue [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "subjected to immunoblot analysis"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "with GST-specific antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.260: B, the results of at least eight separate experiments with each fusion protein were pooled. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "the results of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "at least eight separate experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "with each fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "pooled."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]
Processing 00000000.tx.261: In each case, 125I-A binding to a fusion protein was standardized against that observed with FP6 (meanS.D.). 

Phrase: "In each case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "125I-"

Phrase: "A binding to a fusion protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0033618:Protein Binding [Molecular Function]
   783   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "standardized against that"

Phrase: "observed with FP6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "(meanS."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704970:Means [Conceptual Entity]
   966 E C0444504:Mean [Quantitative Concept]
   966 E C2347634:Mean [Quantitative Concept]
   966 E C2348143:Mean [Quantitative Concept]

Phrase: "D."

Phrase: ")."
Processing 00000000.tx.262: Fusion proteins, which correspond exactly to the sequence of the 18-kDa RBF, were generated and mutated to essentially eliminate the LRP-binding site (FP6d-AA) (39) or substantially reduce binding to LRP while eliminating binding to the previously described 2M signaling receptor (FP6d-AR) (40). 

Phrase: "Fusion proteins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "which"

Phrase: "correspond"

Phrase: "exactly to the sequence of the 18-kDa RBF,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   756   C0597358:Receptor Binding [Molecular Function]
   738   C0004793:Sequence [Nucleotide Sequence]
   738   C0162326:Sequence [Nucleotide Sequence]
   738   C0162327:Sequence [Nucleotide Sequence]
   738   C0243122:binding [Functional Concept]
   738   C0332255:fragment [Functional Concept]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C1145667:Binding [Activity]
   738   C1167622:Binding [Molecular Function]
   738   C1519249:Sequence [Functional Concept]
   738   C1532717:kDa [Quantitative Concept]
   738   C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "to essentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "eliminate"

Phrase: "the LRP-binding site"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   901   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   876   C0005456:Receptor site, NOS [Receptor]
           Binding Site
   876   C1149323:lipoprotein binding [Molecular Function]
   858   C0597358:Receptor Binding [Molecular Function]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   827   C0033618:Protein Binding [Molecular Function]
   827   C0682969:Binding Site [Amino Acid Sequence]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0205145:Site [Spatial Concept]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1515974:Site [Body Location or Region]
   799   C2825164:Site [Spatial Concept]

Phrase: "(FP6d-AA) (39"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1235746:Aa [Plant]
   827   C1882141:aa [Qualitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "substantially"

Phrase: "reduce"

Phrase: "binding to LRP"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   882   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   790   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   783   C0033618:Protein Binding [Molecular Function]
   783   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   783   C0597358:Receptor Binding [Molecular Function]
   783   C1149323:lipoprotein binding [Molecular Function]
   753   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "while"

Phrase: "eliminating binding to the previously"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "2M signaling receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(FP6d-AR) (40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439509:/40 [Temporal Concept]
   827   C2986463:AR+ [Finding]

Phrase: ")."
Processing 00000000.tx.263: By ligand blotting, both forms of FP6d retained A binding activity, supporting our hypothesis that the A and 2M receptor recognition sequences in 2M are non-identical. 

Phrase: "By ligand blotting,"

Phrase: "both"

Phrase: "forms of FP6d"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1522492:Form [Functional Concept]

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "A binding activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2266866:Binding Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "our hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "the A"

Phrase: "and"

Phrase: "2M receptor recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0524637:Recognition [Mental Process]

Phrase: "sequences in 2M"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]

Phrase: "are"

Phrase: "non-identical."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205280:Identical [Qualitative Concept]
   861   C1518422:Non [Functional Concept]
Processing 00000000.tx.264: A slight decrease in the binding of A to FP6-AA and FP6-AR, compared with FP6, may indicate that the mutated Lys residues, although non-essential, impact positively on the interaction. 

Phrase: "A slight decrease in the binding of A to FP6-AA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0392756:Decrease [Qualitative Concept]
   738   C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "FP6-AR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986463:AR+ [Finding]

Phrase: "compared with FP6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "may"

Phrase: "indicate"

Phrase: "that"

Phrase: "the mutated Lys residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "although"

Phrase: "non-essential, impact positively on the interaction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1825598:IMPACT [Gene or Genome]
Processing 00000000.tx.265: Determination of the KD for A Binding to FP6-- In the ligand blotting experiments, the concentration of 125I-A, used as probe, was substantially lower than the likely KD value for 125I-A binding to any of the fusion proteins. 

Phrase: "Determination of the KD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1148554:determination [Laboratory Procedure]

Phrase: "for A Binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "to FP6"

Phrase: "-"

Phrase: "-"

Phrase: "In the ligand blotting experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "the concentration of 125I-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "A,"

Phrase: "used as probe,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0182400:Probe [Medical Device]
   790   C1273517:used [Finding]
   790   C1704681:Probe [Gene or Genome]
   790   C2347609:Probe [Chemical Viewed Functionally]
   790   C3536729:Probe [Manufactured Object]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "substantially lower than the likely KD value"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0441994:Lower [Spatial Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C2003888:Lower [Activity]

Phrase: "for 125I-"

Phrase: "A binding to any of the fusion proteins."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   767   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750 E C0033618:Protein Binding [Molecular Function]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
Processing 00000000.tx.266: Thus, assuming equivalent load and insignificant contributions from "low affinity" or "nonspecific" binding sites, the amount of binding observed is inversely proportional to the KD for each interaction. 

Phrase: "Thus,"

Phrase: "assuming"

Phrase: "equivalent load"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1550025:Load [Idea or Concept]
   861   C1704782:Load [Manufactured Object]
   861   C1708715:Load [Activity]

Phrase: "and"

Phrase: "insignificant contributions from ""low affinity"" or ""nonspecific"" binding sites,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1880177:Contribution [Activity]

Phrase: "the amount of binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "is"

Phrase: "inversely proportional to the KD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205351:Proportional [Qualitative Concept]

Phrase: "for each interaction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.267: To more accurately assess the binding affinity of A for FP6 and FP6d-AA, specific binding experiments were performed. 

Phrase: "To more accurately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the binding affinity of A for FP6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "FP6d-AA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "specific binding experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.268: FP6 and FP6-AA were purified to homogeneity; 

Phrase: "FP6"

Phrase: "and"

Phrase: "FP6-AA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "were"

Phrase: "purified to homogeneity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1881065:Homogeneity [Qualitative Concept]
   790   C1998793:Purified [Functional Concept]

Phrase: ";"
Processing 00000000.tx.269: however, unlike intact 2M-MA and the 18-kDa RBF, the fusion proteins did not bind A in solution, even when refolding protocols were executed. 

Phrase: "however,"

Phrase: "unlike intact 2M-MA"

Phrase: "and"

Phrase: "the 18-kDa RBF,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0597358:Receptor Binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C0332255:fragment [Functional Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "the fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "A in solution, even"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0037633:Solution [Substance]
   827   C0150312:In [Quantitative Concept]
   827   C0332285:In [Spatial Concept]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "when"

Phrase: "refolding protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]

Phrase: "were"

Phrase: "executed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705848:Executed [Activity]
   966 E C3245498:execute [Functional Concept]
Processing 00000000.tx.270: Possible explanations for this observation are provided under "Discussion." 

Phrase: "Possible explanations for this observation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0681841:Explanations [Intellectual Product]

Phrase: "are"

Phrase: "provided under ""Discussion."""
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0557061:Discussion [Therapeutic or Preventive Procedure]
   790   C1999230:Provided [Activity]
   790   C2584313:Discussion [Social Behavior]
Processing 00000000.tx.271: As an alternative approach, we immobilized purified FP6, FP6d-AA, and FP3 on PVDF after exposure to SDS and probed the membranes with 125I-A (0.1M) and increasing concentrations of unlabeled A. 

Phrase: "As an alternative approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "we"

Phrase: "immobilized"

Phrase: "purified FP6,"

Phrase: "FP6d-AA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "and"

Phrase: "FP3 on PVDF"

Phrase: "after exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to SDS"

Phrase: "and"

Phrase: "probed"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0182400:Probe [Medical Device]
   966   C1704681:Probe [Gene or Genome]
   966   C2347609:Probe [Chemical Viewed Functionally]
   966   C3536729:Probe [Manufactured Object]

Phrase: "the membranes with 125I-A (0.1M"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0025255:Membranes [Tissue]
   714 E C0596901:Membrane [Cell Component]
   714 E C1706182:Membrane [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "increasing concentrations of unlabeled A."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.272: Nonspecific binding was defined by the level of 125I-A binding observed in the presence of 30M unlabeled A. 

Phrase: "Nonspecific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C0750540:Nonspecific [Idea or Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "defined by the level of 125I-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C1704788:Defined [Conceptual Entity]
   753   C2946261:Level [Pharmacologic Substance]
   753   C3539106:Defined [Intellectual Product]

Phrase: "A binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "observed in the presence of 30M"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1441672:Observed [Functional Concept]
   753   C1442458:30M [Temporal Concept]
   753   C1552109:30m [Body Part, Organ, or Organ Component]

Phrase: "unlabeled"

Phrase: "A."
Processing 00000000.tx.273: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.274: 8, specific binding of 125I-A to both FP6 and FP6d-AA was detected. 

Phrase: "8,"

Phrase: "specific binding of 125I-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205369:Specific [Qualitative Concept]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1552740:specific [Intellectual Product]

Phrase: "A to both FP6"

Phrase: "and"

Phrase: "FP6d-AA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "was"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.275: The KD values were 2.40.8and 5.20.6M, respectively (meanS.E., n=3with internal triplicate replicates). 

Phrase: "The KD values"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0026691:KD [Disease or Syndrome]
   861   C0042295:Values [Qualitative Concept]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "2.40.8and 5.20.6M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C3171719:6M [Quantitative Concept]

Phrase: "respectively"

Phrase: "(meanS.E.,"

Phrase: "n=3with internal triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205174:Triplicate [Quantitative Concept]

Phrase: "replicates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.276: The Bmax, which is not an informative value when this method is used, was 20-25% higher with FP6. 

Phrase: "The Bmax,"

Phrase: "which"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "an informative value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522609:Value [Quantitative Concept]

Phrase: "when"

Phrase: "this method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "is"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "was"

Phrase: "20-25% higher with FP6."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0205250:High [Qualitative Concept]
   726   C1299351:High [Qualitative Concept]
   726   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.277: Importantly, the binding of 125I-A to FP3 was entirely nonspecific. 

Phrase: "Importantly,"

Phrase: "the binding of 125I-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "A to FP3"

Phrase: "was"

Phrase: "entirely nonspecific."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0750540:Nonspecific [Idea or Concept]
Processing 00000000.tx.278: View larger version (12K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.279: 8.  

Phrase: "8."
Processing 00000000.tx.280: Specific binding isotherms for the interaction of A with FP6 and FP6d-AA. 

Phrase: "Specific binding isotherms for the interaction of A with FP6"

Phrase: "and"

Phrase: "FP6d-AA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]
Processing 00000000.tx.281: Multiple samples, containing the equivalent amount of FP6, FP6d-AA, or FP3, were subjected to SDS-PAGE and electrotransferred to PVDF membranes. 

Phrase: "Multiple samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the equivalent amount of FP6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "FP6d-AA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "or"

Phrase: "FP3,"

Phrase: "were"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "electrotransferred to PVDF membranes."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0071710:polyvinylidene fluoride [Organic Chemical]
   760   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   760   C0025255:Membranes [Tissue]
   726 E C0596901:Membrane [Cell Component]
   726 E C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.282: The membranes were incubated with 125I-A and increasing concentrations of unlabeled A. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated with 125I-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "A"

Phrase: "and"

Phrase: "increasing concentrations of unlabeled A."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]
Processing 00000000.tx.283: A binding was determined by PhosphorImager analysis. 

Phrase: "A binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "determined by PhosphorImager analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.284: The results of three separate experiments with triplicate replicates were averaged to generate the curves that are shown. 

Phrase: "The results of three separate experiments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   725   C2825142:Experimental Result [Finding]
           Result
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]

Phrase: "with triplicate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]

Phrase: "replicates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]

Phrase: "were"

Phrase: "averaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "the curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205134:Curve [Spatial Concept]

Phrase: "that"

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.285: Specific binding to FP6 () or FP6d-AA () is plotted as a function of the total A concentration. 

Phrase: "Specific binding to FP6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205369:Specific [Qualitative Concept]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1552740:specific [Intellectual Product]

Phrase: "("

Phrase: ")"

Phrase: "or"

Phrase: "FP6d-AA ()"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "is"

Phrase: "plotted as a function of the total"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0031843:function [Physiologic Function]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "A concentration."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.286: A did not demonstrate specific binding to FP3. 

Phrase: "A"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "demonstrate"

Phrase: "specific binding to FP3."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205369:Specific [Qualitative Concept]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1552740:specific [Intellectual Product]
Processing 00000000.tx.287: Effects of A on 2M Recognition by LRP-- Others have demonstrated that LRP mediates cellular uptake and degradation of A by binding A2M complexes (33-35). 

Phrase: "Effects of A on 2M Recognition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "by LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "--"

Phrase: "Others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "cellular uptake"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0007634:Cellular [Cell]
   861   C0178539:Cellular [Functional Concept]
   861   C0243144:Uptake [Physiologic Function]
   861   C0347980:% uptake [Quantitative Concept]
   789 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "degradation of A by binding A2M complexes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "(33-35"

Phrase: ")."
Processing 00000000.tx.288: Because of the close proximity of the A and LRP recognition sequences in 2M, we considered the possibility that A might inhibit binding of 2M to LRP even though the binding sites are non-identical. 

Phrase: "Because of the close proximity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1514583:Proximity [Spatial Concept]

Phrase: "of the A"

Phrase: "and"

Phrase: "LRP recognition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0524637:Recognition [Mental Process]
   771   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]

Phrase: "sequences in 2M,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C1519249:Sequence [Functional Concept]

Phrase: "we"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "A"

Phrase: "might"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "binding of 2M"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to LRP even"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   937   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   853   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "though"

Phrase: "the binding sites"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0005456:Binding Sites [Receptor]
   966 E C0682969:Binding Site [Amino Acid Sequence]
   861   C0205145:Sites [Spatial Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "are"

Phrase: "non-identical."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205280:Identical [Qualitative Concept]
   861   C1518422:Non [Functional Concept]
Processing 00000000.tx.289: Each 2M tetramer has four independent LRP recognition sequences (38). 

Phrase: "Each 2M tetramer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039686:Tetramere [Eukaryote]

Phrase: "has"

Phrase: "four independent LRP recognition sequences"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   822   C0002518:protein sequences [Amino Acid Sequence]
   793   C0162326:Sequences [Nucleotide Sequence]
   760 E C0004793:Sequence [Nucleotide Sequence]
   760 E C0162327:Sequence [Nucleotide Sequence]
   760 E C1519249:Sequence [Functional Concept]
   710 E C1548958:Sequential [Idea or Concept]
   710 E C1705294:Sequential [Qualitative Concept]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.290: Thus, even if some of the LRP-binding sites were blocked by A, receptor recognition may still occur. 

Phrase: "Thus,"

Phrase: "even"

Phrase: "if"

Phrase: "some of the LRP-binding sites"
Meta Candidates (Total=25; Excluded=4; Pruned=0; Remaining=21)
   818   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   784   C0684162:receptor binding sites [Receptor]
   764   C0005456:Binding Sites [Receptor]
           RECEPTOR SITES
   764   C0033618:Protein Binding [Molecular Function]
   764   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   762 E C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   762   C0597358:Receptor Binding [Molecular Function]
   762   C1149323:lipoprotein binding [Molecular Function]
   745   C2945843:Site of [Qualitative Concept]
   742   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205145:Sites [Spatial Concept]
   742   C0205392:Some [Quantitative Concept]
   742   C0243122:binding [Functional Concept]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]
   742   C3540770:Some [Intellectual Product]
   731 E C0682969:Binding Site [Amino Acid Sequence]
   708 E C1515974:Site [Body Location or Region]
   708 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "blocked by A,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0028778:Blocked [Pathologic Function]
   790   C0332206:Blocked [Functional Concept]
   790   C2983591:BLOCKED [Research Activity]
   756 E C1533157:Block [Substance]
   756 E C1706084:Block [Geographic Area]
   756 E C2828370:Block [Quantitative Concept]

Phrase: "receptor recognition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0524637:Recognition [Mental Process]

Phrase: "may"

Phrase: "still"

Phrase: "occur."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.291: To address this question, we examined the plasma clearance of 2M-MA in mice. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "this question,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the plasma clearance of 2M-MA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0032105:Plasma [Body Substance]
   748   C0449297:Clearance [Qualitative Concept]
   748   C1382187:Clearance [Clinical Attribute]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.292: In this well characterized system, conformationally modified forms of 2M, such as 2M-MA, clear from the plasma as a first-order process with a t1/2 of 3-5 min, and clearance competition is observed when 125I-2M-MA is injected in the presence of excess unlabeled 2M-MA (51). 

Phrase: "In this well characterized system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "conformationally modified forms of 2M,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "such as 2M-MA,"

Phrase: "clear from the plasma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0032105:Plasma [Body Substance]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   770   C2963144:Clear [Qualitative Concept]

Phrase: "as a first-order process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]
   734   C1373201:First Order [Functional Concept]

Phrase: "with a t1/2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1413227:T1 [Gene or Genome]

Phrase: "of 3-5 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0702093:/min [Temporal Concept]
   734   C0442758:3 5 [Quantitative Concept]

Phrase: "and"

Phrase: "clearance competition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679932:competition [Social Behavior]

Phrase: "is"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "125I-2M-MA"

Phrase: "is"

Phrase: "injected in the presence of excess unlabeled 2M-MA (51"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C0612672:MA-2 [Organic Chemical]
   738   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0392148:Presence [Therapeutic or Preventive Procedure]
   738   C1979886:Excess [Qualitative Concept]
   704   C1720154:Inject [Functional Concept]

Phrase: ")."
Processing 00000000.tx.293: The rapid plasma clearance of 2M-MA represented a clear advantage for our experiments with A, compared with binding or endocytosis experiments performed in vitro, because of the opportunity to minimize the time period during which dissociation of A2M-MA complex may occur. 

Phrase: "The rapid plasma clearance of 2M-MA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0032105:Plasma [Body Substance]
   744   C0449297:Clearance [Qualitative Concept]
   744   C1382187:Clearance [Clinical Attribute]
   744   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   744   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "a clear advantage for our experiments"

Phrase: "with A,"

Phrase: "compared with binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]
   790   C1707455:Compared [Activity]

Phrase: "or"

Phrase: "endocytosis experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "because of the opportunity to"

Phrase: "minimize"

Phrase: "the time period during which dissociation of A2M-MA complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0439582:Time period [Temporal Concept]
   739   C0040223:Time [Temporal Concept]
   739   C0439531:/period [Temporal Concept]
   739   C1948053:Period [Temporal Concept]
   739   C3541383:Time [Temporal Concept]

Phrase: "may"

Phrase: "occur."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.294: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.295: 9 shows the plasma clearance of 125I-2M-MA (n=4) in the absence of competing ligand and in the presence of 40or 80g of GST-RAP. 

Phrase: "9"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the plasma clearance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0032105:Plasma [Body Substance]
   861   C0449297:Clearance [Qualitative Concept]
   861   C1382187:Clearance [Clinical Attribute]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "of 125I-2M-MA (n=4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   839   C0606723:MA 4 [Organic Chemical]
   799   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of competing ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligand [Chemical]

Phrase: "and in the presence of 40or 80g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1515981:And [Idea or Concept]

Phrase: "of GST-RAP."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   858   C0061523:glutathione receptor [Amino Acid, Peptide, or Protein,Receptor]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0332281:Associated [Qualitative Concept]
   766 E C0750490:Associate [Idea or Concept]
   766 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.296: The GST-RAP inhibited the clearance of 125I-2M-MA from the plasma, as anticipated due to competition for plasma-accessible LRP, which is mainly located in the liver (51). 

Phrase: "The GST-RAP"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   858   C0061523:glutathione receptor [Amino Acid, Peptide, or Protein,Receptor]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0332281:Associated [Qualitative Concept]
   766 E C0750490:Associate [Idea or Concept]
   766 E C1706221:Associate [Professional or Occupational Group]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the clearance of 125I-2M-MA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0449297:Clearance [Qualitative Concept]
   748   C1382187:Clearance [Clinical Attribute]
   748   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "from the plasma,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "as"

Phrase: "anticipated due to competition"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0679932:competition [Social Behavior]
   770   C3146286:Due [Idea or Concept]

Phrase: "for plasma-accessible LRP,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   895   C0032120:Plasma protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   895   C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "is"

Phrase: "mainly"

Phrase: "located in the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.297: To determine whether A inhibits 2M-MA binding to LRP, 125I-2M-MA was preincubated with a nearly saturating concentration of A (20M, 16-fold the KD) for 2h at 37C and then injected intravenously in mice. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "A"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "2M-MA binding to LRP,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   762   C0033618:Protein Binding [Molecular Function]
   762   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0597358:Receptor Binding [Molecular Function]
   762   C1149323:lipoprotein binding [Molecular Function]
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: "125I-2M-MA"

Phrase: "was"

Phrase: "preincubated with a nearly"

Phrase: "saturating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522534:saturating [Phenomenon or Process]

Phrase: "concentration of A (20M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086045:Concentration [Mental Process]
   770   C1446561:Concentration [Quantitative Concept]

Phrase: "16-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "the KD) for 2h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0026691:KD [Disease or Syndrome]
   770   C1705240:KD [Gene or Genome]
   770   C1839259:KD [Disease or Syndrome]

Phrase: "at 37C"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intravenously in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]
Processing 00000000.tx.298: The rate of 125I-2M-MA clearance was completely unchanged. 

Phrase: "The rate of 125I-2M-MA clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0025515:clearance rate [Clinical Attribute]
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "completely unchanged."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442739:Unchanged [Finding]
   861   C2346711:Unchanged [Qualitative Concept]
Processing 00000000.tx.299: We cannot rule out the possibility that A dissociated from the 125I-2M-MA after the preparation was injected intravascularly, due to dilution in thebloodstream; 

Phrase: "We"

Phrase: "cannot"

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "A"

Phrase: "dissociated from the 125I-2M-MA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0612672:MA-2 [Organic Chemical]
   748   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "after the preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "was"

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intravascularly,"

Phrase: "due to dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079240:Dilution [Laboratory Procedure]
  1000   C1948037:Dilution [Functional Concept]

Phrase: "in thebloodstream"

Phrase: ";"
Processing 00000000.tx.300: however, given the rapid timeframe of the plasma clearance experiments, our results demonstrate that 2M-associated A either does not interfere with LRP recognition or rapidly dissociates from some sites to free up LRP recognition sequences and allow uptake of the remaining A. 

Phrase: "however,"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the rapid timeframe of the plasma clearance experiments,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332168:Time frame [Temporal Concept]
   744   C0872291:Time Frame [Temporal Concept]

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that 2M-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "A either"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interfere with LRP recognition"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   853   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   778   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   774   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   748   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C0521102:Interfere [Qualitative Concept]
   748   C0524637:Recognition [Mental Process]

Phrase: "or"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "dissociates from some sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205145:Sites [Spatial Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "to free"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332296:free [Functional Concept]
  1000   C1880497:Free [Qualitative Concept]
  1000   C1996904:Free [Qualitative Concept]

Phrase: "up LRP recognition sequences"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   839   C0002518:protein sequences [Amino Acid Sequence]
   799   C0162326:Sequences [Nucleotide Sequence]
   766 E C0004793:Sequence [Nucleotide Sequence]
   766 E C0162327:Sequence [Nucleotide Sequence]
   766 E C1519249:Sequence [Functional Concept]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   716 E C1548958:Sequential [Idea or Concept]
   716 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "uptake of the remaining A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.301: View larger version (24K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(24K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.302: 9.  

Phrase: "9."
Processing 00000000.tx.303: Plasma clearance of 125I-2M-MA after incubation with A. 

Phrase: "Plasma clearance of 125I-2M-MA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0032105:Plasma [Body Substance]
   748   C0449297:Clearance [Qualitative Concept]
   748   C1382187:Clearance [Clinical Attribute]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "after incubation"

Phrase: "with A."
Processing 00000000.tx.304: 125I-2M-MA (20nM) was incubated with 20M A () or with vehicle () for 2h and then injected intravascularly in mice (n=4). 

Phrase: "125I-2M-MA (20nM"

Phrase: ")"

Phrase: "was"

Phrase: "incubated with 20M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "A ()"

Phrase: "or with vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0042444:Vehicle [Biomedical or Dental Material]
   790   C0348005:Vehicle [Manufactured Object]
   718 E C0445373:Vehicular [Functional Concept]

Phrase: "("

Phrase: ")"

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "injected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1720154:Inject [Functional Concept]

Phrase: "intravascularly in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]

Phrase: "(n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.305: 125I-2M-MA that was not preincubated with A was injected in the presence of 40g of GST-RAP () or 80g of GST-RAP () (average of duplicate determinations with each concentration of GST-RAP).  

Phrase: "125I-2M-MA"

Phrase: "that"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "preincubated with A"

Phrase: "was"

Phrase: "injected in the presence of 40g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   719   C1720154:Inject [Functional Concept]

Phrase: "of GST-RAP"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   858   C0061523:glutathione receptor [Amino Acid, Peptide, or Protein,Receptor]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0332281:Associated [Qualitative Concept]
   766 E C0750490:Associate [Idea or Concept]
   766 E C1706221:Associate [Professional or Occupational Group]

Phrase: "("

Phrase: ")"

Phrase: "or"

Phrase: "80g of GST-RAP"

Phrase: "("

Phrase: ")"

Phrase: "(average of duplicate determinations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1510992:Average [Quantitative Concept]
   770   C2825518:AVERAGE [Quantitative Concept]

Phrase: "with each concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of GST-RAP"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   858   C0061523:glutathione receptor [Amino Acid, Peptide, or Protein,Receptor]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0332281:Associated [Qualitative Concept]
   766 E C0750490:Associate [Idea or Concept]
   766 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")."
Processing 00000000.tx.306: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES LRP and its ligands, 2M, apolipoprotein E4, and Kunitz-proteinase inhibitor domain-containing isoforms of APP, form an intriguing functional family, the members of which have been implicated in familial or late-onset AD (52). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "its ligands,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligands [Chemical]

Phrase: "2M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "apolipoprotein E4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Kunitz-proteinase inhibitor domain-containing isoforms of APP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0597298:Protein Isoforms [Amino Acid, Peptide, or Protein]
           Isoforms

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "an intriguing functional family,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]

Phrase: "the members of which"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0680022:members [Population Group]
   737 E C2698041:Member [Professional or Occupational Group]

Phrase: "have"

Phrase: "been"

Phrase: "implicated in familial"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0015576:familial [Family Group]
   790   C0241888:Familial [Functional Concept]
   718 E C1704727:Family [Conceptual Entity]

Phrase: "or"

Phrase: "late-onset AD (52"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205087:Late [Temporal Concept]
   812   C0332162:Onset [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.307: Deciphering the mechanisms whereby these proteins affect AD may be difficult because of their multifunctional nature. 

Phrase: "Deciphering"

Phrase: "the mechanisms whereby"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "these proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "AD"

Phrase: "may"

Phrase: "be"

Phrase: "difficult because of their multifunctional nature."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332218:Difficult [Qualitative Concept]
Processing 00000000.tx.308: For example, LRP may mediate the clearance of A in association with 2M and may be essential for A transport across the blood-brain barrier (53). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the clearance of A in association"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0449297:Clearance [Qualitative Concept]
   753   C1382187:Clearance [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "with 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "may"

Phrase: "be"

Phrase: "essential for A transport"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "across the blood-brain barrier"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
  1000   C1305865:Blood-brain barrier [Organ or Tissue Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1706912:BARRIER [Medical Device]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.309: However, LRP may also mediate the transfer of APP into intracellular compartments where there is increased access to amyloidogenic proteinases (54). 

Phrase: "However,"

Phrase: "LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "also"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the transfer of APP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040671:Transfer [Mental Process]
   753   C1705822:Transfer [Activity]

Phrase: "into intracellular compartments where there"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0175996:intracellular [Cell Component]
   812   C0178719:Intracellular [Spatial Concept]
   812   C1185625:Compartments [Body Space or Junction]
   812   C1382196:Compartments [Natural Phenomenon or Process]
   779 E C2986730:Compartment [Spatial Concept]

Phrase: "is"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "access to amyloidogenic proteinases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0444454:Access [Spatial Concept]
   770   C1554204:access [Idea or Concept]
   737 E C1622131:proteinase [Molecular Function]
   737 E C1947941:Proteinase [Enzyme]

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.310: Like LRP, 2M expresses multiple activities that may be involved in AD progression. 

Phrase: "Like LRP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "expresses"

Phrase: "multiple activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "involved in AD progression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]
   770   C1314939:Involved [Functional Concept]
Processing 00000000.tx.311: Because 2M is a broad-spectrum proteinase inhibitor, which reacts with proteinases from all four major mechanistic classes (15, 55), various proteinases that are involved in A catabolism, such as neprilysin, insulysin, and plasmin (56-59), may be 2M targets. 

Phrase: "Because"

Phrase: "2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "a broad-spectrum proteinase inhibitor,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033607:proteinase inhibitor [Biologically Active Substance,Pharmacologic Substance]
   861   C1961133:Proteinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C2673177:proteinase inhibitor [Molecular Function]
   812   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1622131:proteinase [Molecular Function]
   812   C1947941:Proteinase [Enzyme]
   812   C1999216:Inhibitor [Qualitative Concept]

Phrase: "which"

Phrase: "reacts with proteinases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   756 E C1622131:proteinase [Molecular Function]
   756 E C1947941:Proteinase [Enzyme]

Phrase: "from all four major mechanistic classes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456387:Class [Intellectual Product]
   812   C1705943:Class [Classification]

Phrase: "(15,"

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "various proteinases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827 E C1622131:proteinase [Molecular Function]
   827 E C1947941:Proteinase [Enzyme]

Phrase: "that"

Phrase: "are"

Phrase: "involved in A catabolism,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0543484:catabolism [Functional Concept]
   770   C0699900:Catabolism [Organism Function]
   770   C1314939:Involved [Functional Concept]
   770   C1516314:Catabolism [Physiologic Function]

Phrase: "such as neprilysin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025250:Neprilysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1366499:NEPRILYSIN [Gene or Genome]

Phrase: "insulysin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021669:Insulysin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULYSIN [Gene or Genome]

Phrase: "and"

Phrase: "plasmin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016016:Plasmin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(56-59"

Phrase: ")"

Phrase: ","

Phrase: "may"

Phrase: "be"

Phrase: "2M targets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1521840:Target [Functional Concept]
   793   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.312: The possibility that 2M regulates the activity of proteinases involved in APP processing has also been considered; 

Phrase: "The possibility"

Phrase: "that 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "regulates"

Phrase: "the activity of proteinases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   802   C1150095:proteinase activity [Molecular Function]
   802   C1622131:proteinase activity [Molecular Function]
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "involved in APP processing"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   833   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   790   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0033666:protein processing [Molecular Function]
   783   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0011560:Amyloid [Pathologic Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1314939:Involved [Functional Concept]
   753   C1709634:Precursor [Idea or Concept]
   753   C1709694:Processing [Activity]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.313: however, De Strooper et al. 

Phrase: "however,"

Phrase: "De Strooper et al."
Processing 00000000.tx.314: (60) demonstrated that this does not occur. 

Phrase: "(60"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "this"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "occur."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.315: The lack of an effect of 2M on APP processing is consistent with other studies demonstrating that 2M is poorly reactive with proteinases functioning at or near the cell surface (61). 

Phrase: "The lack of an effect of 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332268:lack [Qualitative Concept]

Phrase: "on APP processing"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0033666:protein processing [Molecular Function]
   812   C1709694:Processing [Activity]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "consistent with other studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "demonstrating"

Phrase: "that 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "poorly reactive with proteinases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205332:Reactive [Qualitative Concept]

Phrase: "functioning at"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   833   C0542341:functioning [Functional Concept]
   799 E C0031843:function [Physiologic Function]
   799 E C0700205:FUNCTION [Classification]
   799 E C1705273:Function [Intellectual Product]

Phrase: "or near the cell surface"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "(61"

Phrase: ")."
Processing 00000000.tx.316: The ability of 2M to function as a carrier and deliver proteins to LRP for catabolism was first demonstrated with TGF- and PDGF-BB (62, 63). 

Phrase: "The ability of 2M to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "function as a carrier"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0007294:Carrier [Finding]
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0560175:Carrier [Finding]
   770   C0700205:FUNCTION [Classification]
   770   C1705273:Function [Intellectual Product]
   770   C1706209:Carrier [Medical Device]
   770   C3273162:Carrier [Intellectual Product]

Phrase: "and"

Phrase: "deliver"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
  1000   C1705822:Deliver [Activity]
  1000   C1874964:DELIVER [Pharmacologic Substance]

Phrase: "proteins to LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   855   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   783   C0597357:proteins receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for catabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0543484:catabolism [Functional Concept]
  1000   C0699900:Catabolism [Organism Function]
  1000   C1516314:Catabolism [Physiologic Function]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "demonstrated with TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   862   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   862   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0018270:'growth' NOS [Organism Function]
   760   C0220844:growth [Physiologic Function]
   760   C1510411:Transforming [Pathologic Function]
   760   C1521761:Factor [Functional Concept]
   760   C1621966:Growth [Organ or Tissue Function]
   760   C2827422:Factor [Conceptual Entity]
   760   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "PDGF-BB"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
  1000   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   937   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0004739:BB [Geographic Area]
   804   C0005821:Platelet [Cell]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0332297:BB [Spatial Concept]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   804   C3245521:derived [Idea or Concept]
   721 E C1963076:Platelets [Finding]

Phrase: "(62,"

Phrase: "63"

Phrase: ")."
Processing 00000000.tx.317: Only activated 2M is functional in this capacity, because native 2M is not recognized by LRP (51). 

Phrase: "Only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "functional in this capacity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0695468:functional capacity [Therapeutic or Preventive Procedure]
   819   C1998319:Functional capacity [Finding]
   770   C0205245:Functional [Functional Concept]
   770   C0542341:Functional [Functional Concept]
   770   C2700217:Functional [Conceptual Entity]

Phrase: "because"

Phrase: "native 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "recognized by LRP"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   790   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   783   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   753   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.318: Growth factors, such as TGF-, bind to native 2M, as well as activated 2M, and the resulting effects on growth factor activity are complicated. 

Phrase: "Growth factors,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "such as TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   884   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   884   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C1510411:Transforming [Pathologic Function]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]

Phrase: ","

Phrase: "bind to native 2M,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0302891:Native [Functional Concept]
   760   C1145667:Bind [Activity]
   760   C1167622:bind [Molecular Function]

Phrase: "as well as"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "2M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "the resulting effects on growth factor activity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "complicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231242:Complicated [Functional Concept]
Processing 00000000.tx.319: When bound to native 2M, growth factors are typically inactive; 

Phrase: "When"

Phrase: "bound to native 2M,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0302891:Native [Functional Concept]
   760   C0332297:bound [Spatial Concept]
   760   C1145667:Bound [Activity]
   760   C1167622:Bound [Molecular Function]
   760   C1689898:% bound [Quantitative Concept]
   760   C2349209:Bound [Conceptual Entity]

Phrase: "growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "typically inactive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205254:Inactive [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.320: however, because this interaction is reversible, 2M-associated growth factors may provide a reservoir, buffering against changes in the free growth factor concentration (13, 64). 

Phrase: "however,"

Phrase: "because"

Phrase: "this interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "is"

Phrase: "reversible, 2M-associated growth factors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0018270:'growth' NOS [Organism Function]
   799   C0220844:growth [Physiologic Function]
   799   C1621966:Growth [Organ or Tissue Function]
   799   C2911660:Growth [Activity]
   766   C1521761:Factor [Functional Concept]
   766   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a reservoir,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442537:Reservoir [Geographic Area]
  1000   C1705182:Reservoir [Medical Device]

Phrase: "buffering against changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in the free growth factor concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(13,"

Phrase: "64"

Phrase: ")."
Processing 00000000.tx.321: In our experiments, A bound selectively to the LRP-recognized or -activated form of 2M, confirming the work of Narita et al. 

Phrase: "In our experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "A bound selectively"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0332297:bound [Spatial Concept]
   861   C1145667:Bound [Activity]
   861   C1167622:Bound [Molecular Function]
   861   C1689898:% bound [Quantitative Concept]
   861   C2349209:Bound [Conceptual Entity]

Phrase: "to the LRP-recognized or -activated form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0348078:Form [Qualitative Concept]
   793   C0376315:Form [Manufactured Object]
   793   C1522492:Form [Functional Concept]

Phrase: "of 2M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the work of Narita et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0043227:Work [Occupational Activity]
Processing 00000000.tx.322: (33). 

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.323: To activate 2M, we reacted the protein with methylamine. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "2M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "we"

Phrase: "reacted"

Phrase: "the protein with methylamine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.324: This reaction induces a conformational change in 2M that is equivalent to the structural rearrangement induced by proteinases (11, 15, 44). 

Phrase: "This reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a conformational change in 2M"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0301641:Conformational change [Molecular Function]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "is"

Phrase: "equivalent to the structural rearrangement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205163:Equivalent [Qualitative Concept]
   760   C0439185:equivalent [Quantitative Concept]

Phrase: "induced by proteinases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]
   756 E C1622131:proteinase [Molecular Function]
   756 E C1947941:Proteinase [Enzyme]

Phrase: "(11,"

Phrase: "15,"

Phrase: "44"

Phrase: ")."
Processing 00000000.tx.325: In the ligand blotting system, denatured 2M subunits retained A binding activity. 

Phrase: "In the ligand blotting system,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "denatured"

Phrase: "2M subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1711351:Subunit [Quantitative Concept]

Phrase: "retained"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retained [Functional Concept]

Phrase: "A binding activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2266866:Binding Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.326: This result suggests that 2M tertiary and quaternary structures are not necessary for A binding. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "tertiary"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205372:Tertiary [Quantitative Concept]

Phrase: "and"

Phrase: "quaternary structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "are"

Phrase: "not necessary for A binding."
Processing 00000000.tx.327: Instead, we hypothesize that 2M activation reveals an otherwise cryptic linear sequence of amino acids that constitute a binding site for A. 

Phrase: "Instead,"

Phrase: "we"

Phrase: "hypothesize"

Phrase: "that 2M activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "reveals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "an otherwise cryptic linear sequence of amino acids"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   776   C0002518:Amino Acid Sequence [Amino Acid Sequence]
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C1519249:Sequence [Functional Concept]

Phrase: "that"

Phrase: "constitute"

Phrase: "a binding site for A."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0005456:Binding Site [Receptor]
   806   C0682969:Binding Site [Amino Acid Sequence]
   760   C0205145:Site [Spatial Concept]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1515974:Site [Body Location or Region]
   760   C2825164:Site [Spatial Concept]
Processing 00000000.tx.328: 2M conformational change is also necessary for recognition by LRP; 

Phrase: "2M conformational change"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0301641:Conformational change [Molecular Function]
   812   C0392747:Change [Functional Concept]
   812   C0443172:change [Quantitative Concept]
   812   C1705241:Change [Quantitative Concept]

Phrase: "is"

Phrase: "also necessary for recognition"

Phrase: "by LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.329: however, this interaction apparently requires retention of secondary and tertiary structure in the 2M RBF (38, 41). 

Phrase: "however,"

Phrase: "this interaction apparently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1704675:Interaction [Functional Concept]

Phrase: "requires"

Phrase: "retention of secondary"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0035280:Retention [Mental Process]
   790   C0333117:Retention [Functional Concept]
   790   C1753315:retention [Cell Function]

Phrase: "and"

Phrase: "tertiary structure in the 2M RBF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205372:Tertiary [Quantitative Concept]
   742   C0678594:Structure [Spatial Concept]

Phrase: "(38,"

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.330: Although the primary sequence in 2M that is responsible for the binding of growth factors is fairly promiscuous, this sequence did not interact with A and apparently did not contribute to the A binding activity of intact 2M. 

Phrase: "Although"

Phrase: "the primary sequence in 2M"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]

Phrase: "that"

Phrase: "is"

Phrase: "responsible for the binding of growth factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "is"

Phrase: "fairly promiscuous,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   789   C0562558:Promiscuity, NOS [Social Behavior]
   789   C2919102:Promiscuity [Finding]

Phrase: "this sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]
   928 E C1548958:Sequential [Idea or Concept]
   928 E C1705294:Sequential [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interact with A"

Phrase: "and"

Phrase: "apparently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750541:apparently [Idea or Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contribute to the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1880177:Contribute [Activity]

Phrase: "A binding activity of intact 2M."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C2266866:Binding Activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.331: Instead, a distinct protein-interaction site was identified, and our analysis of GST fusion proteins suggests that the center of this site is located between amino acids 1314and 1365.

Phrase: "Instead,"

Phrase: "a distinct protein-interaction site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "our analysis of GST fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   750   C1514534:Protein Analysis [Molecular Biology Research Technique]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the center of this site"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205099:Center [Spatial Concept]

Phrase: "is"

Phrase: "located between amino acids 1314and 1365."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   719 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.332: The A binding sequence identified in our experiments may be equivalent to the candidate A-binding site identified by yeast-two hybrid screen (37). 

Phrase: "The"

Phrase: "A binding sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "identified in our experiments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205396:Identified [Qualitative Concept]
   770   C0681814:Experiments [Research Activity]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "may"

Phrase: "be"

Phrase: "equivalent to the candidate A-binding site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205163:Equivalent [Qualitative Concept]
   748   C0439185:equivalent [Quantitative Concept]

Phrase: "identified by yeast-two hybrid screen"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0599647:Two Hybrid [Molecular Biology Research Technique]
   783   C2598686:Yeast identified [Laboratory or Test Result]
   753   C0020205:Hybrid [Organism]
   753   C0036025:yeast [Fungus]
   753   C0043392:Yeast [Food]
   753   C0043393:Yeast [Fungus]
   753   C0205396:Identified [Qualitative Concept]
   753   C0205448:Two [Quantitative Concept]
   753   C0220908:screen [Health Care Activity]
   753   C0717551:YEAST [Immunologic Factor,Pharmacologic Substance]
   753   C1305399:screen [Functional Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1705053:Screen [Medical Device]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.333: Based on these results, we now propose that 2M contains at least two distinct protein-interaction sequences that are functional even when higher order 2M structure is eliminated. 

Phrase: "Based on these results,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737 E C1880279:Base [Biomedical or Dental Material]
   737   C2825142:Result [Finding]

Phrase: "we now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "propose"

Phrase: "that 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "contains at least two distinct protein-interaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0872079:protein interaction [Molecular Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205448:Two [Quantitative Concept]
   748   C0332256:contain [Functional Concept]
   748   C1704675:Interaction [Functional Concept]
   748   C2700400:Contain [Activity]

Phrase: "sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "that"

Phrase: "are"

Phrase: "functional even"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205245:Functional [Functional Concept]
   861   C0542341:Functional [Functional Concept]
   861   C2700217:Functional [Conceptual Entity]

Phrase: "when"

Phrase: "higher order 2M structure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   911   C1512460:Higher Order Structure [Cell Component]
   804   C0678594:Structure [Spatial Concept]

Phrase: "is"

Phrase: "eliminated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]
Processing 00000000.tx.334: These two binding sites demonstrate distinct ligand binding specificities, because the growth factor-binding site in FP3 does not bind A, and the A-binding site in FP6 does not bind TGF-, PDGF-BB, or NGF- (18). 

Phrase: "These two binding sites"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0005456:Binding Sites [Receptor]
   867 E C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Sites [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "demonstrate"

Phrase: "distinct ligand binding specificities,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C1517880:Ligand Binding [Molecular Function]
   812   C0023688:Ligand [Chemical]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   779   C0037791:Specificity [Quantitative Concept]
   779   C1511884:Specificity [Quantitative Concept]
   729 E C0205369:Specific [Qualitative Concept]
   729 E C1552740:specific [Intellectual Product]

Phrase: "because"

Phrase: "the growth factor-binding site in FP3"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   814   C1149299:Growth Factor Binding [Molecular Function]
   778   C0005456:Binding Site [Receptor]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0682969:Binding Site [Amino Acid Sequence]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0205145:Site [Spatial Concept]
   748   C0220844:growth [Physiologic Function]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C1515974:Site [Body Location or Region]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2825164:Site [Spatial Concept]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "A,"

Phrase: "and"

Phrase: "the A-binding site in FP6"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0005456:Binding Site [Receptor]
   790   C0682969:Binding Site [Amino Acid Sequence]
   753   C0205145:Site [Spatial Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1515974:Site [Body Location or Region]
   753   C2825164:Site [Spatial Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: ","

Phrase: "PDGF-BB,"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
  1000   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   937   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0004739:BB [Geographic Area]
   804   C0005821:Platelet [Cell]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0332297:BB [Spatial Concept]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   804   C3245521:derived [Idea or Concept]
   721 E C1963076:Platelets [Finding]

Phrase: "or"

Phrase: "NGF-"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   873   C0814002:Neural Growth [Cell Function,Organism Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C0220844:growth [Physiologic Function]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.335: The LRP recognition sequence includes two Lys residues within an helix that includes amino acids 1370-1377 (41, 42). 

Phrase: "The LRP recognition sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   839   C0002518:Protein Sequence [Amino Acid Sequence]
   799   C0004793:Sequence [Nucleotide Sequence]
   799   C0162326:Sequence [Nucleotide Sequence]
   799   C0162327:Sequence [Nucleotide Sequence]
   799   C1519249:Sequence [Functional Concept]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   727 E C1548958:Sequential [Idea or Concept]
   727 E C1705294:Sequential [Qualitative Concept]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "two Lys residues within an helix"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "that"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "amino acids 1370-1377"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827 E C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acids [Chemical]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "(41,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.336: In the intact three-dimensional structure of the 2M RBF, the two Lys residues are oriented so that the side chains are readily available for interaction with LRP. 

Phrase: "In the intact three-dimensional structure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0450363:3-Dimensional [Spatial Concept]
   812   C0205449:Three [Quantitative Concept]
   812   C0678594:Structure [Spatial Concept]
   741   C0439534:Dimension [Quantitative Concept]
   741   C1707753:Dimensionality [Spatial Concept]

Phrase: "of the 2M RBF,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0597358:Receptor Binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C0332255:fragment [Functional Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "the two Lys residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "oriented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704322:Oriented [Spatial Concept]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "the side chains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0337112:chains [Manufactured Object]
   861   C0441987:Side [Spatial Concept]
   861   C1524075:Chains [Idea or Concept]

Phrase: "are"

Phrase: "readily available for interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0470187:Available [Functional Concept]

Phrase: "with LRP."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.337: Furthermore, the Lys residues are surrounded by a high density of hydrophobic surface residues. 

Phrase: "Furthermore,"

Phrase: "the Lys residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "are"

Phrase: "surrounded by a high density of hydrophobic surface residues."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0178587:density [Quantitative Concept]
   742   C0205148:Surface [Spatial Concept]
   742   C0205250:High [Qualitative Concept]
   742   C0598629:Hydrophobic [Qualitative Concept]
   742   C1282914:Surrounded [Spatial Concept]
   742   C1299351:High [Qualitative Concept]
   742   C2700149:HIGH [Intellectual Product]
   708   C1709915:Residue [Conceptual Entity]
   708   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.338: All of our evidence indicates that the A-binding site and the LRP recognition sequence are adjacent but distinct. 

Phrase: "All of our evidence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0332120:Evidence of [Functional Concept]
           Evidence
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]

Phrase: "indicates"

Phrase: "that"

Phrase: "the A-binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "the LRP recognition sequence"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   839   C0002518:Protein Sequence [Amino Acid Sequence]
   799   C0004793:Sequence [Nucleotide Sequence]
   799   C0162326:Sequence [Nucleotide Sequence]
   799   C0162327:Sequence [Nucleotide Sequence]
   799   C1519249:Sequence [Functional Concept]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   727 E C1548958:Sequential [Idea or Concept]
   727 E C1705294:Sequential [Qualitative Concept]

Phrase: "are"

Phrase: "adjacent"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205117:Adjacent [Spatial Concept]
   928 E C3242705:adjacency [Idea or Concept]

Phrase: "but"

Phrase: "distinct."
Processing 00000000.tx.339: FP6c, which includes the entire helix, did not bind A, whereas FP6a, which lacks the helix, did. 

Phrase: "FP6c,"

Phrase: "which"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the entire helix,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018882:Helix [Eukaryote]
   861   C0229304:Helix [Body Part, Organ, or Organ Component]
   861   C1704821:Helix [Spatial Concept]
   861   C1705682:Helix [Anatomical Structure]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "A,"

Phrase: "whereas"

Phrase: "FP6a,"

Phrase: "which"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the helix,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018882:Helix [Eukaryote]
  1000   C0229304:Helix [Body Part, Organ, or Organ Component]
  1000   C1704821:Helix [Spatial Concept]
  1000   C1705682:Helix [Anatomical Structure]

Phrase: "did."
Processing 00000000.tx.340: Mutants of the RBF, which have been previously shown to not bind LRP (39, 40), still bound A. 

Phrase: "Mutants of the RBF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "which"

Phrase: "have"

Phrase: "been"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "LRP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(39,"

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "still"

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "A."
Processing 00000000.tx.341: Furthermore, a saturating concentration of A did not inhibit the plasma clearance of 2M-MA, which is mediated by LRP (51). 

Phrase: "Furthermore,"

Phrase: "a saturating concentration of A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the plasma clearance of 2M-MA,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0032105:Plasma [Body Substance]
   748   C0449297:Clearance [Qualitative Concept]
   748   C1382187:Clearance [Clinical Attribute]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "which"

Phrase: "is"

Phrase: "mediated by LRP"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   882   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   790   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   783   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   753   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.342: We propose that the center of the A binding sequence is located on the N-terminal side of the LRP recognition helix. 

Phrase: "We"

Phrase: "propose"

Phrase: "that"

Phrase: "the center of the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "A binding sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "is"

Phrase: "located on the N-terminal side"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205088:Terminal [Temporal Concept]
   753   C0441987:Side [Spatial Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]

Phrase: "of the LRP recognition helix."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   839   C1704821:Protein Helix [Spatial Concept]
           Helix
   799   C0018882:Helix [Eukaryote]
   799   C0229304:Helix [Body Part, Organ, or Organ Component]
   799   C1705682:Helix [Anatomical Structure]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
Processing 00000000.tx.343: Comparison of the structure of RBFs from various -macroglobulins has demonstrated that one surface of the RBF is highly conserved (41). 

Phrase: "Comparison of the structure of RBFs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1707455:Comparison [Activity]

Phrase: "from various -macroglobulins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulins [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "has"

Phrase: "demonstrated"

Phrase: "that one surface of the RBF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205148:Surface [Spatial Concept]

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "conserved"

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.344: Jenner et al. 

Phrase: "Jenner et al."
Processing 00000000.tx.345: (41) proposed that the conserved surface is divided into two patches, one of which constitutes the LRP recognition site. 

Phrase: "(41"

Phrase: ")"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that"

Phrase: "the conserved surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205148:Surface [Spatial Concept]

Phrase: "is"

Phrase: "divided into two patches,"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   833   C0441218:Two patches [Medical Device]
   770   C0205448:Two [Quantitative Concept]
   770   C0332849:Divided [Functional Concept]
   770   C0994894:Patches [Medical Device]
   737 E C0332461:Patch [Finding]
   737 E C0445403:Patch [Biomedical or Dental Material]
   737 E C0991556:Patch [Medical Device]
   737 E C1305400:Patch [Medical Device]
   737 E C1533128:Patch [Biomedical or Dental Material]
   737 E C1706366:{Patch} [Quantitative Concept]
   737 E C1707974:Patch [Biomedical or Dental Material]

Phrase: "one of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "constitutes"

Phrase: "the LRP recognition site."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   876   C0005456:Receptor site, NOS [Receptor]
   799   C0205145:Site [Spatial Concept]
   799   C0524637:Recognition [Mental Process]
   799   C1515974:Site [Body Location or Region]
   799   C2825164:Site [Spatial Concept]
   734   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
Processing 00000000.tx.346: Only speculation was offered regarding the function of the second patch, which includes amino acids from our fusion proteins that bind A. 

Phrase: "Only speculation"

Phrase: "was"

Phrase: "offered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444648:Offered [Finding]

Phrase: "regarding"

Phrase: "the function of the second patch,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "which"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "amino acids from our fusion proteins"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   820   C1874187:AMINO ACIDS/PROTEINS [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "that"

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "A."
Processing 00000000.tx.347: The possibility that this second conserved surface patch represents an A-binding site merits consideration. 

Phrase: "The possibility"

Phrase: "that"

Phrase: "this second conserved surface patch"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0332461:Patch [Finding]
   812   C0445403:Patch [Biomedical or Dental Material]
   812   C0991556:Patch [Medical Device]
   812   C1305400:Patch [Medical Device]
   812   C1533128:Patch [Biomedical or Dental Material]
   812   C1706366:{Patch} [Quantitative Concept]
   812   C1707974:Patch [Biomedical or Dental Material]
   741 E C0205413:Patchy [Qualitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an A-binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "merits"

Phrase: "consideration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0518609:consideration [Finding]
Processing 00000000.tx.348: Determining the binding affinity of A for 2M and its derivatives is not straightforward. 

Phrase: "Determining"

Phrase: "the binding affinity of A for 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "its derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243072:derivatives [Chemical Viewed Structurally]
   966 E C1527240:Derivative [Functional Concept]

Phrase: "is"

Phrase: "not straightforward."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1272701:Straightforward [Qualitative Concept]
Processing 00000000.tx.349: With regard to intact 2M, protein conformation is clearly very important, and commercial sources of 2M typically contain mixtures of the different conformational forms. 

Phrase: "With regard to intact 2M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "protein conformation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033625:Protein Conformation [Spatial Concept]
   861   C0026377:Conformation [Spatial Concept]

Phrase: "is"

Phrase: "clearly very important,"

Phrase: "and"

Phrase: "commercial sources of 2M typically"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1516719:Commercial Sources [Classification]
   753   C0449416:sources [Finding]
   719 E C1705919:Source [Idea or Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "mixtures of the different conformational forms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439962:mixtures [Substance]
Processing 00000000.tx.350: Our evidence suggests that each 2M subunit contains an independent A-binding site so that there are four sites per molecule. 

Phrase: "Our evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "each 2M subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an independent A-binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0005456:Binding Site [Receptor]
   861   C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that there"

Phrase: "are"

Phrase: "four sites per molecule."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0205145:Sites [Spatial Concept]
   767   C0596968:molecular site [Functional Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.351: Finally, A may multimerize when associated with 2M, and this may have an effect on the total A binding capacity of 2M. 

Phrase: "Finally,"

Phrase: "A"

Phrase: "may"

Phrase: "multimerize"

Phrase: "when"

Phrase: "associated with 2M,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "this"

Phrase: "may"

Phrase: "have"

Phrase: "an effect on the total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "A binding capacity of 2M."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0439155:Binding capacity [Quantitative Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1516240:Capacity [Quantitative Concept]
Processing 00000000.tx.352: Previously reported KD values for the A2M interaction were 380pM (36) and 350nM (37). 

Phrase: "Previously reported KD values for the A2M interaction"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0026691:KD [Disease or Syndrome]
   744   C0042295:Values [Qualitative Concept]
   744   C1705240:KD [Gene or Genome]
   744   C1839259:KD [Disease or Syndrome]
   711 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "380pM"

Phrase: "(36"

Phrase: ")"

Phrase: "and"

Phrase: "350nM"

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.353: The KD values determined here for A binding to intact 2M-MA, purified 18-kDa RBF, and FP6 are in good agreement with the value reported by Hughes et al. 

Phrase: "The KD values"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0026691:KD [Disease or Syndrome]
   861   C0042295:Values [Qualitative Concept]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "determined"

Phrase: "here for A binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to intact 2M-MA,"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "18-kDa RBF,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0597358:Receptor Binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C0332255:fragment [Functional Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]
   804   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "FP6"

Phrase: "are in good agreement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205170:Good [Qualitative Concept]
   770   C0680240:Agreement [Social Behavior]
   770   C1551058:Are [Quantitative Concept]

Phrase: "with the value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "reported by Hughes et al."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C1709908:Reported By [Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C1551730:Hughes [Population Group]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.354: (37). 

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.355: In each case, we demonstrated that A binding is saturable. 

Phrase: "In each case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "A binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "saturable."
Processing 00000000.tx.356: Specificity in binding was demonstrated in control experiments with BSA and other fusion proteins, such as FP3. 

Phrase: "Specificity in binding"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0037791:Specificity [Quantitative Concept]
   790   C1511884:Specificity [Quantitative Concept]
   718 E C0205369:Specific [Qualitative Concept]
   718 E C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "demonstrated in control experiments"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0009932:control experiments [Group]
   770   C0243148:control [Qualitative Concept]
   770   C0681814:Experiments [Research Activity]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "with BSA"

Phrase: "and"

Phrase: "other fusion proteins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "such as FP3."
Processing 00000000.tx.357: Although the affinity of the 2M subunit for A was low, we hypothesize that the ability of 2M to function as an A binding protein and shuttle A to LRP is actually much higher than would be predicted, based on the KD, due to the fact that each 2M has four A-binding sites and because multimerized A may bind to 2M. 

Phrase: "Although"

Phrase: "the affinity of the 2M subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for A"

Phrase: "was"

Phrase: "low,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "we"

Phrase: "hypothesize"

Phrase: "that"

Phrase: "the ability of 2M to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "function as an"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0031843:function [Physiologic Function]
   790   C0542341:Function [Functional Concept]
   790   C0700205:FUNCTION [Classification]
   790   C1705273:Function [Intellectual Product]

Phrase: "A binding protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "shuttle A to LRP"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C0386684:lipoprotein A receptor [Amino Acid, Peptide, or Protein,Receptor]
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   774   C0065058:Lipoprotein (a) [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0125953:Lipoprotein (a-) [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1096202:Lipoprotein-a [Laboratory Procedure]

Phrase: "is"

Phrase: "actually much higher than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "would"

Phrase: "be"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: ","

Phrase: "based on the KD,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0026691:KD [Disease or Syndrome]
   770   C1527178:Based [Functional Concept]
   770   C1705240:KD [Gene or Genome]
   770   C1705938:Based [Idea or Concept]
   770   C1839259:KD [Disease or Syndrome]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]

Phrase: "due to the fact"

Phrase: "that"

Phrase: "each 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "has"

Phrase: "four A-binding sites"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0005456:Binding Sites [Receptor]
   827 E C0682969:Binding Site [Amino Acid Sequence]
   812   C0205145:Sites [Spatial Concept]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "because"

Phrase: "multimerized"

Phrase: "A"

Phrase: "may"

Phrase: "bind to 2M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]
Processing 00000000.tx.358: Although the purified 18-kDa RBF bound A in solution, under equivalent conditions, FP6 and the FP6-derived fusion proteins demonstrated only limited A binding activity. 

Phrase: "Although"

Phrase: "the purified 18-kDa RBF"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0597358:Receptor Binding [Molecular Function]
   799   C0243122:binding [Functional Concept]
   799   C0332255:fragment [Functional Concept]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
   799   C1708096:Fragment [Qualitative Concept]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "A in solution,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0037633:Solution [Substance]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "under equivalent conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "FP6"

Phrase: "and"

Phrase: "the FP6-derived fusion proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332466:Fusion [Functional Concept]
   812   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: "demonstrated"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "A binding activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2266866:Binding Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.359: Apparently, exposure to denaturant (SDS) was necessary to fully reveal the A-binding site in the fusion proteins. 

Phrase: "Apparently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750541:apparently [Idea or Concept]

Phrase: "exposure to denaturant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposure to [Clinical Attribute]
           Exposure
   790   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "(SDS)"

Phrase: "was"

Phrase: "necessary to fully"

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "the A-binding site in the fusion proteins."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0005456:Binding Site [Receptor]
   770   C0682969:Binding Site [Amino Acid Sequence]
   767   C0242210:Binding Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   750 E C0033618:Protein Binding [Molecular Function]
   744   C0205145:Site [Spatial Concept]
   744   C0243122:binding [Functional Concept]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   744   C1515974:Site [Body Location or Region]
   744   C2825164:Site [Spatial Concept]
Processing 00000000.tx.360: In the absence of denaturant, the A-binding site, in FP6, may be partially buried or form a compatible surface for FP6 self-association. 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of denaturant,"

Phrase: "the A-binding site,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0005456:Binding Site [Receptor]
   901   C0682969:Binding Site [Amino Acid Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "in FP6,"

Phrase: "may"

Phrase: "be"

Phrase: "partially"

Phrase: "buried"

Phrase: "or"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a compatible surface for FP6 self-association."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205148:Surface [Spatial Concept]
Processing 00000000.tx.361: From this study, a model emerges in which the 2M subunit includes two linear sequences that form protein interaction sites with distinct specificities. 

Phrase: "From this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "a model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "emerges in which"

Phrase: "the 2M subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "two linear sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "that form protein interaction sites with distinct specificities."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   744   C0205145:Sites [Spatial Concept]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]
   709   C0449604:Specific site [Spatial Concept]
Processing 00000000.tx.362: The resolution of the growth factor-binding site and the A-binding sequence in 2M is intriguing, given the accumulating evidence that 2M may inhibit AD progression by promoting A clearance while promoting AD progression by neutralizing TGF-. 

Phrase: "The resolution of the growth factor-binding site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1514893:Resolution [Idea or Concept]
   744   C1706463:Resolution [Quantitative Concept]
   744   C2699488:Resolution [Conceptual Entity]

Phrase: "and"

Phrase: "the A-binding sequence in 2M"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C1519249:Sequence [Functional Concept]

Phrase: "is"

Phrase: "intriguing,"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the accumulating evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that 2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "may"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "AD progression by promoting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]

Phrase: "A clearance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449297:Clearance [Qualitative Concept]
  1000   C1382187:Clearance [Clinical Attribute]
  1000   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "while"

Phrase: "promoting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promoting [Activity]

Phrase: "AD progression by neutralizing TGF-"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   814   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   814   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0242656:progression [Pathologic Function]
   748   C0449258:Progression [Functional Concept]
   748   C1510411:Transforming [Pathologic Function]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "."
Processing 00000000.tx.363: We hypothesize that it may be possible to generate 2M derivatives, by site-directed mutagenesis, with defective growth factor binding activity and intact A binding activity. 

Phrase: "We"

Phrase: "hypothesize"

Phrase: "that"

Phrase: "it"

Phrase: "may"

Phrase: "be"

Phrase: "possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "generate"

Phrase: "2M derivatives,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243072:derivatives [Chemical Viewed Structurally]
   793 E C1527240:Derivative [Functional Concept]

Phrase: "by site-directed mutagenesis,"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   827   C0079866:Mutagenesis [Molecular Function]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   827   C3146302:Mutagenesis [Laboratory Procedure]
   793   C0439851:Direct [Qualitative Concept]
   793   C1947931:Direct [Qualitative Concept]
   755 E C0439755:Directions [Spatial Concept]
   755 E C0449738:Direction [Spatial Concept]
   711 E C1707761:Directionality [Functional Concept]
   711 E C3274524:Directionality [Functional Concept]

Phrase: "with defective growth factor binding activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   888   C1149472:growth factor activity [Molecular Function]
   840   C2266866:Binding Activity [Molecular Function]
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]
   717   C1149299:Growth Factor Binding [Molecular Function]

Phrase: "and"

Phrase: "intact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205266:Intact [Qualitative Concept]
  1000   C1554187:Intact [Idea or Concept]

Phrase: "A binding activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2266866:Binding Activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.364: Such derivatives may provide an important tool for understanding the function of 2M in AD.  

Phrase: "Such derivatives"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243072:derivatives [Chemical Viewed Structurally]
   966 E C1527240:Derivative [Functional Concept]

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an important tool for understanding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0336791:Tool [Manufactured Object]
   760   C2827396:Tool [Manufactured Object]

Phrase: "the function of 2M"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "in AD."
Processing 00000000.tx.365: FOOTNOTES * This work was supported by Grant A2001-011 from the American Health Assistance Foundation and by National Institutes of Health Grant CA-53462.

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by Grant A2001-011"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0018173:Grant [Quantitative Concept]
   760   C1521721:Supported [Conceptual Entity]
   760   C1548284:Grant [Idea or Concept]
   726 E C0183683:Support [Medical Device]

Phrase: "from the American Health Assistance Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "and by National Institutes of Health Grant CA-53462."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   818   C0027468:National Institutes of Health [Health Care Related Organization]
           national health institutes
   742   C0018173:Grant [Quantitative Concept]
   742   C0018684:Health [Idea or Concept]
   742   C0021622:Institutes [Organization]
   742   C1515981:And [Idea or Concept]
   742   C1548284:Grant [Idea or Concept]
   742   C3245503:national [Intellectual Product]
   708 E C1272753:Institute [Idea or Concept]
Processing 00000000.tx.366: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.367: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.368: Section 1734solely to indicate this fact. 

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.369: To whom correspondence should be addressed: Depts. of Pathology and of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Box 800214,Charlottesville, VA 22908.Tel.: 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Depts."

Phrase: "of Pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "and of Biochemistry"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0005477:Biochemistry [Occupation or Discipline]
   790   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "Molecular Genetics,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "University of Virginia School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "Box 800214,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0179400:Box [Manufactured Object]
   861   C1533124:Box [Medical Device]

Phrase: "Charlottesville,"

Phrase: "VA 22908.Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0796520:TEL [Gene or Genome]
   827   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.370: 434-924-9192; 

Phrase: "434-924-9192"

Phrase: ";"
Processing 00000000.tx.371: Fax: 434-982-0283; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "434-982-0283"

Phrase: ";"
Processing 00000000.tx.372: E-mail: slg2t@virginia.edu. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "slg2t@virginia.edu."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0059804:EDU [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.373: Published, JBC Papers in Press, January 31,2002,DOI 10.1074/jbc.M106792200  ABBREVIATIONS The abbreviations used are: A, -amyloid peptide; 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "January 31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]

Phrase: "2002,"

Phrase: "DOI 10.1074/jbc.M106792200  ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "A, -"

Phrase: "amyloid peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.374: APP, -amyloid precursor protein; 

Phrase: "APP, -"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: "amyloid precursor protein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
  1000   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   913   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.375: AD, Alzheimer's disease; 

Phrase: "AD,"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.376: 2M, 2-macroglobulin; 

Phrase: "2M,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "2-macroglobulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.377: TGF-, transforming growth factor-; 

Phrase: "TGF-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: ","

Phrase: "transforming growth factor-"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0040691:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1527194:Transforming Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1510411:Transforming [Pathologic Function]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]

Phrase: ";"
Processing 00000000.tx.378: NGF-, nerve growth factor-; 

Phrase: "NGF-"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   873   C0814002:Neural Growth [Cell Function,Organism Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C0220844:growth [Physiologic Function]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]

Phrase: ","

Phrase: "nerve growth factor-"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   873   C0814002:Neural Growth [Cell Function,Organism Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C0220844:growth [Physiologic Function]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]

Phrase: ";"
Processing 00000000.tx.379: LRP, low density lipoprotein receptor-related protein; 

Phrase: "LRP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   875   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "low density lipoprotein receptor-related protein"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   901   C0034821:Low Density Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1366529:LOW DENSITY LIPOPROTEIN RECEPTOR [Gene or Genome]
   901   C1416912:LIPOPROTEIN RECEPTOR-RELATED PROTEIN [Gene or Genome]
   895   C0242972:low protein [Therapeutic or Preventive Procedure]
   895   C0748025:low protein [Finding]
   861   C0023823:Low density lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid]
   839   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   827   C0065059:Lipoprotein Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0023820:Lipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0178587:density [Quantitative Concept]
   799   C0205251:low [Qualitative Concept]
   799   C0439849:Related [Qualitative Concept]
   799   C0445223:Related [Finding]
   799   C1299352:Low [Qualitative Concept]
   799   C1550472:low [Idea or Concept]
   766 E C0163712:Relate [Organic Chemical]
   727 E C0080103:Relation [Family Group]
   727 E C0439794:Dense [Qualitative Concept]
   727 E C0869014:Relations [Social Behavior]

Phrase: ";"
Processing 00000000.tx.380: 2M-MA, methylamine-activated 2M; 

Phrase: "2M-MA,"

Phrase: "methylamine-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0066318:methylamine [Organic Chemical]

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "2M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024420:Macroglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.381: PDGF-BB, platelet-derived growth factor-BB; 

Phrase: "PDGF-BB,"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
  1000   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   937   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0004739:BB [Geographic Area]
   804   C0005821:Platelet [Cell]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0332297:BB [Spatial Concept]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   804   C3245521:derived [Idea or Concept]
   721 E C1963076:Platelets [Finding]

Phrase: "platelet-derived growth factor-BB"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
  1000   C0246681:platelet-derived growth factor BB [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   937   C0032200:Platelet-Derived Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C1979795:Platelet factor [Amino Acid, Peptide, or Protein]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0004739:BB [Geographic Area]
   804   C0005821:Platelet [Cell]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0220844:growth [Physiologic Function]
   804   C0332297:BB [Spatial Concept]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   804   C3245521:derived [Idea or Concept]
   721 E C1963076:Platelets [Finding]

Phrase: ";"
Processing 00000000.tx.382: BSA, bovine serum albumin; 

Phrase: "BSA,"

Phrase: "bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: ";"
Processing 00000000.tx.383: DTT, dithiothreitol; 

Phrase: "DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.384: PVDF, polyvinylidene fluoride; 

Phrase: "PVDF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0071710:polyvinylidene fluoride [Organic Chemical]
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "polyvinylidene fluoride"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0071710:polyvinylidene fluoride [Organic Chemical]
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.385: BS3, bis(sulfosuccinimidyl) suberate; 

Phrase: "BS3,"

Phrase: "bis("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0556985:BIS [Temporal Concept]
  1000   C2247301:BIS [Molecular Function]
  1000   C3540495:BIS [Intellectual Product]

Phrase: "sulfosuccinimidyl"

Phrase: ")"

Phrase: "suberate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0947344:Suberate [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.386: RAP, receptor-associated protein; 

Phrase: "RAP,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   913   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]

Phrase: "receptor-associated protein"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   913   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0332281:Associated [Qualitative Concept]
   793 E C0750490:Associate [Idea or Concept]
   793 E C1706221:Associate [Professional or Occupational Group]

Phrase: ";"
Processing 00000000.tx.387: GST, glutathione S-transferase; 

Phrase: "GST,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "glutathione S-transferase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0017837:Glutathione S-Transferase [Amino Acid, Peptide, or Protein,Enzyme]
           Glutathione Transferase
   827   C0017817:Glutathione [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0040676:Transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.388: BSA, bovine serum albumin; 

Phrase: "BSA,"

Phrase: "bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   901   C0728877:serum albumin [Laboratory or Test Result]
   827   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007452:Bovine [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C1140701:bovine [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: ";"
Processing 00000000.tx.389: RBF, receptor binding fragment; 

Phrase: "RBF,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0597358:Receptor Binding [Molecular Function]
   827   C0243122:binding [Functional Concept]
   827   C0332255:fragment [Functional Concept]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "receptor binding fragment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0597358:Receptor Binding [Molecular Function]
   827   C0243122:binding [Functional Concept]
   827   C0332255:fragment [Functional Concept]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.390: FP, fusion protein; 

Phrase: "FP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1419068:FP [Gene or Genome]
  1000   C1419906:FP [Gene or Genome]
  1000   C3541238:Fp [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3541412:FP [Gene or Genome]

Phrase: "fusion protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0332466:Fusion [Functional Concept]
   861   C1293131:Fusion [Therapeutic or Preventive Procedure]

Phrase: ";"
Processing 00000000.tx.391: aa, amino acid(s).  

Phrase: "aa,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "amino acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "("

Phrase: "s)."
Processing 00000000.tx.392: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.393: Sisodia, S. 

Phrase: "Sisodia,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.394: S., and Price, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.395: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.396: (1995) FASEB J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "FASEB J."
Processing 00000000.tx.397: 9, 366-370[Abstract/Free FullText] 2. 

Phrase: "9,"

Phrase: "366-370"

Phrase: "[Abstract/Free FullText"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.398: Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. 

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Oltersdorf,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Haass,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "McConlogue,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hung,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0544691:hang [Injury or Poisoning]
   966   C1823998:HANG [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.399: Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., and Selkoe, D. 

Phrase: "Y.,"

Phrase: "Seubert,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Vigo-Pelfrey,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.400: J. 

Phrase: "J."
Processing 00000000.tx.401: (1992) Nature 360, 672-674[CrossRef][Medline] [OrderarticleviaInfotrieve] 3. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Nature 360,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "672-674"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.402: Cai, X. 

Phrase: "Cai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064494:CAI [Organic Chemical,Pharmacologic Substance]

Phrase: "X."
Processing 00000000.tx.403: D., Golde, T. 

Phrase: "D."

Phrase: ","

Phrase: "Golde,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.404: E., and Younkin, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Younkin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.405: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.406: (1993) Science 259, 514-516[Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Science 259,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "514-516"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.407: Hardy, J. 

Phrase: "Hardy,"

Phrase: "J."
Processing 00000000.tx.408: (1997) Trends Neurosci. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci."
Processing 00000000.tx.409: 20, 154-159[CrossRef][Medline] [OrderarticleviaInfotrieve] 5. 

Phrase: "20,"

Phrase: "154-159"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.410: Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al.. 

Phrase: "Games,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150593:games [Daily or Recreational Activity]

Phrase: "D."

Phrase: ","

Phrase: "Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "D."

Phrase: ","

Phrase: "Alessandrini,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Barbour,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Berthelette,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Blackwell,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Carr,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Clemens,"

Phrase: "J.,"

Phrase: "Donaldson,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Gillespie,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "et al.."
Processing 00000000.tx.411: (1995) Nature 373, 523-527[CrossRef][Medline] [OrderarticleviaInfotrieve] 6. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Nature 373,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "523-527"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 6."
Processing 00000000.tx.412: Chen, G., Chen, K. 

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.413: S., Knox, J., Inglis, J., Bernard, A., Martin, S. 

Phrase: "S."

Phrase: ","

Phrase: "Knox,"

Phrase: "J.,"

Phrase: "Inglis,"

Phrase: "J.,"

Phrase: "Bernard,"

Phrase: "A.,"

Phrase: "Martin,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.414: J., Justice, A., McConlogue, L., Games, D., Freedman, S. 

Phrase: "J.,"

Phrase: "Justice,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022437:Justice [Qualitative Concept]

Phrase: "A.,"

Phrase: "McConlogue,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Games,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150593:games [Daily or Recreational Activity]

Phrase: "D."

Phrase: ","

Phrase: "Freedman,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.415: B., and Morris, R. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Morris,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.416: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.417: (2000) Nature 408, 975-979[CrossRef][Medline] [OrderarticleviaInfotrieve] 7. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nature 408,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "975-979"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 7."
Processing 00000000.tx.418: Terai, K., Iwai, A., Kawabata, S., Sasamata, M., Miyata, K., and Yamaguchi, T. 

Phrase: "Terai,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Iwai,"

Phrase: "A.,"

Phrase: "Kawabata,"

Phrase: "S."

Phrase: ","

Phrase: "Sasamata,"

Phrase: "M."

Phrase: ","

Phrase: "Miyata,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Yamaguchi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.419: (2001) Brain Res. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.420: 900, 48-56[CrossRef][Medline] [OrderarticleviaInfotrieve] 8. 

Phrase: "900,"

Phrase: "48-56"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 8."
Processing 00000000.tx.421: Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K. 

Phrase: "Sturchler-Pierrat,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Abramowski,"

Phrase: "D."

Phrase: ","

Phrase: "Duke,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1446468:Duke [Laboratory Procedure]

Phrase: "M."

Phrase: ","

Phrase: "Wiederhold,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.422: H., Mistl, C., Rothacher, S., Ledermann, B., Burki, K., Frey, P., Paganetti, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mistl,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Rothacher,"

Phrase: "S."

Phrase: ","

Phrase: "Ledermann,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Burki,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Frey,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Paganetti,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.423: A., Waridel, C., Calhoun, M. 

Phrase: "A.,"

Phrase: "Waridel,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Calhoun,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.424: E., Jucker, M., Probst, A., Staufenbiel, M., and Sommer, B. 

Phrase: "E.,"

Phrase: "Jucker,"

Phrase: "M."

Phrase: ","

Phrase: "Probst,"

Phrase: "A.,"

Phrase: "Staufenbiel,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Sommer,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.425: (1997) Proc. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.426: Natl. 

Phrase: "Natl."
Processing 00000000.tx.427: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.428: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.429: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.430: 94, 13287-13292[Abstract/Free FullText] 9. 

Phrase: "94,"

Phrase: "13287-13292"

Phrase: "[Abstract/Free FullText"

Phrase: "] 9."
Processing 00000000.tx.431: Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., Kholodenko, D., Lee, M., Liao, Z., Lieberburg, I., Motter, R., Mutter, L., Soriano, F., Shopp, G., Vasquez, N., Vandevert, C., Walker, S., Wogulis, M., Yednock, T., Games, D., and Seubert, P. 

Phrase: "Schenk,"

Phrase: "D."

Phrase: ","

Phrase: "Barbour,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dunn,"

Phrase: "W.,"

Phrase: "Gordon,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Grajeda,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Guido,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Hu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Huang,"

Phrase: "J.,"

Phrase: "Johnson-Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0043217:Wood [Substance]
   805 E C0144237:Sylvan [Organic Chemical]
   777 E C0442548:Woods [Geographic Area]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Khan,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kholodenko,"

Phrase: "D."

Phrase: ","

Phrase: "Lee,"

Phrase: "M."

Phrase: ","

Phrase: "Liao,"

Phrase: "Z.,"

Phrase: "Lieberburg,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Motter,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mutter,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Soriano,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Shopp,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Vasquez,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Vandevert,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "S."

Phrase: ","

Phrase: "Wogulis,"

Phrase: "M."

Phrase: ","

Phrase: "Yednock,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Games,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0150593:games [Daily or Recreational Activity]

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Seubert,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.432: (1999) Nature 400, 173-177[CrossRef][Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 400,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "173-177"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.433: Janus, C., Pearson, J., McLaurin, J., Mathews, P. 

Phrase: "Janus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0266700:Janus [Congenital Abnormality]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pearson,"

Phrase: "J.,"

Phrase: "McLaurin,"

Phrase: "J.,"

Phrase: "Mathews,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.434: M., Jiang, Y., Schmidt, S. 

Phrase: "M."

Phrase: ","

Phrase: "Jiang,"

Phrase: "Y.,"

Phrase: "Schmidt,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.435: D., Chishti, M. 

Phrase: "D."

Phrase: ","

Phrase: "Chishti,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.436: A., Horne, P., Heslin, D., French, J., Mount, H. 

Phrase: "A.,"

Phrase: "Horne,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Heslin,"

Phrase: "D."

Phrase: ","

Phrase: "French,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1556084:French [Population Group]

Phrase: "J.,"

Phrase: "Mount,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181909:Mount [Medical Device]
  1000   C0449878:mount [Finding]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.437: T., Nixon, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nixon,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.438: A., Mercken, M., Bergeron, C., Fraser, P. 

Phrase: "A.,"

Phrase: "Mercken,"

Phrase: "M."

Phrase: ","

Phrase: "Bergeron,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.439: E., St., George-Hyslop, P., and Westaway, D. 

Phrase: "E.,"

Phrase: "St.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]

Phrase: "George-Hyslop,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Westaway,"

Phrase: "D."
Processing 00000000.tx.440: (2000) Nature 408, 979-982[CrossRef][Medline] [OrderarticleviaInfotrieve] 11. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nature 408,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "979-982"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 11."
Processing 00000000.tx.441: Sottrup-Jensen, L. 

Phrase: "Sottrup-Jensen,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.442: (1987) in The Plasma Proteins (Putnam, F. W., ed), Vol. 

Phrase: "(1987"

Phrase: ")"

Phrase: "in The Plasma Proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0032120:Plasma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C0036825:Plasma Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0032105:Plasma [Body Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "(Putnam,"

Phrase: "F. W., ed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.443: 5 , pp. 

Phrase: "5 ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "pp."
Processing 00000000.tx.444: 192-291, Academic Press, Inc., Orlando, FL 12. 

Phrase: "192-291,"

Phrase: "Academic Press,"

Phrase: "Inc.,"

Phrase: "Orlando,"

Phrase: "FL 12."
Processing 00000000.tx.445: Crookston, K. 

Phrase: "Crookston,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.446: P., Webb, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Webb,"

Phrase: "D."
Processing 00000000.tx.447: J., Wolf, B. 

Phrase: "J.,"

Phrase: "Wolf,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325001:Wolf [Mammal]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.448: B., and Gonias, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Gonias,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.449: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.450: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.451: Biol. 

Phrase: "Biol."
Processing 00000000.tx.452: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.453: 269, 1533-1540[Abstract/Free FullText] 13. 

Phrase: "269,"

Phrase: "1533-1540"

Phrase: "[Abstract/Free FullText"

Phrase: "] 13."
Processing 00000000.tx.454: Gonias, S. 

Phrase: "Gonias,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.455: L., LaMarre, J., Crookston, K. 

Phrase: "L., LaMarre,"

Phrase: "J.,"

Phrase: "Crookston,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.456: P., Webb, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Webb,"

Phrase: "D."
Processing 00000000.tx.457: J., Wolf, B. 

Phrase: "J.,"

Phrase: "Wolf,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325001:Wolf [Mammal]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.458: B., Lopes, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lopes,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.459: B., Moses, H. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Moses,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.460: L., and Hayes, M. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Hayes,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.461: A. 

Phrase: "A."
Processing 00000000.tx.462: (1994) Ann. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.463: N.Y.Acad. 

Phrase: "N.Y.Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0268596:ACAD [Disease or Syndrome]
   827   C2700624:ACAD [Cell Function]
Processing 00000000.tx.464: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.465: 737, 273-290[Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "737,"

Phrase: "273-290"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.466: Blacker, D., Wilcox, M. 

Phrase: "Blacker,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0005680:Black [Population Group]
   966   C0027567:Black [Population Group]
   966   C0085756:Black [Population Group]
   966   C0439541:Black [Qualitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Wilcox,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.467: A., Laird, N. 

Phrase: "A.,"

Phrase: "Laird,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.468: M., Rodes, L., Horvath, S. 

Phrase: "M."

Phrase: ","

Phrase: "Rodes,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Horvath,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.469: M., Go, R.C., Perry, R., Watson, B., Jr., Bassett, S. 

Phrase: "M."

Phrase: ","

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "R.C., Perry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0722969:R & C [Organic Chemical,Pharmacologic Substance]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Watson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3476816:Watson [Quantitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Bassett,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.470: S., McInnis, M. 

Phrase: "S."

Phrase: ","

Phrase: "McInnis,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.471: G., Albert, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Albert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.472: S., Hyman, B. 

Phrase: "S."

Phrase: ","

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.473: T., and Tanzi, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.474: E. 

Phrase: "E."
Processing 00000000.tx.475: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.476: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.477: 19, 357-360[CrossRef][Medline] [OrderarticleviaInfotrieve] 15. 

Phrase: "19,"

Phrase: "357-360"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 15."
Processing 00000000.tx.478: Barrett, A. 

Phrase: "Barrett,"

Phrase: "A."
Processing 00000000.tx.479: J., Brown, M. 

Phrase: "J.,"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.480: A., and Sayers, C. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Sayers,"

Phrase: "C."
Processing 00000000.tx.481: A. 

Phrase: "A."
Processing 00000000.tx.482: (1979) Biochem. 

Phrase: "(1979"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.483: J. 

Phrase: "J."
Processing 00000000.tx.484: 181, 401-418[Medline] [OrderarticleviaInfotrieve] 16. 

Phrase: "181,"

Phrase: "401-418"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 16."
Processing 00000000.tx.485: Sottrup-Jensen, L., Sand, O., Kristensen, L., and Fey, G. 

Phrase: "Sottrup-Jensen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Sand,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037098:Sand [Biomedical or Dental Material,Inorganic Chemical]

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Kristensen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Fey, G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.486: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.487: (1989) J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.488: Biol. 

Phrase: "Biol."
Processing 00000000.tx.489: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.490: 264, 15781-15789[Abstract/Free FullText] 17. 

Phrase: "264,"

Phrase: "15781-15789"

Phrase: "[Abstract/Free FullText"

Phrase: "] 17."
Processing 00000000.tx.491: Webb, D. 

Phrase: "Webb,"

Phrase: "D."
Processing 00000000.tx.492: J., Wen, J., Karns, L. 

Phrase: "J.,"

Phrase: "Wen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014511:Wen [Anatomical Abnormality]
  1000   C0086809:Wen [Anatomical Abnormality]
  1000   C1547963:Wen [Intellectual Product]

Phrase: "J.,"

Phrase: "Karns,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.493: R., Kurilla, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kurilla,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.494: G., and Gonias, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Gonias,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.495: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.496: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.497: Biol. 

Phrase: "Biol."
Processing 00000000.tx.498: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.499: 273, 13339-13346[Abstract/Free FullText] 18. 

Phrase: "273,"

Phrase: "13339-13346"

Phrase: "[Abstract/Free FullText"

Phrase: "] 18."
Processing 00000000.tx.500: Gonias, S. 

Phrase: "Gonias,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.501: L., Carmichael, A., Mettenburg, J. 

Phrase: "L., Carmichael,"

Phrase: "A.,"

Phrase: "Mettenburg,"

Phrase: "J."
Processing 00000000.tx.502: M., Roadcap, D. 

Phrase: "M."

Phrase: ","

Phrase: "Roadcap,"

Phrase: "D."
Processing 00000000.tx.503: W., Irvin, W. 

Phrase: "W., Irvin,"

Phrase: "W."
Processing 00000000.tx.504: P., and Webb, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Webb,"

Phrase: "D."
Processing 00000000.tx.505: J. 

Phrase: "J."
Processing 00000000.tx.506: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.507: Biol. 

Phrase: "Biol."
Processing 00000000.tx.508: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.509: 275, 5826-5831[Abstract/Free FullText] 19. 

Phrase: "275,"

Phrase: "5826-5831"

Phrase: "[Abstract/Free FullText"

Phrase: "] 19."
Processing 00000000.tx.510: Webb, D. 

Phrase: "Webb,"

Phrase: "D."
Processing 00000000.tx.511: J., Roadcap, D. 

Phrase: "J.,"

Phrase: "Roadcap,"

Phrase: "D."
Processing 00000000.tx.512: W., Dhakephalkar, A., and Gonias, S. 

Phrase: "W., Dhakephalkar,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Gonias,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.513: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.514: (2000) Protein Sci. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Protein Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.515: 9, 1986-1992[Abstract] 20. 

Phrase: "9,"

Phrase: "1986-1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 20."
Processing 00000000.tx.516: Liao, A., Nitsch, R. 

Phrase: "Liao,"

Phrase: "A.,"

Phrase: "Nitsch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.517: M., Greenberg, S. 

Phrase: "M."

Phrase: ","

Phrase: "Greenberg,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.518: M., Finckh, U., Blacker, D., Albert, M., Rebeck, G. 

Phrase: "M."

Phrase: ","

Phrase: "Finckh,"

Phrase: "U.,"

Phrase: "Blacker,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0005680:Black [Population Group]
   966   C0027567:Black [Population Group]
   966   C0085756:Black [Population Group]
   966   C0439541:Black [Qualitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Albert,"

Phrase: "M."

Phrase: ","

Phrase: "Rebeck,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.519: W., Gomez-Isla, T., Clatworthy, A., Binetti, G., Hock, C., Mueller-Thomsen, T., Mann, U., Zuchowski, K., Beisiegel, U., Staehelin, H., Growdon, J. 

Phrase: "W., Gomez-Isla,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Clatworthy,"

Phrase: "A.,"

Phrase: "Binetti,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hock,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003086:Hock [Body Location or Region]
  1000   C1522382:Hock [Body Location or Region]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Mueller-Thomsen,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mann,"

Phrase: "U.,"

Phrase: "Zuchowski,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Beisiegel,"

Phrase: "U.,"

Phrase: "Staehelin,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Growdon,"

Phrase: "J."
Processing 00000000.tx.520: H., Tanzi, R. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.521: E., and Hyman, B. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.522: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.523: (1998) Hum. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Hum."
Processing 00000000.tx.524: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.525: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.526: 7, 1953-1956[Abstract/Free FullText] 21. 

Phrase: "7,"

Phrase: "1953-1956"

Phrase: "[Abstract/Free FullText"

Phrase: "] 21."
Processing 00000000.tx.527: Dodel, R. 

Phrase: "Dodel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.528: C., Du, Y., Bales, K. 

Phrase: "C., Du,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540681:DU [Idea or Concept]

Phrase: "Y.,"

Phrase: "Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2826220:BALE [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.529: R., Gao, F., Eastwood, B., Glazier, B., Zimmer, R., Cordell, B., Hake, A., Evans, R., Gallagher-Thompson, D., Thompson, L. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gao,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Eastwood,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Glazier,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336386:Glazier [Professional or Occupational Group]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Zimmer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cordell,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Hake,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0452985:Hake [Food]
  1000   C1021854:hake [Fish]

Phrase: "A.,"

Phrase: "Evans,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gallagher-Thompson,"

Phrase: "D."

Phrase: ","

Phrase: "Thompson,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.530: W., Tinklenberg, J. 

Phrase: "W., Tinklenberg,"

Phrase: "J."
Processing 00000000.tx.531: R., Pfefferbaum, A., Sullivan, E. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Pfefferbaum,"

Phrase: "A.,"

Phrase: "Sullivan,"

Phrase: "E."
Processing 00000000.tx.532: V., Yesavage, J., Alstiel, L., Gasser, T., Farlow, M. 

Phrase: "V., Yesavage,"

Phrase: "J.,"

Phrase: "Alstiel,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Gasser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Farlow,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.533: R., Murphy, G. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Murphy,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.534: M., Jr., and Paul, S. 

Phrase: "M."

Phrase: ","

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "and"

Phrase: "Paul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.535: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.536: (2000) Neurology 54, 438-442[Abstract/Free FullText] 22. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neurology 54,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "438-442"

Phrase: "[Abstract/Free FullText"

Phrase: "] 22."
Processing 00000000.tx.537: Myllykangas, L., Polvikoski, T., Sulkava, R., Verkkoniemi, A., Crook, R., Tienari, P. 

Phrase: "Myllykangas,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Polvikoski,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sulkava,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Verkkoniemi,"

Phrase: "A.,"

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tienari,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.538: J., Pusa, A. 

Phrase: "J.,"

Phrase: "Pusa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2806186:Pusa [Mammal]

Phrase: "A."
Processing 00000000.tx.539: K., Niinisto, L., O'Brien, P., Kontula, K., Hardy, J., Haltia, M., and Perez-Tur, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Niinisto,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "O'Brien,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Kontula,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Haltia,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Perez-Tur,"

Phrase: "J."
Processing 00000000.tx.540: (1999) Ann. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.541: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.542: 46, 382-390[CrossRef][Medline] [OrderarticleviaInfotrieve] 23. 

Phrase: "46,"

Phrase: "382-390"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.543: Koster, M. 

Phrase: "Koster,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.544: N., Dermaut, B., Cruts, M., Houwing-Duistermaat, J. 

Phrase: "N., Dermaut,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Houwing-Duistermaat,"

Phrase: "J."
Processing 00000000.tx.545: J., Roks, G., Tol, J., Ott, A., Hofman, A., Munteanu, G., Breteler, M. 

Phrase: "J.,"

Phrase: "Roks,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Tol,"

Phrase: "J.,"

Phrase: "Ott,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1423088:OTT [Gene or Genome]
  1000   C3273338:OTT [Gene or Genome]

Phrase: "A.,"

Phrase: "Hofman,"

Phrase: "A.,"

Phrase: "Munteanu,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Breteler,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.546: M., van Duijn, C. 

Phrase: "M."

Phrase: ","

Phrase: "van Duijn,"

Phrase: "C."
Processing 00000000.tx.547: M., and Van Broeckhoven, C. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.548: (2000) Neurology 55, 678-684[Abstract/Free FullText] 24. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neurology 55,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   861   C0450382:55 [Intellectual Product]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "678-684"

Phrase: "[Abstract/Free FullText"

Phrase: "] 24."
Processing 00000000.tx.549: Jhoo, J. 

Phrase: "Jhoo,"

Phrase: "J."
Processing 00000000.tx.550: H., Kim, K. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kim,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.551: W., Lee, D. 

Phrase: "W., Lee,"

Phrase: "D."
Processing 00000000.tx.552: Y., Lee, K. 

Phrase: "Y.,"

Phrase: "Lee,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.553: U., Lee, J. 

Phrase: "U.,"

Phrase: "Lee,"

Phrase: "J."
Processing 00000000.tx.554: H., Kim, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kim,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.555: Y., Youn, J. 

Phrase: "Y.,"

Phrase: "Youn,"

Phrase: "J."
Processing 00000000.tx.556: Y., Youn, J. 

Phrase: "Y.,"

Phrase: "Youn,"

Phrase: "J."
Processing 00000000.tx.557: C., and Woo, J. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Woo,"

Phrase: "J."
Processing 00000000.tx.558: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.559: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.560: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.561: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.562: 184, 21-25[CrossRef][Medline] [OrderarticleviaInfotrieve] 25. 

Phrase: "184,"

Phrase: "21-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450347:21/25 [Quantitative Concept]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 25."
Processing 00000000.tx.563: Gibson, A. 

Phrase: "Gibson,"

Phrase: "A."
Processing 00000000.tx.564: M., Singleton, A. 

Phrase: "M."

Phrase: ","

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A."
Processing 00000000.tx.565: B., Smith, G., Woodward, R., McKeith, I. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Woodward,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "McKeith,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.566: G., Perry, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Perry,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.567: H., Ince, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ince,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.568: G., Ballard, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ballard,"

Phrase: "C."
Processing 00000000.tx.569: G., Edwardson, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Edwardson,"

Phrase: "J."
Processing 00000000.tx.570: A., and Morris, C. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Morris,"

Phrase: "C."
Processing 00000000.tx.571: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.572: (2000) Neurology 54, 433-438[Abstract/Free FullText] 26. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neurology 54,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "433-438"

Phrase: "[Abstract/Free FullText"

Phrase: "] 26."
Processing 00000000.tx.573: Van Gool, D., De, Strooper, B., Van Leuven, F., Triau, E., and Dom, R. 

Phrase: "Van Gool,"

Phrase: "D."

Phrase: ","

Phrase: "De,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011198:DE [Geographic Area]
  1000   C0017480:DE [Geographic Area]
  1000   C3541240:DE [Idea or Concept]

Phrase: "Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Van Leuven,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Triau,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Dom,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539821:DOM [Gene or Genome]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.574: (1993) Neurobiol. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.575: Aging 14, 233-237[Medline] [OrderarticleviaInfotrieve] 27. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "14,"

Phrase: "233-237"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 27."
Processing 00000000.tx.576: Lysiak, J. 

Phrase: "Lysiak,"

Phrase: "J."
Processing 00000000.tx.577: J., Hussaini, I. 

Phrase: "J.,"

Phrase: "Hussaini,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.578: M., Webb, D. 

Phrase: "M."

Phrase: ","

Phrase: "Webb,"

Phrase: "D."
Processing 00000000.tx.579: J., Glass, W. 

Phrase: "J.,"

Phrase: "Glass,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017596:Glass [Manufactured Object]
  1000   C1947936:Glass [Medical Device]
   928 E C0074759:Glassy [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   928 E C0522500:Glassy [Qualitative Concept]

Phrase: "W."
Processing 00000000.tx.580: F., 2nd, Allietta, M., and Gonias, S. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "2nd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205436:2nd [Quantitative Concept]

Phrase: "Allietta,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Gonias,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.581: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.582: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.583: Biol. 

Phrase: "Biol."
Processing 00000000.tx.584: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.585: 270, 21919-21927[Abstract/Free FullText] 28. 

Phrase: "270,"

Phrase: "21919-21927"

Phrase: "[Abstract/Free FullText"

Phrase: "] 28."
Processing 00000000.tx.586: Weaver, A. 

Phrase: "Weaver,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0326812:Weaver [Bird]

Phrase: "A."
Processing 00000000.tx.587: M., Owens, G. 

Phrase: "M."

Phrase: ","

Phrase: "Owens,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.588: K., and Gonias, S. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Gonias,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.589: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.590: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.591: Biol. 

Phrase: "Biol."
Processing 00000000.tx.592: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.593: 270, 30741-30748[Abstract/Free FullText] 29. 

Phrase: "270,"

Phrase: "30741-30748"

Phrase: "[Abstract/Free FullText"

Phrase: "] 29."
Processing 00000000.tx.594: Fabrizi, C., Businaro, R., Lauro, G. 

Phrase: "Fabrizi,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Businaro,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lauro,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.595: M., Starace, G., and Fumagalli, L. 

Phrase: "M."

Phrase: ","

Phrase: "Starace,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Fumagalli,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.596: (1999) Exp. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.597: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.598: 155, 252-259[CrossRef][Medline] [OrderarticleviaInfotrieve] 30. 

Phrase: "155,"

Phrase: "252-259"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 30."
Processing 00000000.tx.599: Wyss-Coray, T., Lin, C., Yan, F., Yu, G.Q., Rohde, M., McConlogue, L., Masliah, E., and Mucke, L. 

Phrase: "Wyss-Coray,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Yan,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "G.Q., Rohde,"

Phrase: "M."

Phrase: ","

Phrase: "McConlogue,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Mucke,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.600: (2001) Nat. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.601: Med. 

Phrase: "Med."
Processing 00000000.tx.602: 7, 612-618[CrossRef][Medline] [OrderarticleviaInfotrieve] 31. 

Phrase: "7,"

Phrase: "612-618"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.603: Kim, E. 

Phrase: "Kim,"

Phrase: "E."
Processing 00000000.tx.604: S., Kim, R. 

Phrase: "S."

Phrase: ","

Phrase: "Kim,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.605: S., Ren, R. 

Phrase: "S."

Phrase: ","

Phrase: "Ren,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022646:Ren [Body Part, Organ, or Organ Component]
  1000   C1419338:REN [Gene or Genome]
  1000   C1427479:REN [Gene or Genome]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.606: F., Hawver, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hawver,"

Phrase: "D."
Processing 00000000.tx.607: B., and Flanders, K. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Flanders,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1875156:Flanders [Inorganic Chemical,Pharmacologic Substance]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.608: C. 

Phrase: "C."
Processing 00000000.tx.609: (1998) Mol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.610: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.611: 62, 122-130[Medline] [OrderarticleviaInfotrieve] 32. 

Phrase: "62,"

Phrase: "122-130"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 32."
Processing 00000000.tx.612: Flanders, K. 

Phrase: "Flanders,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1875156:Flanders [Inorganic Chemical,Pharmacologic Substance]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.613: C., Ren, R. 

Phrase: "C., Ren,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022646:Ren [Body Part, Organ, or Organ Component]
   861   C1419338:REN [Gene or Genome]
   861   C1427479:REN [Gene or Genome]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.614: F., and Lippa, C. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Lippa,"

Phrase: "C."
Processing 00000000.tx.615: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.616: (1997) Progress Neurobiol. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Progress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1272688:progress [Functional Concept]
  1000   C1280477:Progress [Functional Concept]

Phrase: "Neurobiol."
Processing 00000000.tx.617: 54, 71-88[CrossRef][Medline] [OrderarticleviaInfotrieve] 33. 

Phrase: "54,"

Phrase: "71-88"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 33."
Processing 00000000.tx.618: Narita, M., Holtzman, D. 

Phrase: "Narita,"

Phrase: "M."

Phrase: ","

Phrase: "Holtzman,"

Phrase: "D."
Processing 00000000.tx.619: M., Schwartz, A. 

Phrase: "M."

Phrase: ","

Phrase: "Schwartz,"

Phrase: "A."
Processing 00000000.tx.620: L., and Bu, G. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Bu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006463:BU [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.621: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.622: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.623: 69, 1904-1911[Medline] [OrderarticleviaInfotrieve] 34. 

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "1904-1911"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 34."
Processing 00000000.tx.624: Kang, D. 

Phrase: "Kang,"

Phrase: "D."
Processing 00000000.tx.625: E., Pietrzik, C. 

Phrase: "E.,"

Phrase: "Pietrzik,"

Phrase: "C."
Processing 00000000.tx.626: U., Baum, L., Chevallier, N., Merriam, D. 

Phrase: "U.,"

Phrase: "Baum,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Chevallier,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Merriam,"

Phrase: "D."
Processing 00000000.tx.627: E., Kounnas, M. 

Phrase: "E.,"

Phrase: "Kounnas,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.628: Z., Wagner, S. 

Phrase: "Z.,"

Phrase: "Wagner,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.629: L., Troncoso, J. 

Phrase: "L., Troncoso,"

Phrase: "J."
Processing 00000000.tx.630: C., Kawas, C. 

Phrase: "C., Kawas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0521083:Kawas [Plant]

Phrase: "C."
Processing 00000000.tx.631: H., Katzman, R., and Koo, E. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Katzman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Koo,"

Phrase: "E."
Processing 00000000.tx.632: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.633: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.634: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.635: Invest. 

Phrase: "Invest."
Processing 00000000.tx.636: 106, 1159-1166[Abstract/Free FullText] 35. 

Phrase: "106,"

Phrase: "1159-1166"

Phrase: "[Abstract/Free FullText"

Phrase: "] 35."
Processing 00000000.tx.637: Hyman, B. 

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.638: T., Strickland, D., and Rebeck, G. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Strickland,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Rebeck,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.639: W. 

Phrase: "W."
Processing 00000000.tx.640: (2000) Arch. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.641: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.642: 57, 646-650[Abstract/Free FullText] 36. 

Phrase: "57,"

Phrase: "646-650"

Phrase: "[Abstract/Free FullText"

Phrase: "] 36."
Processing 00000000.tx.643: Du, Y., Ni, B., Glinn, M., Dodel, R. 

Phrase: "Du,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540681:DU [Idea or Concept]

Phrase: "Y.,"

Phrase: "Ni,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348274:Ni [Element, Ion, or Isotope]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Glinn,"

Phrase: "M."

Phrase: ","

Phrase: "Dodel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.644: C., Bales, K. 

Phrase: "C., Bales,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2826220:BALE [Quantitative Concept]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.645: R., Zhang, Z., Hyslop, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Zhang,"

Phrase: "Z.,"

Phrase: "Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.646: A., and Paul, S. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Paul,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.647: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.648: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.649: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.650: 69, 299-305[Medline] [OrderarticleviaInfotrieve] 37. 

Phrase: "69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "299-305"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 37."
Processing 00000000.tx.651: Hughes, S. 

Phrase: "Hughes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551730:Hughes [Population Group]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.652: R., Khorkova, O., Goyal, S., Knaeblein, J., Heroux, J., Riedel, N. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Khorkova,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Goyal,"

Phrase: "S."

Phrase: ","

Phrase: "Knaeblein,"

Phrase: "J.,"

Phrase: "Heroux,"

Phrase: "J.,"

Phrase: "Riedel,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.653: G., and Sahasrabudhe, S. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Sahasrabudhe,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.654: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.655: Natl. 

Phrase: "Natl."
Processing 00000000.tx.656: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.657: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.658: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.659: 95, 3275-3280[Abstract/Free FullText] 38. 

Phrase: "95,"

Phrase: "3275-3280"

Phrase: "[Abstract/Free FullText"

Phrase: "] 38."
Processing 00000000.tx.660: Sottrup-Jensen, L., Gliemann, J., and Van Leuven, F. 

Phrase: "Sottrup-Jensen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Gliemann,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Van Leuven,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.661: (1986) FEBS Lett. 

Phrase: "(1986"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.662: 205, 20-24[CrossRef][Medline] [OrderarticleviaInfotrieve] 39. 

Phrase: "205,"

Phrase: "20-24"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 39."
Processing 00000000.tx.663: Nielsen, K. 

Phrase: "Nielsen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.664: L., Holtet, T. 

Phrase: "L., Holtet,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.665: L., Etzerodt, M., Moestrup, S. 

Phrase: "L., Etzerodt,"

Phrase: "M."

Phrase: ","

Phrase: "Moestrup,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.666: K., Gliemann, J., Sottrup-Jensen, L., and Thogersen, H. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gliemann,"

Phrase: "J.,"

Phrase: "Sottrup-Jensen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Thogersen,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.667: C. 

Phrase: "C."
Processing 00000000.tx.668: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.669: Biol. 

Phrase: "Biol."
Processing 00000000.tx.670: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.671: 271, 12909-12912[Abstract/Free FullText] 40. 

Phrase: "271,"

Phrase: "12909-12912"

Phrase: "[Abstract/Free FullText"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.672: Howard, G. 

Phrase: "Howard,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.673: C., Yamaguchi, Y., Misra, U. 

Phrase: "C., Yamaguchi,"

Phrase: "Y.,"

Phrase: "Misra,"

Phrase: "U."
Processing 00000000.tx.674: K., Gawdi, G., Nelsen, A., DeCamp, D. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Gawdi,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Nelsen,"

Phrase: "A.,"

Phrase: "DeCamp"

Phrase: ","

Phrase: "D."
Processing 00000000.tx.675: L., and Pizzo, S. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Pizzo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.676: V. 

Phrase: "V."
Processing 00000000.tx.677: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.678: Biol. 

Phrase: "Biol."
Processing 00000000.tx.679: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.680: 271, 14105-14111[Abstract/Free FullText] 41. 

Phrase: "271,"

Phrase: "14105-14111"

Phrase: "[Abstract/Free FullText"

Phrase: "] 41."
Processing 00000000.tx.681: Jenner, L., Husted, L., Thirup, S., Sottrup-Jensen, L., and Nyborg, J. 

Phrase: "Jenner,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Husted,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Thirup,"

Phrase: "S."

Phrase: ","

Phrase: "Sottrup-Jensen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Nyborg,"

Phrase: "J."
Processing 00000000.tx.682: (1998) Structure 6, 595-604[Medline] [OrderarticleviaInfotrieve] 42. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Structure 6,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "595-604"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 42."
Processing 00000000.tx.683: Huang, W., Dolmer, K., Liao, X., and Gettins, P. 

Phrase: "Huang,"

Phrase: "W.,"

Phrase: "Dolmer,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Liao,"

Phrase: "X.,"

Phrase: "and"

Phrase: "Gettins,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.684: G.W. 

Phrase: "G.W."
Processing 00000000.tx.685: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.686: Biol. 

Phrase: "Biol."
Processing 00000000.tx.687: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.688: 275, 1089-1094[Abstract/Free FullText] 43. 

Phrase: "275,"

Phrase: "1089-1094"

Phrase: "[Abstract/Free FullText"

Phrase: "] 43."
Processing 00000000.tx.689: Imber, M. 

Phrase: "Imber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3393516:Imber [Eukaryote]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.690: J., and Pizzo, S. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Pizzo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.691: V. 

Phrase: "V."
Processing 00000000.tx.692: (1981) J. 

Phrase: "(1981"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.693: Biol. 

Phrase: "Biol."
Processing 00000000.tx.694: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.695: 256, 8134-8139[Abstract/Free FullText] 44. 

Phrase: "256,"

Phrase: "8134-8139"

Phrase: "[Abstract/Free FullText"

Phrase: "] 44."
Processing 00000000.tx.696: Gonias, S. 

Phrase: "Gonias,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.697: L., Reynolds, J. 

Phrase: "L., Reynolds,"

Phrase: "J."
Processing 00000000.tx.698: A., and Pizzo, S. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Pizzo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.699: V. 

Phrase: "V."
Processing 00000000.tx.700: (1982) Biochim. 

Phrase: "(1982"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.701: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.702: Acta 705, 306-314[Medline] [OrderarticleviaInfotrieve] 45. 

Phrase: "Acta 705,"

Phrase: "306-314"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 45."
Processing 00000000.tx.703: Hussaini, I. 

Phrase: "Hussaini,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.704: M., Figler, N. 

Phrase: "M."

Phrase: ","

Phrase: "Figler,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.705: L., and Gonias, S. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Gonias,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.706: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.707: (1990) Biochem. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.708: J. 

Phrase: "J."
Processing 00000000.tx.709: 270, 291-295[Medline] [OrderarticleviaInfotrieve] 46. 

Phrase: "270,"

Phrase: "291-295"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 46."
Processing 00000000.tx.710: Sottrup-Jensen, L., Petersen, T. 

Phrase: "Sottrup-Jensen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Petersen,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.711: E., and Magnusson, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Magnusson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.712: (1980) FEBS Lett. 

Phrase: "(1980"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.713: 121, 275-279[CrossRef][Medline] [OrderarticleviaInfotrieve] 47. 

Phrase: "121,"

Phrase: "275-279"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 47."
Processing 00000000.tx.714: Swenson, R. 

Phrase: "Swenson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.715: P., and Howard, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Howard,"

Phrase: "J."
Processing 00000000.tx.716: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.717: (1980) J. 

Phrase: "(1980"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.718: Biol. 

Phrase: "Biol."
Processing 00000000.tx.719: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.720: 255, 8087-8091[Abstract/Free FullText] 48. 

Phrase: "255,"

Phrase: "8087-8091"

Phrase: "[Abstract/Free FullText"

Phrase: "] 48."
Processing 00000000.tx.721: Harpel, P. 

Phrase: "Harpel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.722: C., Hayes, M. 

Phrase: "C., Hayes,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.723: B., and Hugli, T. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Hugli,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.724: E. 

Phrase: "E."
Processing 00000000.tx.725: (1979) J. 

Phrase: "(1979"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.726: Biol. 

Phrase: "Biol."
Processing 00000000.tx.727: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.728: 254, 8669-8678[Abstract] 49. 

Phrase: "254,"

Phrase: "8669-8678"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 49."
Processing 00000000.tx.729: Van Leuven, F., Cassiman, J. 

Phrase: "Van Leuven,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Cassiman,"

Phrase: "J."
Processing 00000000.tx.730: J., and Van den Berghe, H. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Van den Berghe,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.731: (1981) J. 

Phrase: "(1981"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.732: Biol. 

Phrase: "Biol."
Processing 00000000.tx.733: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.734: 256, 9016-9022[Free FullText] 50. 

Phrase: "256,"

Phrase: "9016-9022"

Phrase: "[Free FullText"

Phrase: "] 50."
Processing 00000000.tx.735: Wolf, B. 

Phrase: "Wolf,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325001:Wolf [Mammal]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.736: B., and Gonias, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Gonias,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.737: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.738: (1994) Biochemistry 33, 11270-11277[Medline] [OrderarticleviaInfotrieve] 51. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Biochemistry 33,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "11270-11277"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 51."
Processing 00000000.tx.739: Pizzo, S. 

Phrase: "Pizzo,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.740: V., and Gonias, S. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Gonias,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.741: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.742: (1984) in The Receptors (Conn, P. M., ed), Vol. 

Phrase: "(1984"

Phrase: ")"

Phrase: "in The Receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Conn,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "M."

Phrase: ","

Phrase: "ed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.743: 1 , pp. 

Phrase: "1 ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "pp."
Processing 00000000.tx.744: 177-221, Academic Press, Inc., Orlando, FL 52. 

Phrase: "177-221,"

Phrase: "Academic Press,"

Phrase: "Inc.,"

Phrase: "Orlando,"

Phrase: "FL 52."
Processing 00000000.tx.745: Ulery, P. 

Phrase: "Ulery,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.746: G., and Strickland, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Strickland,"

Phrase: "D."
Processing 00000000.tx.747: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.748: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.749: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.750: Invest. 

Phrase: "Invest."
Processing 00000000.tx.751: 106, 1077-1079[Free FullText] 53. 

Phrase: "106,"

Phrase: "1077-1079"

Phrase: "[Free FullText"

Phrase: "] 53."
Processing 00000000.tx.752: Shibata, M., Yamada, S., Kumar, S. 

Phrase: "Shibata,"

Phrase: "M."

Phrase: ","

Phrase: "Yamada,"

Phrase: "S."

Phrase: ","

Phrase: "Kumar,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.753: R., Calero, M., Bading, J., Frangione, B., Holtzman, D. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Calero,"

Phrase: "M."

Phrase: ","

Phrase: "Bading,"

Phrase: "J.,"

Phrase: "Frangione,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Holtzman,"

Phrase: "D."
Processing 00000000.tx.754: M., Miller, C. 

Phrase: "M."

Phrase: ","

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.755: A., Strickland, D. 

Phrase: "A.,"

Phrase: "Strickland,"

Phrase: "D."
Processing 00000000.tx.756: K., Ghiso, J., and Zlokovic, B. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ghiso,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Zlokovic,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.757: V. 

Phrase: "V."
Processing 00000000.tx.758: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.759: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.760: Invest. 

Phrase: "Invest."
Processing 00000000.tx.761: 106, 1489-1499[Abstract/Free FullText] 54. 

Phrase: "106,"

Phrase: "1489-1499"

Phrase: "[Abstract/Free FullText"

Phrase: "] 54."
Processing 00000000.tx.762: Ulery, P. 

Phrase: "Ulery,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.763: G., Beers, J., Mikhailenko, I., Tanzi, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Beers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004922:Beers [Food]

Phrase: "J.,"

Phrase: "Mikhailenko,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Tanzi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.764: E., Rebeck, G. 

Phrase: "E.,"

Phrase: "Rebeck,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.765: W., Hyman, B. 

Phrase: "W., Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.766: T., and Strickland, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Strickland,"

Phrase: "D."
Processing 00000000.tx.767: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.768: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.769: Biol. 

Phrase: "Biol."
Processing 00000000.tx.770: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.771: 275, 7410-7415[Abstract/Free FullText] 55. 

Phrase: "275,"

Phrase: "7410-7415"

Phrase: "[Abstract/Free FullText"

Phrase: "] 55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.772: Barrett, A. 

Phrase: "Barrett,"

Phrase: "A."
Processing 00000000.tx.773: J., and Starkey, P. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Starkey,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.774: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.775: (1973) Biochem. 

Phrase: "(1973"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.776: J. 

Phrase: "J."
Processing 00000000.tx.777: 133, 709-724[Medline] [OrderarticleviaInfotrieve] 56. 

Phrase: "133,"

Phrase: "709-724"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 56."
Processing 00000000.tx.778: Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H. 

Phrase: "Iwata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tsubuki,"

Phrase: "S."

Phrase: ","

Phrase: "Takaki,"

Phrase: "Y.,"

Phrase: "Watanabe,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sekiguchi,"

Phrase: "M."

Phrase: ","

Phrase: "Hosoki,"

Phrase: "E.,"

Phrase: "Kawashima-Morishima,"

Phrase: "M."

Phrase: ","

Phrase: "Lee,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.779: J., Hama, E., Sekine-Aizawa, Y., and Saido, T. 

Phrase: "J.,"

Phrase: "Hama,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1291910:HAMA [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1295018:HAMA [Laboratory Procedure]
  1000   C3541258:HAMA [Intellectual Product]

Phrase: "E.,"

Phrase: "Sekine-Aizawa,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.780: C. 

Phrase: "C."
Processing 00000000.tx.781: (2000) Nat. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.782: Med. 

Phrase: "Med."
Processing 00000000.tx.783: 6, 143-150[CrossRef][Medline] [OrderarticleviaInfotrieve] 57. 

Phrase: "6,"

Phrase: "143-150"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 57."
Processing 00000000.tx.784: Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. 

Phrase: "Iwata,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tsubuki,"

Phrase: "S."

Phrase: ","

Phrase: "Takaki,"

Phrase: "Y.,"

Phrase: "Shirotani,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lu,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024171:LU [Body System]
  1000   C0024176:LU [Geographic Area]
  1000   C2697939:LU [Quantitative Concept]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gerard,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.785: P., Gerard, C., Hama, E., Lee, H. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Gerard,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Hama,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1291910:HAMA [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1295018:HAMA [Laboratory Procedure]
  1000   C3541258:HAMA [Intellectual Product]

Phrase: "E.,"

Phrase: "Lee,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.786: J., and Saido, T. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Saido,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.787: C. 

Phrase: "C."
Processing 00000000.tx.788: (2001) Science 292, 1550-1552[Abstract/Free FullText] 58. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Science 292,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1550-1552"

Phrase: "[Abstract/Free FullText"

Phrase: "] 58."
Processing 00000000.tx.789: Mukherjee, A., Song, E., Kihiko-Ehmann, M., Goodman, J. 

Phrase: "Mukherjee,"

Phrase: "A.,"

Phrase: "Song,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "E.,"

Phrase: "Kihiko-Ehmann,"

Phrase: "M."

Phrase: ","

Phrase: "Goodman,"

Phrase: "J."
Processing 00000000.tx.790: P., Jr., Pyrek, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Pyrek,"

Phrase: "J."
Processing 00000000.tx.791: S., Estus, S., and Hersh, L. 

Phrase: "S."

Phrase: ","

Phrase: "Estus,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Hersh,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.792: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.793: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.794: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.795: 20, 8745-8749[Abstract/Free FullText] 59. 

Phrase: "20,"

Phrase: "8745-8749"

Phrase: "[Abstract/Free FullText"

Phrase: "] 59."
Processing 00000000.tx.796: Tucker, H. 

Phrase: "Tucker,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.797: M., Kihiko, M., Caldwell, J. 

Phrase: "M."

Phrase: ","

Phrase: "Kihiko,"

Phrase: "M."

Phrase: ","

Phrase: "Caldwell,"

Phrase: "J."
Processing 00000000.tx.798: N., Wright, S., Kawarabayashi, T., Price, D., Walker, D., Scheff, S., McGillis, J. 

Phrase: "N., Wright,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1261259:Wright [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "S."

Phrase: ","

Phrase: "Kawarabayashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "D."

Phrase: ","

Phrase: "Scheff,"

Phrase: "S."

Phrase: ","

Phrase: "McGillis,"

Phrase: "J."
Processing 00000000.tx.799: P., Rydel, R. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Rydel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.800: E., and Estus, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Estus,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.801: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.802: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.803: 20, 3937-3946[Abstract/Free FullText] 60. 

Phrase: "20,"

Phrase: "3937-3946"

Phrase: "[Abstract/Free FullText"

Phrase: "] 60."
Processing 00000000.tx.804: De Strooper, B., Van Leuven, F., and Van den Berghe, H. 

Phrase: "De Strooper,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Van Leuven,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Van den Berghe,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0178587:DEN [Quantitative Concept]
   827   C0557775:Van [Manufactured Object]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.805: (1992) FEBS Lett. 

Phrase: "(1992"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.806: 308, 50-53[CrossRef][Medline] [OrderarticleviaInfotrieve] 61. 

Phrase: "308,"

Phrase: "50-53"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 61."
Processing 00000000.tx.807: Hall, S. 

Phrase: "Hall,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.808: W., Humphries, J. 

Phrase: "W., Humphries,"

Phrase: "J."
Processing 00000000.tx.809: E., and Gonias, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Gonias,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.810: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.811: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.812: Biol. 

Phrase: "Biol."
Processing 00000000.tx.813: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.814: 266, 12329-12336[Abstract/Free FullText] 62. 

Phrase: "266,"

Phrase: "12329-12336"

Phrase: "[Abstract/Free FullText"

Phrase: "] 62."
Processing 00000000.tx.815: LaMarre, J., Hayes, M. 

Phrase: "LaMarre,"

Phrase: "J.,"

Phrase: "Hayes,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.816: A., Wollenberg, G. 

Phrase: "A.,"

Phrase: "Wollenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.817: K., Hussaini, I., Hall, S. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hussaini,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Hall,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.818: W., and Gonias, S. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Gonias,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.819: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.820: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.821: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.822: Invest. 

Phrase: "Invest."
Processing 00000000.tx.823: 87, 39-44[Medline] [OrderarticleviaInfotrieve] 63. 

Phrase: "87,"

Phrase: "39-44"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 63."
Processing 00000000.tx.824: Crookston, K. 

Phrase: "Crookston,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.825: P., Webb, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Webb,"

Phrase: "D."
Processing 00000000.tx.826: J., Lamarre, J., and Gonias, S. 

Phrase: "J.,"

Phrase: "Lamarre,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Gonias,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.827: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.828: (1993) Biochem. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.829: J. 

Phrase: "J."
Processing 00000000.tx.830: 293, 443-450[Medline] [OrderarticleviaInfotrieve] 64. 

Phrase: "293,"

Phrase: "443-450"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 64."
Processing 00000000.tx.831: Philip, A., and O'Connor-McCourt, M. 

Phrase: "Philip,"

Phrase: "A.,"

Phrase: "and"

Phrase: "O'Connor-McCourt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.832: D. 

Phrase: "D."
Processing 00000000.tx.833: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.834: Biol. 

Phrase: "Biol."
Processing 00000000.tx.835: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.836: 266, 22290-22296[Abstract/Free FullText] 65. 

Phrase: "266,"

Phrase: "22290-22296"

Phrase: "[Abstract/Free FullText"

Phrase: "] 65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]
Processing 00000000.tx.837: Herz, J., Goldstein, J. 

Phrase: "Herz,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439482:Herz [Quantitative Concept]

Phrase: "J.,"

Phrase: "Goldstein,"

Phrase: "J."
Processing 00000000.tx.838: L., Strickland, D. 

Phrase: "L., Strickland,"

Phrase: "D."
Processing 00000000.tx.839: K., Ho, Y.K., and Brown, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "Y.K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.840: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.841: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.842: Biol. 

Phrase: "Biol."
Processing 00000000.tx.843: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.844: 266, 21232-21238[Abstract/Free FullText] Copyright  2002 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "266,"

Phrase: "21232-21238"

Phrase: "[Abstract/Free FullText"

Phrase: "] Copyright  2002 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

